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Abstract 
The mechanism(s) responsible for the cardiotoxicity of CO are not clear and do not 
appear to arise solely from tissue hypoxia. Tissue hypoxia is produced by CO binding to 
haemoglobin and reducing the amount of oxygen carried by the blood in vivo. CO-induced 
hypoxia in vivo may be responsible for producing conditions such as those found during 
ischaemia/reperfusion (l/R) injury. Reactive oxygen species (ROS) produced during l/R 
injury is established and responsible for cellular/tissue damage from the oxidative 
damage. We postulate that oxidative stress is responsible for the CO-associated cardiac 
morbidities found in some cases following severe acute exposure to CO. 
Isolated perfused rat hearts were used to investigate the physiological and biochemical 
changes in hearts following CO exposure. Hearts were perfused with buffer equilibrated 
with different mixtures of CO (0-0.05% CO for 30 minutes) in the presence of 2 1 % oxygen 
during and after CO exposure (for 90 minutes), i.e. normoxic conditions were used 
throughout. Some hearts were perfused with water-soluble antioxidants (ascorbic acid and 
TroloxC) before and during the CO exposure. The reduced heart rate and perfusate flow 
suggest that CO may have a direct effect in heart tissue. Biochemical measurements 
suggest that no tissue hypoxia occurred under these conditions. The results provide 
evidence to suggest that oxidative stress occurred in ventricle tissue after CO exposure 
and was attenuated by the antioxidants. However, isolated rat liver mitochondria exposed 
to CO and/or hyperoxia showed no ROS production suggesting that mitochondria may not 
be a source of the oxidative stress. 
CO exposure may also produce altered myocardial energetics by oxidatively modifying 
and/or binding to myoglobin. Tissue damage initiated by CO-induced oxidative stress and 
hypoxia may potentiate ageing within heart tissue in vivo and could be responsible for 
producing the observed CO-associated heart morbidity in an MR-like injury. 
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1.1 Background 
Carbon monoxide (CO) is an odourless, tasteless, non-irritant, and colourless gas that 
diffuses across lung alveoli with relative ease compared to oxygen (Traber & Bradford, 
1996). Natural gas contains no CO, whereas coal gas has ca. 8% CO by volume (de Vries 
a/., 1977). CO intoxication is the leading cause of unintentional death in the United 
States (Varon & Marik. 1997) and these properties of CO have led this gas to be termed a 
'silent killer" (Henry, 1999). Admissions to hospital with CO poisoning are largely from fire 
smoke Inhalation, suicide attempts and faulty heating systems (Cobb & Etzel, 1991). CO 
exposure can also occur as a result of smoking cigarettes (Allred et a/., 1989; Zevin a/., 
2001). 
Fire smoke comprises a mixture of gases depending on the fuel source undergoing 
pyrolysis (Bucci et a/., 1978). These include hydrogen cyanide and other irritants (Kulig. 
1991; Kulling. 1992; Shusterman et a/., 1996). Chemical solvents affect hepatic 
metabolism; a classic exannple Is the production of cyanide via the microsomal 
metabolism of aliphatic nitriles, which was shown to be potentiated by acetone and 
inhibited by CO (Freeman & Hayes, 1988; Scolnick et a/.. 1993; Wlllhite & Smith. 1981). 
Fire victims have a significant correlation between blood cyanide and CO concentrations 
(Baud et a/.. 1991). The inhalation of dichloromethane (DCM), a solvent used In many 
applications, produces endogenous CO through Its metabolism by oxidative dechlorination 
(see 1.4.2.1). CO is widespread in domestic fire smoke and is recognized as a major 
determinant of patient survival after fire smoke inhalation (Traber & Bradford. 1996). CO Is 
a toxic by-product arising from the incomplete combustion of carbon containing 
(carbonaceous) materials (Levasseur a/., 1996). The lethal effects of combustion 
products were first mentioned by Aristotle In 3 BC (Weaver, 1999): 
"Coal fumes lead to heavy head and death." 
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Exposure to CO during pregnancy (from the maternal inhalation of fire smoke, 
environmental exposure, or smoking) can damage the developing foetus in utero, 
producing cardiac defects, and limiting the newborns' growth and development (Finette et 
a/.. 1998; Ginsberg & Myers, 1976; Nelson, 2001; Sozzi & Pierotti. 1998). It has also been 
found to alter nerve myelination and vascular reactivity; and change dopaminergic 
transmission associated with impaired sexual behaviour in newborn male rats intoxicated 
during prenatal CO exposure (Cagiano et a/.. 1998; Carratu et a/.. 2000a; Montagnani et 
ai, 1996). Sphingomyelin homeostasis is impaired in the peripheral nervous system of 
male rats. These rat brains showed no altered metabolism of sphingomyelin precursors 
after prenatal exposure to CO (Carratu et a/., 2000b). Severe acute exposure to CO can 
cause foetal death or toxic effects such as anatomical defomiities and dysfunction 
(Norman & Halton. 1990). 
Blood [COHb] are elevated in smokers and urban populations due to CO inhalation. 
Smoking tobacco may initiate angina pectoris as a result of the inhaled CO (Oram & 
Sowton, 1963). Chronic smokers have blood COHb levels ranging from 4 to 6%; this can 
augment myocardial hypoxia due to the nicotine-induced coronary vasoconstriction 
(Walden & Gottlieb, 1990). Some workers have reported these levels to be higher, with 
blood COHb levels approaching 14% in heavy smokers compared to the 1-2% in non-
smokers (Loennechen et a/.. 1999). 
CO toxicity in mammals was solely attributed to tissue hypoxia from CO binding to 
haemoglobin (Turner a/., 1999). CO binds to the ferrous haem of haemoglobin (Hb) with 
a greater affinity (ca. 250 times) relative to oxygen. Therefore, hypoxia results due to the 
decreased oxygen carrying capacity of the erythrocytes (Shimosegawa et a/., 1992; and 
described in 1.2.1). Oxygen combines with Hb ca. ten times faster than CO, although CO 
dissociates very slowly from COHb due to its high affinity for Hb (Killick. 1940). CO binds 
to other haem-containing proteins (haemoproteins) and this binding is also considered to 
play a major role in the cellular toxicity of CO (Somogyi et a/., 1981). One such 
mitochondrial haemoprotein is cytochrome c oxidase whose function is in cellular 
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respiration (see 1.4.2.3). This inhibition of cytochrome c oxidase leads to impaired cellular 
function by the limited cellular respiration (Kulling, 1992). 
The literature presented (in this chapter) emphasizes the severity of CO poisoning and 
that CO toxicity does not result solely from tissue hypoxia, and that it may also have direct 
toxic effects. This chapter will conclude with the hypothesis (1.7), and the overall aim and 
objectives (1.8) of the research that are described in later chapters (1.9). 
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1.2 Clinical Symptoms of CO Poisoning 
CO intoxication is difficult to diagnose from the clinical symptoms (Table 1.1). Chronic 
exposure to CO can produce flu-like symptoms, headaches, fatigue, visual disturbances, 
diarrhoea and are easily mistaken for other ailments (Meredith & Vale, 1988; MIn, 1986; 
Raub et a/., 2000). It is estimated that nearly one third of all the cases of CO poisoning are 
undiagnosed (Hardy & Thom, 1994). The symptoms shown in Table 1.1 have been 
classified into behavioural and physiological to highlight the severity and diversity of CO 
poisoning. 
Levels of CO can accumulate rapidly in the workplace due to poor ventilation and can be 
responsible for poor health. Racing drivers have poor psychomotor performance due to 
CO and heat exposure, i.e. analogous to house fire conditions (Walker et a/., 2001). 
Muscle necrosis has been observed in several cases of CO poisoning and 
rhabdomyolysis has been found in a patient following the secondary exposure to CO from 
inhaling fire smoke (Finley et a/., 1977; Shapiro et a/., 1989) Severe acute exposure to CO 
can cause heart failure (Ginsberg & Myers. 1976). Autopsy has showed signs of 
circulatory failure in 45% of cases following acute CO poisoning (Marek & Piejko, 1972). 
Other uncommon symptoms can be found in the references cited in this section (1.2). 
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Physiological presentation Behavioural changes 
Abnormal ECG traces 
Cardiorespiratory arrest 
Convulsions 
Fever 
Gastroenteritis 
Hypotension 
Leukocytosis 
Necrosis of the globus pallidus 
Urinary incontinence 
Cerebral, cerebellar, and mid-brain damage 
(e.g. Parkinsonism and akinetic mutism) 
Hallucinosis 
Memory impairment 
Mood swings 
Reduced level of consciousness 
Verbal and/or physical aggression 
Table 1.1 Common symptoms observed after CO inhalation that could be misdiagnosed. 
These physiological and behavioural symptoms were taken from Chiodi at at. (1941); 
Gorman et a/. (1992); Kulling (1992); Meredith & Vale (1988); and Min (1986). 
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1.2.1 Carboxyhaemoglobin (COHb) 
Haemoglobin (Hb) is the oxygen carrying haemoprotein in blood cells that transports 
oxygen to the tissues (Goldbaum ef a/., 1976). Other than canying oxygen, Hb behaves 
as a buffer in erythrocytes contributing to the bicarbonate-carbonic acid buffering system. 
The dissociation of oxygen (O2) from oxyhaemoglobin (Hb02) controls (to some degree) 
the amount of carbon dioxide that can be carried by the blood (Dawber & Moore. 1980). 
CO binding to Hb produces carboxyhaemoglobin (COHb), producing a leftward shift in the 
oxygen-dissociation curve with increasing blood [COHb] (see Figure 1.1); therefore, 
resulting in tissue hypoxia (Roughton & Darling. 1944). The sigmoidal characteristic of the 
oxygen dissociation curve (in the absence of any CO) is due to the cooperative nature of 
the haemoglobin molecule, with oxygen being released (at tissues) under low partial 
pressures of arterial oxygen (Roughton, 1970). COHb reduces the dissociation of oxygen 
already bound to Hb, therefore, potentiating tissue hypoxia (Broome at., 1988). The 
binding of CO to the widely found normal adult haemoglobin, i.e. haemoglobin A (Hb A) 
has been considered. It should be mentioned for completeness that Hb taken from sickle 
cell containing blood (Hb S) has a small significant difference in the relative affinity for CO 
(Rodkey et a/., 1974). The lower oxygen carrying capacity of Hb in these blood conditions 
could exacerbate CO poisoning (Chevalier et a/., 1963; Rodkey et a/., 1969). 
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Figure 1.1 The oxygen dissociation curve for haemoglobin in the presence of carbon 
monoxide (CO). The plots show a loss of the sigmoidal relationship with increasing CO 
levels. The blood levels of COHb are 0. 10. 25. 50 and 75% are shown by I, II, III. IV and 
V. respectively. (The illustration is taken from: 
http://www.phymac.med.wayne.edu/facultyprofile/penney/COHQ/coHaldane1.htm). 
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The percentage of COHb and observed symptoms following exposure to CO is shown in 
Table 1.2. Blood [COHb] can indicate exposure to CO. The level cannot Indicate the 
severity of the poisoning, predict the outcome, or suggest a suitable protocol for treatment 
(Brown a/., 1996; Dolan, 1985; Hardy & Thom, 1994; Raub et a/., 2000; Scheinkestel et 
a/., 1999; Wald ef a/., 1981). 
CO level In air Estimated range of Effects 
(^ppm) COHb in blood (%) 
100 10 to 20 Mild headache within 4-6h; and a shift 
towards anaerobic metabolism. 
200 25 to 35 Mild frontal headache within 2-3h; 
nausea and syncope; mild exertional 
dyspnoea; and gastroenteritis. 
400 40 to 45 Severe frontal headache; nausea within 
2-3h; and visual disturbances. 
600 55 to 65 Severe headache; nausea in 1h; 
unconscious in 2-3h with death after 4h; 
and seizures and coma. 
800 > 60 Unconscious after 1h with death in 2-3h; 
cardiopulmonary dysfunction and death. 
Table 1.2 Steady-state concentration of blood carboxyhaemoglobin (COHb) following the 
inhalation of carbon monoxide (CO) produces symptoms above COHb levels of 10% 
(Meredith & Vale, 1988). The relationship between the CO concentration in alveolar 
breath and the blood COHb level is linear (with a correlation coefficient of 0.97) in 
smokers and non-smokers (Wald et a/., 1981). The above data was compiled from Raub 
et ai (2000); Scharf ef at. (1974); and Varon & Marik (1997). 
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1.3 Treatment for CO Toxicity 
The obvious rationale for treatment is to alleviate the CO-induced tissue hypoxia. CO 
toxicity and the presence of COHb in the blood has led to using artificial blood to deliver 
oxygen. Rats whose blood was replaced by a fluorocarbon substitute, that can carry 
seven percent of oxygen by volume, showed no symptoms of CO poisoning despite being 
exposed to 10% CO (Broome et a/., 1988). The primary treatment of CO intoxicated 
victims is to remove the CO before it causes any morbidity. Hyperbaric oxygen therapy is 
the chosen treatment for victims of CO poisoning (below). 
1.3.1 Hyperbaric Oxygen Therapy (HBOT) 
Hyperbaric oxygen therapy (HBOT) comprises exposing the patient to 100% O2 at 
pressures ranging from 2-2.8 atmospheres (atm). All liquids have the ability to dissolve 
gases; blood exposed to pure oxygen at 38°C and 1 atm will dissolve approximately 2.3ml 
of oxygen in 100ml, and twice as much oxygen if the pressure is doubled in accordance to 
Henry's Law (End & Long, 1942). High pressures are used to increase the amount of 
dissolved oxygen into the blood and so displace CO from haemoglobin within erythrocytes 
(Smith & Sharp, 1960) and provide oxygen to hypoxic tissues. 
The elimination of CO is increased when HBOT is performed compared to normoxic 
oxygen therapy (100% at 1 atm) or breathing air with half-lives (ti/2) of 23. 80, and 320 
minutes, respectively (Myers et a/., 1985; Scheinkestel et a/.. 1999). This treatment 
appears beneficial with reference to the increased elimination and symptoms of CO 
poisoning (Table 1.1); therefore, this is the rationale for its clinical use. However, this 
treatment is restricted to the facilities that are available at the administered hospital, and 
guided by the protocol(s) that are based on previous cases of CO and fire smoke 
inhalation (Broome etai, 1988). 
HBOT is used as supplementary therapy in other conditions such as wound healing, 
arterial gas embolism, calciphylaxis (Dean & Werman; 1998), regeneration of nerves 
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(Haapaniemi et a/., 1998), reversing radiation-induced progressive obliterative endarteritis 
of small blood vessels (Baert et a/., 1998), decompression sickness and it is a primary 
treatment for symptomatic fire smoke victims (Hammarlund & Sundberg, 1994; Kindwall, 
1993; Rogatsky et a/.. 1999; Uhl et a/., 1994). The protocol(s) used for treating fire smoke 
victims varies between hospitals due to the differing experiences encountered by the 
hyperbaric teams. Oxygen inhaled at 3 atm occupies 6.4-6.6 ml of blood per 100ml; this is 
similar to the volume of oxygen used by tissues upon one pass through the capillary bed. 
This pressure is assumed to supply an adequate level of oxygen to the tissues during 
hypoxia resulting from the formation of COHb during intoxication (Davis & Hunt. 1977; 
End & Long, 1942). Haldane (1895) failed to recognise the therapeutic benefits of HBOT 
while studying mice. In these experiments, mice with fully saturated Hb by CO poisoning, 
were subjected to oxygen under pressure (2 atm). The results showed live mice after HBO 
was administered relative to the dead mice (in controls) that were given air (End & Long, 
1942). 
1.3.2. Risks of HBOT 
The work carried out by Bert in 1878 (as described in End & Long, 1942) studied 
"excessive pressures" on various small animals. Pneumonia or convulsions were 
observed in these animals and attributed to oxygen toxicity. There are risks of oxygen 
convulsions during routine HBOT, although this associated risk is low at ca. 3% (Hampson 
et a/., 1996). The data (from 300 patients) studied by Hampson and workers showed that 
increasing the pressure (2.45-3 atm) during HBOT significantly increased the likelihood of 
seizures. A/-methyl D-aspartate (NMDA) receptor antagonists have been shown to delay 
the incidence of these HBO-induced convulsions in male Sprague-Dawley rats (Dale et 
a/., 2000). The body tissues receive an adequate oxygen supply during HBOT. However, 
some cells/tissues may not be able to utilise this oxygen (due to metabolic inhibition) 
thereby resulting in localized tissue hyperoxia. CNS injury due to CO poisoning often 
requires the use of higher pressures than normally used and may produce further injury 
from oxygen toxicity. The work by Shilling and Adams in 1935 showed oxygen inhalation 
at 4 atm to be dangerous. However, it could be used at 3 atm for up to three hours and 
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even longer periods at lower pressures (End & Long. 1942). Morbidity following CO 
intoxication in man occurs commonly through a loss of higher mental functioning and 
depression (Gorman etal., 1992). 
Jiang & Tyssebotn (1997) showed that HBOT improved the "short-term" outcome 
assessed by mortality and neurological morbidity in rats exposed to CO (0.27% in air for 
1h) compared to NBO treated rats. Lipid peroxidation in the rat brain following CO 
exposure was prevented by HBOT (3 atm for 45min). HBOT prevented the conversion of 
xanthine dehydrogenase (XDH) to xanthine oxidase (XO). which is known to be activated 
by leukocytes and so prevented the leukocyte-associated myeloperoxidase activity 
(Thom, 1993). However, treatment in this case with 1 or 2 atm HBO, or 3 atm normoxic 
gas (7% O2) did not prevent the observed CO-mediated lipid peroxidation. Oxidative 
stress (1.5) has been reported following HBO exposure (Bearden et al., 1999). 
Changes have been observed in the lens nuclei within the eyes of guinea pigs treated with 
HBO. These observations are typical of those occurring naturally over time and were 
attributed to cytoskeletal proteins being oxidised due to HBO (Padgaonkar ef a/., 1999). 
Acute exposure of HBO is shown to cause significant reversible changes in Sprague-
Dawley rat erythrocyte rheology and morphology (Amin et al., 1995). Some patients have 
been found to undergo middle ear trauma associated with HBOT (Blanshard et al., 1996). 
Oxygen under high pressures can inhibit nucleic acid synthesis (Rueckert & Meuller. 
1960) and shown to produce DNA damage on the first treatment followed by an adaptive 
response after subsequent treatments (Dennog et al., 1999; RothfuB et a/., 1998). HBO is 
also shown to be mutagenic in mouse lymphoma cells (Rothfuss et al., 2000). Increased 
oxygen tensions can enhance NaVK*-ATPase in the brain and impair the vital electrolyte 
balance (Schmit & Gottlieb, 1982). 
1.3.3 Pregnancy and HBOT 
The use of HBOT during pregnancy is still under debate, however, some pregnant women 
have had HBOT following fire smoke inhalation (Brown et al., 1992). Early work by Telford 
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et al. (1969) showed foetal wastage (as assessed by foetal reabsorption) in rats subjected 
to HBOT (2 atm for 6h) (Van Hoesen et al., 1989). There is evidence to support and 
contradict the use of HBOT during pregnancy. Some literature suggests that foetuses are 
resistant to CO poisoning (Gasche et a/.. 1993; Mathieu a/.. 1996). However, a study on 
foetal outcome following accidental CO exposure concluded that there were short and 
long-term risks due to the increased accumulation of CO in the foetus relative to the 
mother, and a slower elimination of CO by the foetus with respect to the maternal 
circulation (Gabrielli et al. 1995; Koren et a/., 1991). Ethical consideration preclude human 
experiments in this area. 
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1.4 CO & The Myocardium 
The brain and myocardial tissues require oxygen for their function and to sustain life. The 
high oxygen demand by these tissues limits their tolerance to hypoxia and so they are 
considered target organs for C O poisoning (Cramlet a/., 1975; Silver a/., 1996). Klebs 
first noted the involvement of the heart in C O poisoning by recording tachycardia and 
arrhythmias. He also observed punctiform and diffuse haemorrhages In the pericardium 
and endocardial tissues (Ehrich et a/., 1944). The follow i^ng will highlight some 
physiological and biochemical changes that occur In the myocardium due to C O exposure. 
1.4.1 Physiological C h a n g e s In T h e Heart 
Cardiac complications after C O exposure (Table 1 .1) arise following changes in the 
myocardium induced during and/or after C O exposure. 
1.4.1.1 Electrocardiogram and tissue abnormalities 
Contractile changes suggest immediate damage from C O as shown by changes In 
electrocardiography ( E C G ) traces. Ehrich et a/. (1944) described an alteration in the T-
waves and S-T segments of stray dogs that had inhaled C O . The T-wave changes 
Included depression and inversions, however, permanent negative T-waves were evident 
when the [COHb] in blood was increased to 70-75%. Elevated R-T segment was observed 
at 40% COHb and heart block occurred when [COHb] exceeded 75%. These workers also 
found similar T-wave changes after the transfusion of CO-saturated erythrocytes. 
Microscopic examination of the CO-exposed hearts showed haemorrhages and necrotic 
regions. However, these workers also concluded degenerative changes in individual 
muscle fibres based on their observations. Prenatal exposure to 0.0075 and 0.015% C O 
altered developmental changes in Ion channels responsible for the electrical properties of 
muscle fibres in newborn rats (Carratu et a/.. 1993; De Luca a/.. 1996). C O has caused 
direct smooth muscle relaxation in a number of tissue preparations (Cotpaert a/., 2002). 
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Other studies conducted in man also show similar damage from C O poisoning (Kjeldsen 
et a/., 1974; Middleton et a/., 1961). Anderson et at. (1967) found Inverted T-waves. 
depressed S-T segment and a prolonged Q-T period in several c a s e s . Follow-up of these 
c a s e s in victims who survived showed normal E C G trace recovery after periods ranging 
from 1 day to 2.5 months. Postmortem of the heart (in one case ) showed degenerative 
focal lesions throughout the heart, although predominantly in the left ventricle. Swollen 
and necrotic muscle fibres were observed with inflammatory cells in a few regions. Other 
workers have reported atrial fibrillation and intraventricular block (Cosby & Bergeron, 
1963; Hayes & Hall. 1964; Middleton et a/.. 1961; Stearnes a/., 1938). Focal areas of 
leukocyte aggregation and punctate haemmorhages are observed in heart tissue after C O 
exposure (GOrich, 1926; Klebs, 1865). 
1.4.1.2 Heart disease and CO exposure 
Patients with atherosclerotic cardiovascular disease are at increased risk of morbidity after 
C O intoxication. The depressed coronary blood flow (prevalent in this condition) cannot 
compensate for the required increase in coronary flow (CF) during elevated myocardial 
oxygen demand, such as in (myocardial) hypoxia caused by intense exercise, high 
altitude or C O exposure (DeBias et a/., 1976). Allred et al. (1989) showed that blood 
[COHb] of 2 and 3.9% in coronary artery disease (CAD) patients decreased the time of 
onset to angina by 4.2% and 7.1%, respectively. Similar findings have been reported in 
studies using patients with ischaemic heart disease (Anderson et a/.. 1973; Aronow & 
Isbell, 1973; Aronow. 1981; Sheps etaL, 1987). 
C O has been directly implicated by several groups in inducing myocardial infarction (Ml), 
although these findings are rare. Ebisuno et al. (1986) reported the c a s e of a 28-year old 
male who suffered a Ml after C O poisoning. The diagnostic evidence ( E C G trace, serum 
enzyme profile and scintigrams) reported for this case led these workers to conclude a Ml 
attributed to CO-induced hypoxia. These workers suggested that C O may induce coronary 
vasospasm or increase thrombotic formation by decreasing blood flow; therefore, 
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producing a Ml from the reduced myocardial oxygen supply. Similar findings have been 
reported by Anderson et a/. (1967); Ayres et a/. (1970); Marius-Nunez (1990); and Scharf 
et a/. (1974). 
Ayres et al. (1970) showed the development of angina pectoris in patients who showed no 
previous arteriographic evidence for CAD. They concluded that myocardial hypoxia arising 
from COHb may be responsible for producing the symptoms of angina pectoris. Scharf et 
ai (1974) estimated the maximum concentration of blood [COHb) to be 15-25% at the 
onset of symptoms and concluded that this level could cause cardiac alterations as 
a s s e s s e d by E G G traces, and was responsible for the observed transmural Ml. Physical 
exertion increases the ventilatory rate and subsequently the rate of uptake of C O . A study 
using firefighters found that a fixed level of atmospheric C O (0.03%) could quickly elevate 
the blood [COHb] to lethal levels (Griggs, 1977). An epidemiological study has shown that 
the cardiac mortality rate for tunnel workers was greater than bridge officers (in New York) 
due to the higher levels of C O found in the tunnels (Stern a/., 1988). 
1.4.1.3 Haemodynamic changes 
C O poisoning in vivo produces cardiac morbidity and/or mortality. Immediate 
cardiovascular changes during C O exposure occur to compensate for the CO-induced 
hypoxia in vivo. Long-tenn change(s) are difficult to predict because of affected 
myocardial tissue from the initial C O insult {1.4.1.1 and 1.4.1.2). Haemodynamic changes 
in the absence of C O are regulated principally by the oxygen demand. Therefore, factors 
such as gaseous exchange, temperature, hormonal status and cardiac output (a reflection 
of the work rate) are constantly changing to maintain the oxygen demand of the tissues. 
Forbes et al. (1945) showed the relationship between COHb saturation and ventilation 
rate, duration of inhalation and the percentage fraction of inspired C O . Tachycardia is 
observed during acute exposure to C O in both anaesthetized and conscious dogs and 
rats. This response appears to be dependent on the [COHb] (Penney, 1988). However, 
this reflex change in heart rate during C O exposure is not consistent (Penney et a/.. 
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1979). Dogs exposed to C O developed bradycardia, although this was later normalised to 
a regular rhythm by pacing the heart (Dergal et a/., 1976). 
Other findings also support cardiovascular changes during CO-induced hypoxia. Sylvester 
et a/. (1979) showed the stroke volume (SV) increased accordingly (in response to C O 
exposure) in anaesthetized paralysed dogs with a constant ventilation rate. Similar 
responses have been observed in the rat model when maintained in a narrow COHb 
range or increasing the blood [COHb] (Kanten a/., 1983; Penney et a/.. 1979). 
Extrapolation to larger mammals would be expected to give similar findings, however, 
discrepancies have been found. Some workers have observed no change in S V in 
humans with symptomatic levels of COHb at rest or during exercise (Klausen et a/.. 1968; 
Vogel & Gleser, 1972). The lack of response observed in larger mammals such as 
humans, monkeys and dogs compared to the rat model, could be attributed to changes in 
peripheral resistance (or afterioad) (Penney. 1988) or metabolic rate. The rate of C O 
uptake required to reach equilibrium with COHb (i.e. saturation) is slower in humans with 
respect to the rodent model (Montgomery & Rubin. 1971) and suggests that S V may be 
related to the rate of reaching maximal blood [COHb]. 
The total volume of blood pumped by each ventricle per minute is called the cardiac 
output and can be calculated from the product of the HR and S V (Vander. 1990). Cardiac 
output (Q) is found to rise in animals acutely or chronically exposed to C O . However, the 
degree of response varies during the post exposure period and between mammal species 
(Penney, 1988). Stewart et a/. (1973) showed a linear increase in Q when the percentage 
of blood saturation of COHb was increased from 0 to 15% in humans. Blood pressure 
(BP) changes due to C O exposure are less predictable and show a wide range of 
response with experimental conditions and animal species. A general decrease in arterial 
BP is observed under acute and chronic C O exposure (Penney, 1988). This C O -
associated hypotension is thought to arise from the local effect of C O causing peripheral 
vasodilation (Coburn. 1979). It should be noted that the normal mechanism in response to 
sensing hypoxia via the carotid body receptors are not stimulated by CO-induced hypoxia, 
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and only from the arterial oxygen tension (Lahirl, 1980). Low blood [COHb] reduce the 
myocardial oxygen consumption in conscious dogs (Adams et a/., 1973). 
Increased blood volume (6V) In c a s e s of chronic C O exposure occurs to maintain an 
adequate delivery of oxygen, and lower the [COHb] by dilution (Penney et a/., 1979; 
Penney et a/.. 1984; Theodore a/., 1971; Wilks et a/., 1959). The changes following 
acute C O exposure have not been found In the literature, however, it seems likely that the 
response may depend upon the degree of hypoxia sustained during exposure. Penney et 
a/. (1984) investigated CO-induced cardiomegaly (see 1.4.1.4) in rat hearts and showed 
that carboxyhaemoglobinaemia was evident for several weeks after the C O exposure had 
ceased. Relevant haemodynamic parameters showed a higher working heart rate. 
Increased blood viscosity and volume, whilst Q remained elevated and hypotension had 
depressed marginally (Penney & Bishop, 1978). The additional work carried out by the 
heart during prolonged hypoxia, either by C O exposure, high-altltude, or high intensity 
exercise may be responsible for the changing heart size (Zak. 1973). Stroke work was 
reported to remain high due to the high blood viscosity (Penney & Baylerian, 1982). The 
Hb content per unit volume of erythrocytes is similar for different mammalian species and 
any discrepancies in C O exposure outcomes may not be accounted for by the difference 
of C O loading in the blood (Enzmann, 1934). 
1.4.1.4 Cardiomegaly 
Cardiomegaly is a term defining an enlargement of the heart (Clubb Jr. et a/., 1986). It is 
established that chronic exposure to C O can Induce cardiomegaly In rats (Penney a/., 
1974a). Cardiomegaly Is produced by CO-induced hypoxia or by hypoxic hypoxia, e.g. 
high-altitude (Penney, 1988). This response is age-dependent and generally shows a 
relatively marked response in younger rats (in utero or neonates) relative to adult rats 
(Styka & Penney. 1978). Cardiac output (Q; 1.4.1.3} is Increased during hypoxia caused 
by C O (or high-altltude) to maintain adequate oxygen delivery to the tissues (Penney 
a/., 1992). This larger workload Is not tolerated by younger hearts and Is considered to be 
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responsible for the greater myocardial enlargement observed in comparison to older rats 
(Penney a/., 1979). 
Chronic exposure (for 32 days) with 0.05% C O showed sex differences in the growth rates 
of rats based on their body weight (BW) (Penney et al., 1982). Male rats had a higher 
growth rate relative to the female group in both air (control) and CO-treated groups. 
However, C O exposure decreased the growth of both sexes, with the greatest difference 
being observed in male rats. The ratio of both ventricles (2V) to BW w a s higher in the C O 
exposure period relative to the control group, indicating an increase in heart size due to 
C O exposure. These findings are similar to those reported by others (Dubeck et at., 1989; 
Penney & Weeks, 1979; Penney a/.. 1988; Penney et al., 1992). CO-induced 
cardiomegaly has been suggested to occur from the combination of rapid haemodynamic 
responses to COHb saturation and long-term changes that occur after C O exposure. 
1.4.1.5 Hypoxia & Cardiac Physiology 
Newborn rat cardiac myocytes exposed to increasing hypoxia show increased cell 
proliferation (Hollenberg et al., 1976). Hypoxia (in foetal lambs) induced by aortic 
constriction produced an enlarged LV with no observed increase in the cross-sectional 
area of the cardiac myocytes (Fishman et al., 1978). This suggests that cardiomegaly 
occurs by hyperplasia (increased cell proliferation) rather than hypertrophy (or increased 
cell mass) . Furthermore, C O exposure in the neonatal period (in Sprague-Dawley rats) 
resulted in elevated myocyte hyperplasia of the ventricles with the greatest increase 
observed in the RV (Clubb Jr. a/., 1986). Hyperplasia has also been observed in adult 
rats chronically exposed to C O . Hyperplasia is greatest in rats exposed to C O during the 
foetal or newborn period (Penney & Weeks, 1979). 
Hypoxia (or CO-induced hypoxia) causes increases in S V and Q to satisfy tissue oxygen 
demand resulting from the depressed oxygen content in the blood (see 1.4.1.3). CO 
increases coronary blood flow to compensate for the myocardial hypoxia from increased 
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blood [COHb] (McGrath, 1984). Increased haematocrit and blood volume are also 
observed in response to chronic C O exposure (Penney et a/., 1992; Wilks et a/.. 1959). 
The overall increase in workload by the heart is thought to contribute in the development 
of cardiomegaly by an elevated preload (Ford, 1976; Penney et a/., 1988). CO-induced 
hypoxia and hypoxic hypoxia are not equivalent; CO-induced hypoxia does alter the 
coronary perfusion, whereas hypoxia (either by C O or hypoxic conditions) produces a 
varying degree of cardiomegaly depending on the degree and duration of hypoxia. 
Hypoxic hypoxia due to high-altitude exposure (or long-term intense exercise) results in 
an elevated pressure loading in the right hand side of the heart inducing RV cardiomegaly 
of the concentric type, where wall thickness is increased (Penney et a/., 1984). Chronic 
C O exposure induces cardiomegaly in an eccentric type, where an increase in lumen 
volume occurs (Penney et a/., 1992). To summarise, chronic LV pressure overioad leads 
to wall thickening and hypertrophy, whereas LV volume overioad is characterised by an 
enlarged chamber (Grossman et a/.. 1975). 
1.4.2 C a r d i a c Biochemistry 
This section will introduce some of the general changes that occur in heart tissue following 
C O intoxication. 
1.4.2.1 Endogenous Production of CO 
CO is produced endogenously via the catabolism of haem products such as haemoglobin 
(Coburn et a/., 1964) and haemin (White. 1970). The C O produced in this two-step 
pathway is responsible for the low levels of C O H b normally found in the blood (Brouard et 
a/., 2000). Figure 1.2 shows the mechanism of C O production via haem metabolism. 
Although C O is produced by this route, this may not actually occur in heart tissue as 
Vreman et at. (1998) found no production of C O in heart homogenates. The role of haem 
oxygenase (HO) is crucial as its inducible form is expressed under conditions of stress 
such as hypoxia and hyperoxia (Dennog et a/., 1999; Marilena. 1997; Padgaonkar et a/.. 
39 
Intnxiuclion 
1997). Cytokines can also induce haem oxygenase (inducible isoform; HO-1) and 
contribute in the production of CO in situ (Manlena, 1997). 
CO is also produced through the metabolism of dichloromethane (DCM). The metabolism 
of DCM proceeds through the cytochrome P450-dependent monoxygenase system and 
requires NADPH and molecular oxygen (Jung. 2002). This detoxif ication of DCM results in 
CO. carbon dioxide and chloride being produced (Wirkner et al., 1997). The detoxifying 
enzyme is identified as the ethanol-inducible form of cytochrome P450. i.e. cytochrome 
P450 2E1 (CYP2E1; Figure 1.3). DCM is also detoxif ied by a glutathione dependent 
pathway that also produces CO (Oh et al.. 2002). Cytochrome P450 is suggested to be 
more inhibited by CO than cytochrome c oxidase, therefore, this may play a role in the 
toxicity of some drugs (Jaffe, 1997). 
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Figure 1.2 The endogenous production of carbon monoxide (CO) through the catabolism 
of haem. The destruction of red blood cells (RBCs) eventually produces haem This is 
enzymatically converted to biliverdin and bilirubin by haem oxygenase ( H O ) and biliverdin 
reductase {BR), respectively. The action of HO produces iron and CO. 
41. 
Chapter I IntriHiuction 
CO is also suggested to be metabolized to CO2 (Tobias et a/.. 1945) by cytochrome c 
oxidase (Breckenridge. 1953). This oxidative pathway is thought to be a minor 
detoxification route in clearing CO from the body, however, this pathway may be 
upregulated under chronic exposure to CO. Mixtures of CO and oxygen have been 
reported to increase the oxygen uptake of rat skeletal and cardiac muscle via its oxidation 
to CO2 (Clark Jr.. 1950). 
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Figure 1.3 The metabolism of dichloromethane (DCM) by cytochrome P450 2E1 
(CYP2E1) produces CO. 
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1.4.2.2 Hypoxia & Hyperoxia 
CO-induced and hypoxic hypoxia produce biochemical changes that undertie the 
physiological changes (described in 1.4.1). The undehying biochemical mechanism(s) of 
these changes are unclear. CO-induced hypoxia may produce metabolic acidosis, 
changes in plasma levels of glucose, a decrease in the myocardial A T P levels and an 
increase in the plasma uric acid levels (Hattori et al., 1990). These particular changes are 
typical of ischaemia/reperfusion and involve oxidative stress (see 1.5 and 1.6) that is 
established to be the likely cause of tissue dysfunction (Korthius et al., 1992). Nitric oxide 
(NO) has also been implicated in various hypoxic conditions. This role of reactive oxygen 
species (ROS; 1.5) and reactive nitrogen species (RNS) such a s NO are established in 
the underlying pathogenesis of many tissues. NO has been shown to lower the myocardial 
oxygen consumption in vivo (Shennan et al., 1997). 
1.4.2.2 Cellular respiration and mitochondria 
CO binds avidly to some haems and its targets include haemoproteins such as Hb, 
myoglobin and cytochrome P450s (Piantadosi, 1987). One such haemoprotein is 
cytochrome c oxidase (or Complex IV) which has an important role in the generation of 
ATP via oxidative phosphorylation. The electron transport chain ( E T C ) has a 'leakage' of 
R O S and so mitochondria are considered a major site of free radical production (Staniek 
& Nohl, 2000). The inhibition of cytochrome c oxidase by C O (binding to the reduced 
haem centre) is suggested to increase R O S production in a similar manner to that 
observed when the E T C is blocked using antimycin (Staniek & Nohl, 1999). This may 
potentiate tissue dysfunction in accordance to the free radical theory of aging. In brief, the 
free radical theory of aging proposes that ageing is a result of deleterious tissue damage 
caused by free radicals. (Cadenas & Davies, 2000; Harman, 1993). These cellular 
conditions suggest that impaired mitochondrial component(s) may contribute to the 
underlying cardiomyopathies and other morbidities associated with C O intoxication 
(Coburn, 1979; Zhang & Piantadosi. 1992). 
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1.4.2.4 Cell Signalling 
The possible involvement of oxidative stress suggests that other diverse mediators may 
be involved as oxidative stress is responsible for stimulating other signalling pathways in 
heart tissue (Omura et a/., 1999; Shin & Murray. 2001; Tanaka et a/.. 2001). These 
include stress kinases, ion homeostasis by disruption of ion-channel regulatory proteins 
and the recruitment of inflammatory mediators. R O S / R N S have been found to initiate 
apoptosis (or programmed cell death; P C D ) and may contribute to cardiac dysfunction 
following C O exposure (Piantadosi et a/., 1997). 
C O is responsible for neuronal signalling and modulating vascular tone (Maines, 1993; 
Marilena. 1997; Seki et a/.. 1997). This precedes through the production of guanosine-
3'.5'-cyclic monophosphate (cGMP) by activating guanylate cyclase ( G C ; Downard et a/., 
1997). cGMP is involved in the recruitment of neutrophils and is enhanced by C O 
(VanUffeten et a!., 1996). In bacteria. C O can regulate gene transcription by binding to 
haemoproteins that serve as sensors (Aono et a/., 1996; Fox et a/., 1996). The M-subunit 
of lactate dehydrogenase (LDH) is increased in the hearts of rats exposed to 0.05% C O in 
air over 42 days (Penney a/., 1974b). C O reduces the number of lysosomes in cultured 
neonatal rat cardiomyocytes (Brenner & Wenzel, 1972). Levels of endothelin-1 (Et-1) are 
increased in heart tissue subjected to chronic C O - or hypoxic hypoxia (Loennechen a/., 
1999). Et-1 is expressed in endothelial cells, cardiomyocytes and fibroblasts of the 
myocardium and this may contribute to endothelial dysfunction, which is an eariy event in 
atherogenesis. and other vascular d iseases such a s heart failure, stroke, and transplant 
vasculopathy. Upregulation of Et-1 is thought to involve the hypoxia-inducible factor-1 (Hif-
1; a haemoprotein). 
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1.5 Oxidative Stress 
In general, any condition that generates free radicals and/or other oxidising species (such 
as reactive oxygen species) or reduces the antioxidant capacity constitutes oxidative 
stress. Reactive oxygen species ( R O S ) comprise the hydroxyl radical ('OH) (VIessis et a/.. 
1991), the superoxide radical (0{ ) (Lebovitz a/.. 1996) and singlet oxygen (^02) (Lee et 
a/., 1999). Hydrogen peroxide (H2O2) is also a R O S , however, it has no unpaired electrons 
and is not classed as a radical (Halliwell & Gutteridge, 1985). These R O S are involved in 
many pathological states and can also regulate cell/tissue function by modulating 
numerous signalling pathways (Russell ef a/., 1989). 
Antioxidant capacity is comprised of enzymatic and non-enzymatic components. 
Enzymatic antioxidants comprise glutathione reductase (GR) and glutathione peroxidase 
(GPX; Reed, 1990), superoxide dismutase (SOD; Fridovich, 1974). and catalase (CAT; 
Das et a/.. 1986). Catalase itself has a high affinity for C O (Coburn, 1979) and this may 
cause oxidative stress by lowering the activity of CAT . Some non-enzymatic components 
include ascorbate (Maranzana & Mehlhorn. 1998). reduced glutathione (Kleinman & 
Richie, 2000), vitamin E (a mixture of the tocopherols; Milchak & Bricker, 2002), albumin 
(Watts & Maiorano. 1999), histidine (Lee et a/.. 1999) melatonin (Kondoh a/.. 2002) and 
bilirubin (Asad et a/.. 2000; and mentioned briefly in 1.4.2.1). Other cellular/tissue non-
enzymatic components are emerging which show protective roles in oxidative stress such 
as adenosine (Maggirwar et a/., 1994). Some of the non-enzymatic antioxidants also 
exhibit pro-oxidant activity. 
The cumulative cascade of oxidant-initiated reactions produces damage to an array of 
biomolecules including structural, contractile, transport proteins, enzymes, receptors, 
lipids and nucleic acids (Halltwell & Gutteridge, 1999). These oxidant-induced changes 
produce a loss of cellular activity or function. For example, the peroxidation of linolenic 
acid in the chains of cardiolipin, can lead to a loss of cytochrome c oxidase activity 
(described briefly in 1.4.2.3) which is critical for cellular function (Soussi et a/.. 1990). The 
widespread occurrence of lipids and ease of peroxidation can yield devastating cell 
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dysfunction via changes in membrane fluidity and cellular compartmentalization. These 
changes can lead to altered membrane receptor mobility, impaired second messenger 
functioning and cause leakage of intracellular enzymes (such as lactate dehydrogenase 
and creatine kinase) into the plasma (Jaffe, 1965; Shapiro et al., 1989). 
Heart tissue is abundant in haemoproteins (typically myoglobin; and pertused by 
erythrocytes containing haemoglobin) that may lose their iron and participate in the 
Fenton reaction (Gutteridge, 1986). The Fenton reaction produces hydroxyl radicals in the 
presence of peroxides and reactive iron (under appropriate conditions). Oxidant-mediated 
damage to structural, transport and contractile proteins in the post-ischaemic myocardium 
and skeletal muscle may explain the contractile dysfunction observed in repertused 
muscle tissue (Korthius a/., 1992; and 1.6). Recent work suggests the role of nitric 
oxide (NO) in causing the negative inotropic responses observed in heart muscle tissue 
(Igarashi et al., 1998; Ohashi et al., 1997). CO-induced hypoxia is shown to produce 
oxidative stress in the mitochondria of rat brains (Zhang & Piantadosi, 1992). Exposure to 
C O produced a 9-fold production of NO in the brains of rats exposed to C O (Ischiropoulos 
et al., 1996). Cigarette smoke is also shown to significantly increase oxidative stress in 
several organs by elevating the level of oxidative adduct 8-hydroxydeoxyguansoine (8-
OHdG; Howard et al., 1998). Oxidative stress could induce DMA damage in the 
organogenesis-stage conceptus that may produce organ dysfunction in utero (Vinson & 
Hales, 2001). 
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1.6 Ischaemia/Reperfusion (l/R) Injury 
In addition to the hypoxic/anoxic injuries caused by C O poisoning in vivo, reoxygenation 
may initiate Its own toxic insult and/or potentiate the damage from C O hypoxia, and 
simulate an Ischaemia/reperfuslon (l/R) like injury. The Ischaemia described In this Injury 
refers to the partial or complete cessation of blood supply to a tissue/organ. This Injury 
has been discussed briefly, in light of the likely hypoxla/reoxygenation subjected to victims 
of fire-smoke inhalation and subsequently treated with hyperbaric oxygen therapy. 
The l/R concept was first described for post-ischaemic intestinal tissue and has since 
been extended to other organs such as the heart, pancreas, liver, kidneys and brain 
(Korthlus et a/.. 1992). The importance of re-establishing an adequate blood supply to 
primarily provide oxygen and nutrients to tissues Is without question. Much evidence has 
established that reperfuslon results in a number of events that cause tissue Injury. Cardiac 
reperfuslon injury is associated with the generation of reactive oxygen species (Das et a/., 
1986; 1.5) and can also Indirectly produce local ischaemia (or hypoxia) through the 'no-
reflow' phenomenon. This event is characterised by capillaries failing to reperfuse once 
blood flow is restored. Minor morphologic changes are seen In the heart during ischaemia 
(Hearse, 1977). Reperfusion injury In the heart is also characterised by major 
ultrastructural changes including cell swelling, release of cytosolic enzymes and 
depressed contractile function. Other findings include a number of electrophysiologic 
abnormalities that can lead to potentially lethal arrhythmias (Hearse, 1977). 
Reperfusion extends the damage associated with Ischaemia and may have a likely role 
during the oxygenation (by HBOT or NBO) in victims of C O intoxication. The initial hypoxia 
caused by COHb formation following C O exposure in vivo may mimic ischaemia at the 
molecular level, the subsequent reoxygenation via HBOT (or NBO) could simulate 
reperfuslon and may be responsible for some cardiac dysfunction found in c a s e s following 
severe C O exposure. 
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Reperfusion of ischaemic tissues is associated with massive leukocyte infiltration (Carden 
& Korthius, 1989). Studies in the small bowel and skeletal muscle have shown that 
neutrophil accumulation after reperfusion is decreased by pretreatment with various 
oxidant scavengers, for example. S O D , CAT, dimethylthiourea (DMTU; Mohazzab-H et 
ai, 1997) and desferrioxamine (Link et al., 1999). These findings implicate reactive 
species in the recruitment of neutrophils to post-ischaemic tissues (Granger, 1988) and 
highlight oxidative damage as a contributing factor in tissue morbidity. The participation of 
many other signalling pathways in heart tissue is also expected to contribute to 
reoxygenation injury (Kuzuya et al., 1993). 
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1.7 Hypothesis 
Inhalation of carbon monoxide (CO) via the lungs introduces C O into the body. The 
inspired C O binds to haemoglobin (Hb) in erythrocytes producing elevated blood [COHb]. 
This process occurs very rapidly owing to its rapid diffusion during gas exchange and its 
high binding affinity for Hb relative to oxygen. The C O H b has a lowered oxygen carrying 
capacity as C O occupies the binding sites for oxygen (described in 1.2). COHb also 
decreases the oxygen dissociation from Hb by altering the functional cooperativity of Hb. 
Therefore, C O poisoning in vivo produces tissue hypoxia that results in a range of 
morbidity depending on the degree (or dose) and duration of C O exposure. 
The high affinity of haemoproteins for C O is thought to contribute to the toxicity of C O . 
The binding of C O to haem groups influences its biochemical toxicity and affects 
cell/tissue function. C O can bind to the reduced cytochrome c oxidase (Complex IV of the 
mitochondrial E T C ) . Inhibition of mitochondrial respiration is thought to produce an 
accumulation of reducing equivalents upstream of Complex IV. Therefore, this results in 
an increased production of R O S , in particular superoxide (02"). Myoglobin (Mb) is thought 
to facilitate the diffusion of O2 in cells (Adachi & Morishima. 1989; Cobum, 1979; Turek et 
al., 1973; Wyman, 1966). C O binding to Mb may limit the intracellular diffusion of oxygen 
to mitochondria for respiration The accumulated O2" is likely to cause oxidative stress and 
lower the antioxidant capacity in affected cells/tissues. 
Tissue hypoxia resulting from the formation of C O H b can be considered to produce 
chemical ischaemia (or hypoxia), i.e. similar to ischaemia caused by limiting blood supply. 
Upon cessation of the C O exposure, either by removing the subject to a CO-free 
environment (normoxia), or treating the patient with hyperbaric oxygen (HBO) 
reoxygenation will occur. The mechanism of cardiotoxicity by C O is thought to occur 
similarly to tissue dysfunction observed in l/R injury (described in 1.6). The hypothesis 
postulates that the cardiotoxicity of C O occurs in an MR-like injury and is responsible for 
the observed CO-associated tissue morbidity. The hypothesis is illustrated in Figure 1.4. 
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Figure 1.4 (overleaf) The mechanism(s) of the cardiotoxicity of carbon monoxide (CO) is 
hypothesised to occur in an ischaemia/reperfusion (\/R)-like injury. Carboxyhaemoglobin 
(COHb) is produced from Inhaled C O binding to haemoglobin (Hb) in blood cells. Tissue 
hypoxia results from the limited binding and dissociation of oxygen (O2) from Hb. C O also 
binds to myoglobin (Mb) and produces carboxymyoglobin (COMb) that may limit the 
availability of O2 for respiration by the mitochondrial electron transport chain (ETC) . These 
events are considered to produce chemical ischaemia (or hypoxia) at the molecular level 
within cells. In subjects removed to a CO-free environment (or treated with hyperbaric 
oxygen) this scenario is thought to mimic reoxygenation (or reperfusion). The hypothesis 
is that this UR-like injury may produce oxidative stress that is responsible for the observed 
CO-associated heart morbidity. Key. HbOs and Mb02 are the oxygenated forms of Hb and 
Mb, respectively. C c O is cytochrome c oxidase (or Complex IV) of the E T C . Reactive 
oxygen species and nitric oxide are denoted by R O S and NO, respectively. 
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1.8 Aims & Objectives 
Tissue hypoxia occurs during exposure to C O in vivo, although the cause(s) of tissue 
dysfunction in the heart associated with CO-induced hypoxia are not clear at present. The 
overall aim is to elucidate the mechanism(s) of cardiotoxicity following C O exposure using 
a suitable model. The chosen cellular model comprised using adult rat ventricular 
myocytes. This model was chosen firstly, due to its established isolation procedure; and 
secondly, to allow the cellular changes in cardiac physiology and biochemistry to be 
determined. This study aims to test that: 
(a) C O has direct toxicity in exposed heart cells under nonmoxic conditions; 
(b) cellular/tissue changes in heart tissue occur after acute C O exposure; 
(c) intracellular hypoxia produced from carboxymyoglobin (COMb) formation may be a key 
component in the cardiotoxicity of C O ; 
(d) test the hypothesis that an MR-like injury may be responsible in producing R O S that 
may be responsible for heart tissue morbidity following C O exposure; and 
(e) administration of antioxidants prior to or during C O exposure may limit the degree of 
heart tissue damage following treatment with C O exposure. 
Specific objectives were: 
(i) to establish a suitable model to carry out the desired aims of the research; 
(ii) to establish cell markers to measure cell/tissue viability over time under the 
experimental conditions; 
(iii) to Identify specific CO-induced morphological cellular changes a s well as identifying 
likely organelle structural aberrations; 
(iv) to associate changes in the identified biochemical markers with physiological 
alterations to examine the underlying occurring events and elucidate the mechanism of 
C O toxicity; 
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(v) to show R O S production during C O exposure by looking at appropriate markers of 
oxidative stress, the role of antioxidants in C O toxicity and identifying the source(s) of 
R O S production resulting from C O exposure; and 
(vi) to evaluate oxidative stress in causing CO-associated heart tissue morbidity by 
investigating the modification(s) of protein targets such as myoglobin. 
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1.9 Overview of Thesis 
Chapter 1 has highlighted the present findings of C O toxicity with specific emphasis on 
heart tissue, stated the hypothesis that this study wishes to address, and highlighted the 
aims and objectives of the research. 
The initial in vitro model to investigate C O toxicity was to be conducted using isolated 
adult rat heart muscle cells (in Chapter 2)). This was later abandoned due to time 
constraint, therefore, this work is presented as a developmental chapter for possible 
reference. The isolated perfused rat heart was chosen as an alternative in vitro model to 
the isolated cardiac myocytes (Chapter 3) to examine the cardiotoxicity of C O . Chapter 3 
describes the suitability of this model and presents the preliminary work performed to 
validate its use in addressing the aims and objectives. The chosen isolated rat heart 
model was suitable for the devised experiments in assessing the physiological and 
biochemical changes in heart tissue exposed to C O . Chapters 4 and 5 show some novel 
physiological and biochemical changes, respectively. 
Chapter 6 addresses the role of oxidative stress in C O poisoning. This chapter features a 
novel application of experiments that investigate the possible role of mitochondria in 
producing reactive oxygen species (ROS) during or after C O exposure. Chapter 7 
examines covalently modified myoglobin (via oxidative stress) as a potentially novel 
marker to determine oxidative stress in rat hearts. Other novel work is Included that 
examined the role(s) of antioxidants in preserving myoglobin function under oxidative 
conditions. The overall findings from the work described (in the above chapters) are drawn 
together and addressed as a general discussion with conclusions in Chapter 8. 
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Chapter Two 
Isolated Cardiac Myocyte Model 
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2.1 Introduction 
2.1.1 Background in Using Isolated Heart Musc le Ce l ls 
Isolated heart muscle cells (or cardiac myocytes) have been used to examine various 
changes In cardiac function. Viable cardiac myocytes (CM) show a phenotype found in the 
intact organ (Figure 2.1), therefore. CM are used to a s s e s s morphological changes during 
experimental treatment(s). Isolated CM retain some of their metabolic and biochemical 
activity (Altschuld et a/., 1987). CM have been used previously to evaluate signalling 
cascades in the heart (Farmer et a/., 1977; Laderoute & Webster, 1997; MIzukami et a/., 
2001); Investigate atherosclerosis (Bourne a/., 1997); examine hormonal responses 
(Eckel et a/., 1983; Eckel ei a/., 1985; Liu et a/., 1999; Onorato & Rudolph, 1981); 
bioenergetic changes (Altschuld et a/., 1987; Spanier & Weglicki. 1982), a s s e s s the 
temperature dependency of contractile activity (Vahouny et a/., 1970); and examined gene 
expression by reactive oxygen species ( R O S ; Cheng ef a/., 1999; Sabri et a/., 1998). 
CM have also been used to a s s e s s myocardial ion homeostasis (by using fluorescent 
dyes and voltage-clamp techniques) as these cells retain their electrophysiology (Dow 
a/., 1981; Shattock & Matsuura, 1993). The role of intracellular calcium in damaging heart 
tissue during hypoxia/reoxygenation has been shown using this model (Allshire a/., 
1987). Relevant articles are cited for interested readers to highlight the many uses of this 
in vitro model in myocardial research: Balligand a/. (1994); Boivin & Allen (2003); 
Brunner et ai (2003); Daleau (1999); Hansen & Stawski (1994); Hattori et a/. (1997); 
Ikeda et ai (1997); Kan et a/. (1999); Kasai a/. (1997); Kukielka et al. (1995); Kumar et 
a/. (1999): Kuzuya ef ai (1993); Li et ai (1998); Liu & Schreur (1995); Martin et ai (2000); 
Massey et ai (1995); Nakajima et ai (2000); Nyui et ai (1998); Oddls et ai (1995. and 
1996); Oddis & Finkel (1996); Oh et ai (1998); Ohashi et ai (1997); Rumsey et ai (1990); 
Sandirasegrane & Diamond (1999); SartI et ai (1994); Shindo et ai (1994); Simm et ai 
(1998); Singh et ai (1996); Tanaka et ai (1998); Turner et ai (1991). 
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Figure 2.1 The architecture and the arrangement of cardiac myocytes in myocardial fibres 
with their intercalated discs (marked as ID). Scanning electron micrographs in 
backscattered electron (A) and secondary electron (B) images of the same area of 
healthy ventricle. The scale indicates lOyvcn {in panel B). The electron micrographs were 
taken from Okabe et a/. (2000). 
This model permits in vitro analysis of the properties of CM without interference from other 
systemic vanables such as different cell types, the exogenous influences of hormones, 
and altered blood flow Many studies have used this isolated cell model , therefore, this 
model could be used to examine the myocardial toxicity of CO The isolated cell model 
has shown significant uses in many in vitro studies. However, further studies are required 
before any results derived from a model can be extrapolated to the in vivo setting or to 
other species. The following excerpt elegantly summarises this: 
"Ce//s are isolated from the extracellular matrix and from association with other cell types 
with which they may be interdependent" (Rojkind ef a/., 1980) 
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Carbon monoxide (CO) poisoning is lethal owing to its chemical properties (Chapter 1). 
The use of hyperbaric oxygen treatment (HBOT) is established in increasing the rate of 
elimination of C O from the blood (1.3). HBOT has side-effects in some patients 
undergoing this therapy such as convulsions Induced by oxygen under pressure 
(Hampson et a/., 1996). HBOT has been suggested to produce oxidative stress a s shown 
by an elevation in markers of oxidative stress (Bearden et a/., 1999; Dennog a/., 1999). 
This model would also allow the effects of HBOT (following C O exposure) to be studied. 
Very few studies investigating C O toxicity using isolated CM are found. Earlier studies 
examined the effects of C O on several cultured cell types from neonatal hearts (such as 
endotheloid and muscle cells). The findings can be summarized to the extent that C O 
inhibited the cell growth, depressed the contractile rate, and decreased specific enzyme 
activities in vitro (Brenner & Wenzel, 1972; Wenzel & Brenner, 1973). Another study has 
examined the role of myoglobin in CM exposed to C O (Wittenberg & Wittenberg, 1993). 
No other studies have been perfomned using CM to specifically evaluate the cardiotoxicity 
of C O . 
2.1.2 Rationale for Isolating Heart Ce l ls & Their Culturing 
2.1.2.1 Isolation of cardiac myocytes (CM) 
The first goal Is to achieve a primary tissue digest of viable cells that are fully 
differentiated and morphologically similar to the intact heart (De Young et a/., 1989). In 
heart tissue, the muscle cells are firmly connected to each other via intercalated discs and 
the extracellular matrix (Piper et a/., 1990). These connections must be disrupted 
enzymatically to isolate celts, although the conditions used for cellular dissociation can 
damage the cells. Cell dissociation requires the absence of calcium to separate the 
basement and plasma membranes prior to reintroducing calcium to the cells for normal 
function (De Young et a/. 1989). Loss of the glycocalyx Is not thought to play a role In the 
biochemistry/physiology of these tissues (Isenberg & KIGckner, 1980). Isolated myocytes 
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have an external membrane that is selectively permeable to electrolytes. CM have a 
negative resting potential (-60 to -70mV depending on experimental conditions) and retain 
the ion conductances and voltage-sensitivities that are essential for action potentials 
(Powell etai. 1980). 
The heart is highly dependent on aerobic metabolism and requires oxygen (Chapter 1), 
therefore, heart tissue must be adequately reoxygenated after being removed from the 
animal. To prevent tissue hypoxia during cell isolation, the isolated heart is placed on an 
artificial circulation system, the Langendorff perfusion apparatus (described in Chapter 3). 
This ensures adequate perfusion of the heart to maintain tissue homeostasis and integrity. 
The perfusion apparatus allows the appropriate balance of salts, nutrients, glucose, and 
dissolved oxygen at 37°C to be delivered to the organ ex vivo for several hours (De Young 
et a/., 1989). 
Most methods used to isolate CM involve perfusing isolated hearts with proteolytic 
enzymes (Kono, 1969) in the absence (or nominally free) of calcium. The gradual 
reintroduction of external calcium to isolated cells is a major factor in the successful 
preparation of heart cells. The duration of calcium-free perfusion influences the viability of 
the isolated cell preparation; rt must allow adequate cell dissociation to occur without 
damaging cells, yet balanced to minimise membrane damage during the reintroduction of 
calcium (Zimmerman & Hulsmann, 1966). This 'calcium paradox' renders difficult the 
preparation of viable calcium tolerant heart cells (De Young et a/., 1989; Haworth et a/., 
1989; Montini et a!., 1981). However, successful high quality cell isolations are possible, 
and the calcium paradox has been extensively investigated (Allshire et a/., 1987; Alto & 
Dhalla, 1979; Frangakis et a/.. 1980; and Lambert et a/.. 1986). 
Ischaemia and anoxia play a vital role in the calcium paradox. Therefore, a rapid excision 
of the heart and short period prior to the Langendorff perfusion are essential to maximize 
the yield of viable CM (Cheung et a/., 1984; Spanier & Weglickl, 1982). Isolated viable 
cells may be further purified with gentle centrifugatlon, with or without density 
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centrifugation using Percoll or FIcoll (Glick et ai, 1974; Powell, 1984; and 2.5.16). 
However, Percoll is not used a s it inhibits Ion transporters in the cell membrane (personal 
communication with Dr. Richard Handy. University Of Plymouth). The dimensions of 
viable rod-shaped CM vary from widths of 10-35^fn and lengths of 80-150^m (Powell & 
Twist, 1976). The viability of Isolated cells Is determined from their morphology using light 
microscopy or by using marker dyes such as trypan blue (Black & Berenbaum, 1964). The 
cardiac myocyte is a rigid polygonal cell that Is easily damaged by mechanical shock 
compared to other cell types. CM from adult heart ventricle tissue are considered 
tenninally differentiated and non-proliferating. Therefore, they are used at the viability and 
yield that they were Isolated at (Stemmer et ai, 1992; Yasui et ai, 2000). Determining the 
viability of Intact cells using trypan blue has been shown to depend on other factors such 
as pH, concentration of dye and the protein content of the medium (Black & Berenbaum, 
1964; Piper et ai, 1982). Therefore, the viability of the isolated cells were determined from 
their morphological appearance. 
Atrial tissue from adult hearts contain cells that can differentiate, although age is another 
factor that can influence the Isolated yield and cell types (Barnes, 1988; Cantin et ai, 
1981; Farmer et ai, 1977). By using adult rat heart ventricle tissue, C M can be obtained 
lacking contamination from other cells such as endothelial cells, fibroblasts, and the 
extracellular matrix (ECM). It has been found that using rats older than four days yield CM 
that do not develop rhythmic spontaneous contractions In culture, and the yield of viable 
cells declines with age from 5 day-old animals (Kasten, 1973; Stemmer et ai, 1992). 
Therefore, this gives an impression that using rats older than 5d does not yield good 
Isolated cell preparations, although optimal cell preparations can be isolated from 180-220 
grams post-weaned adult Sprague-Dawley rats (personal communication with Dr. Richard 
Handy). Numerous biochemical and physiological differences exist between embryonic, 
neonatal, and adult cells. The number of nuclei in CM vary with species and age. Human 
myocytes are predominantly mononucleated, whereas rat myocytes have one or two 
nuclei depending on the age of the animals. Binucleation develops during the early 
postnatal period of rats, whereas adult values are reached at 12-14 days of age (Korecky 
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et a/., 1979). Adult mammaliam CM do not undergo DNA synthesis and show no mitotic 
activity (Cantin etai, 1981). 
2.1.2.2 Primary cell culture of isolated cardiac myocytes (CM) 
Cell Isolation renders the freshly isolated cell preparation to lose some of its Intracellular 
content; therefore, studies using this model have to ensure some degree of similarity to 
the in vivo state. The Isolation procedure produces a large number of damaged cells 
(Piper et a/,, 1982). Isolated CM are cultured to mirror or approach the in vivo intracellular 
content. In brief, a period of recovery aids the repair of this superficial damage and allows 
the physiological state of the cells to stabilize. Freshly isolated calcium tolerant CM lose 
some of their intracellular ATP and creatine phosphate content (Farmer et a/.. 1983) and 
show a gradual replenishment over the first day in culture (Piper a/.. 1982). The loss of 
ATP may be attributed to a compromised sarcolemma (Stemmer a/.. 1992). 
Adult ventricular CM do not divide in culture and so these cultures have to be prepared 
using freshly isolated cells. These cells have to be used at the density at which they are 
plated, although CM from atrial tissue show some potential to divide (Stemmer et a/., 
1992). The short-term culturing of CM can enrich the viability of the cells. Long-term 
culturing is not applicable for the proposed experiments as cell morphology is shown to 
change significantly (Piper e^ a/., 1990). The viable rod-shaped cells do not fonm confluent 
cultures as they do not attach to the dish without spreading. Long-term cultures can 
spread and fonm a few contacts, however, these contacts are not over the whole culture 
region. 
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2.2 Aims 
The in vitro cellular model uses adult rat ventricular myocytes to allow cellular changes In 
cardiac morphology and biochemistry to be studied following C O exposure. Cell 
biochemistry would be performed to associate any structural changes with biochemical 
measurements to evaluate the order of events. Biochemical parameters for examination 
include the cellular antioxidant status, mitochondrial function, monitoring the release of 
intracellular enzymes to determine cell viability, a s s e s s for any production of reactive 
oxygen species (ROS) , and examine ion fluxes based on the cellular electrolyte content. 
The aims were to: 
(a) to investigate the immediate effects of C O exposure and subsequent HBO on cellular 
oxidative metabolism by monitoring mitochondrial (respiratory) enzyme activities; 
(b) to investigate R O S production by looking for appropriate markers of oxidative stress; 
and 
(c) to look at cellular changes after acute C O exposure (and/or HBO) with particular 
emphasis on cytochrome c oxidase inhibition and mitochondrial function. 
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2.3 Materials & Methods 
Animals were supplied from A. Tuck & Son Ltd. (Essex) . Chemicals and reagents were 
provided from Sigma Chemicals (Dorset) unless othenn/ise stated. 
2.3.1 Animal Handling and Removing the Heart 
Hearts from adult male Sprague-Dawley rats (230*250 grams) were rapidly excised after 
an intraperitoneal (/.p.) injection of 60mg sodium pentobarbitone (Sagatal, Rhone 
Merieux) and 10mg heparin (sodium salt from porcine Intestinal mucosa; 1820 U S P units) 
and immediately transferred to ice-cold cardioplegic (in mM: NaCI 130; KCI 20, MgCb 1, 
CaCl2 1. NaH2P04 1. Na2HP04 4. procaine 1; HEPES 10, and D-(+)-glucose 11; adjusted 
to pH 7.4 with 4M NaOH). Unwanted tissues such as the lungs and thymus were removed 
to allow access to the aorta whilst maintaining the heart In ice-cold cardioplegia (to reduce 
its metabolism). The heart was then weighed In a tared Petri dish containing cardioplegia. 
The aorta was cannulated to achieve retrograde perfusion. A secure fit was tested by 
passing Ice-cold cardioplegic (ca. 10ml) and observing blood leave the heart via the 
micro-circulation Indicating good perfusion, i.e. no damage to the aortic valve (personal 
communication with Dr. Maria Odblum). The cannulated heart was then fitted to the 
Langendorff perfusion apparatus to commence cell isolation (2.3.2). The heart was 
perfused at 6ml.mln"\g'^ of heart tissue. Care must be taken to ensure that no air bubbles 
are Introduced to limit the tissue perfusion. Note, at this point the heart beats itself and 
aids in ejecting the remaining blood. 
2.3.2 Isolation of Calc ium Tolerant C a r d i a c Myocytes (CM) 
This was perfonned using the modified method of Montini et a/. (1981). Medium A is 
Joklik's Modification of Minimum Essential Medium (ICN) supplemented with 20mM 
H E P E S . Medium B Is 0.1% B S A (fatty acid free) and 0.05% collagenase (Type II; Batch 
number S7B951, Worthington Biochemical) in medium A. Medium C contained 0.25mM 
CaCl2 In Joklik's medium (as above) with 1% BSA. Calcium-free Joklik's solution (medium 
A) was perfused for 2min (at 36.9°C and pH 7.0), with a flow rate of two drops.s'^ (of 
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perfusate) from the apex of the heart. This was collected and discarded to remove the 
blood and prevent unwanted material being recirculated (below). Collagenase (medium B; 
pH 7.2) was then perfused for 2mln to washout medium A. at a flow rate equivalent to one 
drop.s V At this stage the heart swells with no severe colour change. Medium B Is 
recirculated for 16mln.g'^ of tissue (wet weight). 
The heart was removed and the ventricular tissue sliced away from the unwanted atria 
and blood vessels. The ventricle tissue was homogenised rapidly with two scalpels in a 
gentle manner to yield soft tissue. This tissue was transfen-ed to a 50ml sterilin pot 
containing ca. 8ml of collagenase (medium B) at 37°C and gently pipetted to aid cell 
dissociation and placed on a metabolic shaker at 100 strokes.min'^ with gentle bubbling of 
medical oxygen (100% 02). This Incubation produces a heavy suspension of cell debris 
that was filtered through nylon gauze (200^m pores supplied from Lockertex Ltd., 
Wamngton, Cheshire) after 5-10 min; carefully ensuring not to pour off the large tissue 
pieces. The remaining tissue was incubated in fresh collagenase (medium B) and was 
repeated another 5-7 times. An equivalent volume of medium C (pH 7.3) was added 
slowly to the filtrate to reduce the digestion by collagenase; also to introduce calcium to 
the cells to heal gaps in their glycocalyx, and to minimise the calcium paradox occurring 
later. The filtrate fractions were stored at ambient temperature to minimise Na^-loading; 
with constant gentle bubbling of oxygen to prevent hypoxia and maintain the cell viability. 
These fractions were then centrifuged at 30g for 50s In 13ml centrifuge tubes (Sarstedt). 
The pellet was gently resuspended using a Pasteur pipette, as mechanical force can 
damage these sensitive cells (personal communication with Dr. Richard Handy), and 
assessed for viability by counting the elongated rod-shaped cells and expressing this a s a 
percentage relative to the total number of cells (using a haemocytometer and cell tally 
counter). The trypan blue assessment for viability was not performed due to time and the 
good association of elongated morphology with viability (Piper a/.. 1982; Powell & Twist, 
1976). 
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The fractions with good viability's, i.e. greater than 60%, were pooled and washed In 
medium C by centrifugation (as described above). The pellet was resuspended in a ca . 
7ml Joklik's medium containing 0.5mM CaCl2, and left at room temperature for 10-15min 
with gentle inversion of the centrifuge tube and regular oxygenation. These cells were 
then washed and resuspended in Joklik's medium containing ImM CaCl2 for lOmIn before 
washing. The cells were washed in ImM calcium to remove unwanted cells (I.e. those 
cells with a round morphology due to hypercontracture via Ca^^-overload) by two 
centrifugations at 30g for 70 and 60s, respectively. The cell suspension was resuspended 
in 1ml culture medium (below) at room temperature, and Its viability determined followed 
by a cell count to dilute the cells appropriately for culturing (2.3.3). 
2.3.3 Primary Cel l Culture 
Isolated CM were plated at a density of 2 x 10^ cells per well in 6-well culture plates 
(Nunc) using glutamine- and serum-free medium M199 containing Earle's salts with 
NaHCOa and 1.2mM calcium (Piper et ai, 1982). Six-well culture plates were pretreated 
with 1ml 4% foetal calf serum ( F C S ; for 2-3h at 37''C) in a humidified air atmosphere with 
added C O j (5%) to the container. The semm was removed by washing each well twice 
with 2ml of culture medium (glutamine-free medium Ml99 containing Earle's salts with 
NaHCOa) prior to plating. The isolated CM were diluted to a density of 2 x 10^ cells.ml*^ In 
culture media M199 supplemented with (in mM): creatine 5, L-carnitine 2, taurine 5; and 
essentially fatty acid free BSA (0.2% w/v). Insulin (O.ljiM), penicillin (100 U/ml) and 
streptomycin (lOO^g/ml). Cells were plated by adding 1ml of cell suspension to each well 
containing 2ml of culture media. Cells were plated by aspirating the cells evenly over each 
well to obtain a primary culture of CM. The cells were incubated under similar conditions 
used for pretreating the culture plates. Cell media was changed at 3h, 24h and then every 
24h by slowly removing 2ml of media from the centre of each well, and replaced with 2ml 
of oxygenated (95% 02/5% CO2) culture media at 37°C, The elongated rod-shaped cells 
adhere at a faster rate compared to the dead (rounded) cells, and an increase in the 
viability Is observed relative to the viability determined after celt isolation. Cultures were 
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maintained for 2-3d and the cells were removed for experimental use by gently agitating 
the plates in a circular manner. 
2.3.4 C O / H B O Experiments 
To evaluate the cardiotoxicity of C O , we proposed to expose the cultured CM to different 
duration and doses of C O . whilst performing biochemical a s s a y s and monitoring the 
morphological cellular changes. The viability of the CM was a s s e s s e d by scraping off the 
attached cells, quickly spinning down the cells, and assaying the cell culture media 
(supernatant) for intracellular enzymes. The intracellular enzymes chosen for assessing 
cell viability were lactate dehydrogenase (LDH) and creatine kinase (CK) (Cheung et a/., 
1984; Penney & Maziarka. 1976). Viability would be expressed as a percentage from 
experimental and detergent (0.1% Triton-X 100 at final concentration) lysed cells using 
specific enzyme activities. Some of the CM pellet would be fixed with buffered 
glutaraldehyde to a s s e s s ultrastructural changes. The cell pellets were to be stored for 
isolating mitochondria to evaluate mitochondrial function following C O exposure. 
The duration of C O exposure would be: 0. 2. 5, 10, 20, 30 and 60min. The use of 6-well 
plates would allow three wells to be treated with C O prior to biochemical/histological 
analysis. The remaining three wells would undergo HBOT with suitable air-matched 
(normoxic) controls from another plate. The 3 wells would serve as replicates; with a total 
of 6 plates to be used at each dose and duration of C O exposure to allow satisfactory data 
analysis. The HBO exposure would be performed at 1-3 atm to evaluate the effect on 
cellular function and a s s e s s for any recovery following C O exposure (below). 
The doses of C O to be used were: 0, 0.05. 0.1 and 0.2%. The certified gas mixtures were 
purchased from B O C G a s e s (Dorset) and all contained 21% oxygen (O2). 5% carbon 
dioxide (CO2) balanced with nitrogen. The gases contained 5% CO2 to be used in 
conjunction with the bicarbonate buffer present in the cell culture media. The HBO 
treatment was to be perfonmed in pressure vessels that can hold up to 4 cell culture 
plates. These pressure vessels were tested for air tightness and withstand pressures up 
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to 3 bars. These vessels were constructed from stainless steel to prevent C O adsorption, 
therefore, ensuring adequate C O exposure to the cells. Some of the treated cells would 
be fixed for histological preparation to a s s e s s for ultrastructural change(s) to comment on 
tissue physiology and associate any biochemical changes. 
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2.4 General Findings 
This section shows and discusses the work performed to isolate cells for culturing 
purposes. The fomiat of this chapter is not consistent with following chapters due to the 
developmental nature of this work. The data shown is expressed a s the mean ± S E M 
(unless othenwise stated) with the number of hearts used (n). No statistical analysis was 
performed to detenmine the significance of each variable changed; instead, the 
effectiveness of each change was evaluated qualitatively using the detenmined viability. 
2.4.1 Cel l Isolation 
Adult ventricular cardiac myocytes (CM) were isolated from male Sprague-Dawley rats 
(230-260 grams) using aortic retrograde digestive perfusion with collagenase (Montini et 
a/.. 1981). In brief, the method produced intercellular dissociation by perfusing the isolated 
heart with an essentially calcium-free media. This is followed by cell dissociation from the 
extracellular connective tissue using collagenase with a low level of calcium. The aim is to 
isolate calcium tolerant CM (Frangakis et a/.. 1980; Rodrigues & Severson, 1997). The 
rapid introduction of calcium to physiological levels can damage the cells and this event is 
temied the calcium paradox. Calcium tolerant CM were required for our purposes and 
obtained by gradually reintroducing calcium. Initially, the cell isolation resulted in low 
yields of viable cells. Cell viability was detemiined by counting the rod-shaped (viable) 
cells using a light microscope and expressing it as a percentage of the total cells. Dead 
cells appeared as round hypercontracted 'blebs* as illustrated in F igure 2.2. 
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Figure 2.2 Isolated cardiac myocytes. Viable myocytes exhibit a long rod-like shape (ca 
20 X 100nm; Nash et a/., 1979), whereas, dead or dying cells appear highly rounded 
(arrow) or in transition (A) Higher magnif ication light micrograph illustrates the 
intercalated disc region and crossed striations in a viable cell (B) The intercalated disc 
regions have the presence of protein and polysaccharide (Yokoyama et a/.. 1961). The 
figure is taken from Rodrigues & Severson (1997). 
Firstly, the in house method was employed (as used previously by Dr. Maria Odblom; 
described in 2 3.1 and 2.3 2). This method isolated calcium tolerant CM of 18 ± 2 4 % 
viability (mean ± SEM; range: 0 to 50%; n = 6 hearts). The greatest viable cell preparation 
was obtained from the first heart (50% viability of 4x10^ cells), whereas the other hearts 
showed decreasing viability and cell numbers. The total numbers of cells obtained from 
the other 5 hearts were not determined following their poor viability. 
Many changes were performed to improve the viability and yield (see below) In brief, a 
min imum of 3 hearts was used (where stated othen/vise) to evaluate each variable of the 
protocol. The reason(s) for the change are discussed with the results of the modif ied step 
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The number of animals used to optimise this model was 48 and highlights the amount of 
work perfonned (over 8 months). Although 48 animals were used for isolating and 
culturing the cardiomyocyte cells, the number of hearts used was 39 and 14 for the 
isolation and culturing of cells, respectively. The loss of 9 hearts were attributed to 
technical faults and are described below (2.4.1.1 to 2.4.1.8). The primary culture of 
isolated CM was performed when there were sufficient numbers of cells to use; otherwise 
it would be costly and labour intensive. 
2.4.1.1 Contamination of the Langendorff apparatus 
The administration of anaesthesia, removal of the heart from the animal, and the 
preparation of reagents (for washing and perfusions) were conducted using sterile utensils 
and working conditions. The presence of organic and inorganic impurities in the water for 
preparing the perfusing and incubation buffers was of analytical grade (purified by using 
the Milli-Q filtration system) as myocardial cells are sensitive to impurities (Piper et a/., 
1990). The initial low viability (above) was overcome by flushing the Langendorff perfusion 
apparatus (with 70% ethanol) followed by water. A white emulsion w a s observed when 
rinsing with water and was considered to be cellular material, as the apparatus had not 
been used for several months (prior to commencing work). These isolated cells had 41 ± 
29% viability (range: 8-62%; n = 3 hearts) and the total cell count ranged from 7.21x10^ to 
2.28x10^ cells (1.65x10® ± 8.22x10^ cells). 
2.4.1.2 Osmolarity and pH of perfusing media 
The pH and osmolarity of each reagent used was measured prior to their use to ensure 
that no shock treatment was subjected to the hearts. The osmolarity of all the solutions 
were in the ideal range for cardiac tissues of 290-320 mmol.kg'^ (or mOsm.r^ Starr et at., 
1999). No mari^ed deviations were found to account for the poor yield and viability of cells. 
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2.4.1.3 Perfusion of heart tissue 
The heart weight (HW) was estimated from the body weight (BW) for the first 11 hearts; 
based on the assumption that HW is 0.3% of the BW (as used previously by Dr. Maria 
Odblom and Dr. Richard Handy). This was found to be incorrect with the HW being 
greater than 0.3% of the BW (ca. 0.6%). This may have produced hearts to be 
underperfused when perfused using a flow rate of 6ml.min"\g"^ (of wet heart tissue). 
Therefore, to reduce the risk of error hearts were weighed prior to cannulating the organ. 
Underperfusion of the tissues may account for the low cell viability and/or cell yield 
observed during the cell isolation. Any underperfusion may also exacerbate any tissue 
ischaemia incurred following the removal of the organ (from the anaesthetized animal). 
Following this the hearts were perfused at the same flow rate ( F R ) of 6ml.min"\g'^ based 
on the actual HW. rather than the estimated HW (above). However, this FR appeared to 
show no marked difference as observed by the similar F R of perfusate falling from the 
apex of the heart (ca. 2 drops.s"^). The viability also showed no innprovement to that 
obtained previously. The mean viability was 49 ± 10% with a total cell count ranging from 
8.3x10^ to 1.8x10® cells (mean total cell count of 1.27x10* ± 4.16x10^) from 4 hearts. Five 
animals were used to evaluate the correct FR; although only 4 hearts were used. One 
heart was rejected as a thrombus was observed inside a ventricle when removing the atria 
following its perfusion. An anticipated low viability due to a poor tissue perfusion 
prevented any further use of this heart. 
2.4.1.4 Collagenase 
Calcium is a cofactor for collagenase and tissues tend to soften faster when calcium is 
restored (Haworth e^ a/., 1989). The incubation of collagenase (in nominally calcium-free 
medium) has ca . 50^M trace calcium that is sufficient to activate the enzyme. Collagenase 
disrupts the cellular connections with the extracellular matrix (ECM) for a suitable period 
prior to producing cellular/tissue damage. Therefore, it has to be used in a controlled 
manner to avoid damaging isolated cells. The proteolytic enzymes in collagenase are 
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poorly defined, however, the enzyme and batch used in our methods were tested and 
shown to work prior to their use (by Dr. Maria Odblom). 
Collagenase perfused the hearts for 16.5min.g'^ (wet weight of tissue) following the 
calcium-free perfusion (medium A for 2min). The period of calcium-free perfusion was 
increased to 3min to allow greater loss of calcium from the Intercalated discs to assist the 
action of the collagenase. Although the period is ca . 2min to completely switch over 
(equilibrate) with the previous perfusing media (by personal communication with Dr. 
Richard Handy). All the reported viability's are from cells in the final suspension, i.e. in the 
presence of ImM CaCl2. Perfusion with collagenase for 2min ensured that the perfusion 
buffer was equilibrated with collagenase prior to recirculating the heart (for 16.5min.g*^ 
tissue). However, the extended calcium-free perfusion (of medium A by Imin) may have 
resulted in a loss of essential cofactors (for collagenase) from the heart. Some 
components of the E C M are necessary for cell dissociation by providing cofactors for 
collagenase (personal communication with Dr. Maria Odblom). This may appear to be the 
case as Piper et a/. (1982) also recirculated collagenase to aid digestion of the ventricle 
tissue. 
Collagenase was also added to the stock bottle prior to its use during the calcium-free 
perfusion (rather than standing ca. lOmin prior to use). This was performed routinely after 
the 9th heart. This change may have reduced some loss of collagenase activity from its 
incubation at 45^0 prior to perfusing the heart (at 37°C). The cell numbers did not 
increase compared to the previous levels and the cell viability decreased. The cell viability 
and yields were 30 ± 20% {n = 3) and 1.43x10^ ± 1.06x10° (n = 2; a s the information to 
determine the yield was not recorded for 1 heart), respectively. 
To maintain a stable preparation of active collagenase to perfuse the heart and/or 
compensate for loss of the necessary E C M cofactors (above), we increased the level of 
collagenase from 0.05 to 0.06% (w/v). This change was considered to be satisfactory and 
lay within the recommended range, a s too much collagenase can dissociate CM quickly 
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and render them susceptible to later damage by the calcium paradox. The increase in 
[collagenase] produced no improvement in cell viability or yield. The mean cell viability 
and yield of isolated cells was 46 ± 3% and 1.16x10® ± 7.26x10^ cells, respectively (from n 
= 2 hearts). Three animals were used to determine the viability when using 0.06% 
collagenase, however, 1 heart could have been pooriy perfused due to the absence of 
tissue swelling after its perfusion with collagenase. This may be accounted for by damage 
to the aortic valve, as the tissue was stiff relative to the soft state normally found (following 
its perfusion with collagenase). This heart was cannulated in the normal manner prior to 
its perfusion. However, the heart had slipped off its cannula during the perfusion (with 
collagenase) and may have been damaged when being recannulated. 
2.4.1.5 Introduction of calcium to the cell suspensions 
The level of calcium in the perfusate during cell isolation is critical and a sensitive window 
exists between 20-25nm Ca^* (Haworth et a/., 1989). Calcium was added back slower 
than before to ensure we were not rapidly introducing calcium to the cells. This was 
performed by adding calcium solutions made at a lower concentration. This change did 
not improve the cell viability or yield. Cell viability was 44 ± 12% (n = 6 hearts) with cell 
numbers ranging from 2x10^ to 1.68x10®. All the reported viability's are from cells in the 
final suspension, i.e. in the presence of ImM C a C b (i e. prior to culture) The mean cell 
yield was 8.60x10® ± 6.32x10^ (n = 5 hearts, a s the information from 1 heart was not 
recorded to detemiine its yield). The stepwise addition of calcium chloride (CaCb) lowered 
the cell viability at each addition. However, the viability remained for at least one hour 
when gently oxygenated similar to the findings of Montini et a/. (1981). 
Eight animals were used to evaluate this variable; although 6 hearts were used to compile 
this information a s 2 hearts were rejected. One heart was discarded after air had entered 
the organ and led to a poor perfusion. Therefore, this was expected to produce a cell 
preparation of low viability as the poor perfusion produced patches of yellow/white regions 
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indicating the calcium paradox. The other heart failed to swell after the collagenase 
perfusion and could suggest a poor perfusion and/or inactive collagenase. 
2.4.1.6 Introduction of calcium to the perfused heart 
We next adopted the method of De Young et al. (1989). whose rationale introduced 
calcium back to the perfusing heart during the collagenase perfusion rather than Isolated 
cells {2.4.1.5). Unfortunately this method did not improve the viability or yield of cells. The 
mean cell viability was 33 ± 9% (n = 3) and the mean yield was 9.15x10^ ± 7.78x10^ {n = 
2; as the infonmation to determine the yield for 1 heart was not recorded). Five animals 
were planned to evaluate the method of De Young al. (1989). although only 3 animals 
(hearts) were used successfully. One heart was rejected after air entered the organ and 
this was observed too late to salvage the tissues. The other heart appeared dead before 
being perfused as observed by the lack of contractile activity when placed in ice-cold 
cardtoplegic. This heart was anticipated to yield no viable cells, although it was perfused 
before being discarded when it showed no signs of contraction during the perfusion. De 
Young et al. (1989) obtained ca . 70% viability with low yields, however, they also used 
Percoll to purify out dead cells by centrifugation. Using Percoll (or Ficoll) sedimentation 
step(s) were not used as these are difficult to remove, and their presence could interfere 
with the proposed biochemical assays (from personal communication with Dr. John 
Moody, University Of Plymouth). 
2.4.1.7 Pore size of nylon gauze 
A range of nylon gauze with different pore sizes were used to rule out that some viable 
cells may be retained from the flitrate resulting in low viability's. The final cell suspensions 
(in Joklik's-medium containing ImM C a C y were divided into 3 batches before passed 
through nylon gauze with pore sizes of 150. 200 and 250^m. The ideal pore size was 
found to be 250^m as this had higher viability compared to those cells passed through the 
smaller pore sized gauzes. These findings are consistent with the gauze used by De 
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Young et at. (1989). This is reported using 2 hearts, although 4 animals were used to 
evaluate this variable. Two hearts were expected to yield cells of poor quality as one 
perfusion was inevitably prolonged (due to the fire alarm); and the other may have 
become ischaemic during the removal of blood (from the anaesthetized animal). The latter 
heart showed contractile activity, although it displayed signs of a poorty perfused heart, 
i.e. not swollen (in this case) . 
2.4.1.8 Increasing the cell yield 
The low cell yields obtained did not allow the required number of culture plates to be 
made to perform the any experiments. Therefore, in order to increase the yield of cells the 
perfusion apparatus was modified to perfuse two hearts. This modification comprised a 
double luer fitting to allow two hearts to be perfused simultaneously with an appropriate 
set-up to allow the recirculation (of collagenase). 
The cell isolation protocol perfused hearts at a flow rate (FR) of 6ml.min'Vg*\ therefore, a 
higher flow rate was used to ensure satisfactory perfusion of both hearts. The F R used 
was 10ml.min"\g"^ as described in the method of Piper et a/. (1990) for perfusing two 
hearts simultaneously. The FR was not unifonn as shown by a different flow of perfusate 
from each heart (in drops.s^). This could be due to the difference in heart weight 
producing an uneven perfusion by gravimetric flow. Using two hearts resulted in increased 
cell numbers (not detemnined). however, the observed cell viability w a s very poor (15 + 
3%; n = 3, i.e. 6 hearts in this case) . This was anticipated from the poor tissue perfusion 
(suggested above) occurring in at least one heart. A poor perfusion may have led to a 
greater loss of calcium, and the subsequent loss in viability may be potentiated by a poor 
oxygen supply. 
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2.4.2 Primary Cel l Culture 
Primary cell culture was incorporated to allow time to perform the proposed C O 
experiments (described in 2.3.5). The cell isolation procedure may be responsible for 
producing oxidative damage similar to an ischaemia/reperfusion-like injury during organ 
excision and prior to its perfusion (1.6). Oxidative damage to freshly isolated cells is 
shown to occur in the liver, however, no references were found to support this for heart 
tissue. The work perfonmed to increase (or at least maintain) the viability of CM following 
their isolation is shown below (in 2.4.2.1 to 2.4.2.4). 
2.4.2.1 Pretreating of culture plates 
The presence of foetal calf serum (PCS) in the culture medium following the pretreatment 
of culture plates produces CM that retain their elongated shape during the first 12-24h and 
most become spherical by the end of day two. The absence of P C S in the culture media 
(after pretreating plates) has been shown to preserve the elongated morphology of CM for 
up to 2 weeks (Piper a/., 1990). The role of P C S in the primary culture of CM is for 
cellular attachment. However, the precise nature of the constituents of P C S and its mode 
of action during attachment is not clear (Piper et a/., 1990). Serum-free culture conditions 
were used for the culturing of adult CM, although prior to plating cells the culture plate(s) 
were pretreated with P C S (in media). Neonatal CM require different culturing conditions 
and contain a diverse range of cell types due to the presence of fibroblasts (Polinger, 
1970; Van Der Laarse et a/., 1979). Cultured neonatal CM exhibit different phenotypes 
compared to when isolated and do not accurately represent the in vivo picture. Neonatal 
cells were not used because they are not fully differentiated and may introduce other 
variables into the study. 
The duration of pretreatment determined the degree of attachment. It was found that a 
pretreatment period of 6h required careful handling during media change. However, a 
longer pretreatment (28h) allowed harsher conditions to be used due to the greater 
attachment (of both dead and viable cells). It was also observed that viable cells that had 
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attached loosely prior to the media change would not survive (in most cases) . Longer 
pretreatment conditions (>8h) showed aggregates a s cells adhered rapidly between 
attached viable and unattached viable/dead cells. Cells also attached at a faster rate 
relative to a shorter pretreatment period (such as 2-4h). The adhesion of viable and dead 
cells is unaccountable. The shorter period appeared to favour the attachment of viable 
cells. Although it may occur due to a higher level of calcium (1.2mM) in the culture 
medium relative to ImM calcium (in Joklik's media). Excluding the pretreatment step 
resulted in the attachment of both dead and viable CM. This absence also produced a 
greater loss of cell viability (in the same batch of isolated cells) compared to cells cultured 
in pretreated plates. These findings support the use of pretreated culture plates. The 
pretreatment period must be used to compromise between attaching predominantly viable 
cells from freshly isolated cells and maintaining the attachment (of viable cells) during 
media changes. 
Tissue culture plates used from different manufacturers are shown to produce different 
outcomes when culturing CM. Tissue culture grade polystyrene by Falcon and Costar 
(used here) were shown to be successfully pretreated by serum (Piper et a/., 1990). The 
pretreating of plates (with F C S ) prior to culturing adult CM was shown to be necessary. 
The duration of F C S incubated in culture plates (for pretreatment) was found to vary 
between methods (shown in Table 2.1). The difference in pretreatment time may arise 
from the initial cell viability prior to culturing. However, most of these workers (in Table 
2.1) did not cite their isolated cell yield and viability prior to culturing. 
Table 2.1 (overleaf) Ceil culturing conditions used for cardiac myocytes isolated from rat 
hearts. 
* personal communication with Dr. Richard Handy (Department of Biological Sciences; 
University of Plymouth). * M199 is Medium 199 culture media; " B S A is bovine semm 
albumin; " F C S is foetal calf serum; P B S is phosphate buffered saline; * H E P E S (buffer) 
is A/-2-hydroxyethylpiperazine-A/-2-ethanesulphonic acid); ' MEM is Minimum Essential 
Medium; * NEAA is non-essential amino acid. 
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Culturing 
conditions 
Culture media Supplements used Reference 
Plated 10^ cells per 
well (in pretreated 6-
well culture plates). 
Used 4% FCS'^or 
laminin (lOf^g/ml) to 
pretreat culture 
plates. 
Gin-free Ml99^ 
with Earle's salts. 
37''C: 95% O2: 
5% CO2 
Creafinine (5mM). L-
carnifine (2mM), 
taurine (5mM). 0.2% 
essentially fatty acid-
free BSA*, insulin 
(lOOnM), penicillin 
(100 U/ml) and 
streptomycin 
(100ng/ml). 
Handy* 
Plated 1.5 X 10^ 
elongated cells per 
60mm culture dish. 
Attached cells for 
30min after 
pretreatment (24h) 
with 4% F C S in 
M199^ 
Used PBS^'for cell 
washes. 
Modified Gin-free 
Ml 99^ with 
Earie's salts 
0.2% B S A ^ insulin 
(lOOnM). penicillin 
(100 U/ml) and 
streptomycin 
(lOOng/ml). 
Volz et al. (1991) 
Pretreated tissue 
culture plastic or 
glass with 4-8% FCS* ' 
in 3ml M199 medium 
per 60mm dish (5-
15h). 
Change media 1-4h 
after plating cells if 
cells are required for 
>12h. 
Media changed 
normally every third 
day after the first 
media change. 
Ml99 with Earle's 
salts buffered 
with bicarbonate-
CO2 (or H E P E S * 
with no CO2) 
Creatinine (5mM), L-
carnitine (2mM), 
taurine (5mM). 0.2% 
BSA*. insulin (lOOnM), 
penicillin (100 U/ml) 
and streptomycin 
(100ng/ml). 
Piper et ai (1990) 
Plated 7 xlO'* cells in 
35 plastic dishes 
coated with 0.1% 
gelatin. 
Gin-free MEM' 
with Earle's salts; 
10%FCS'=: 
vitamins (x2) and 
1 X NEAA^. 
37°C; 5% CO2 in 
air 
For first 7 days media 
had lOmM araC to 
prevent fibroblast 
growth. 
Always supplemented 
with 1% penicillin and 
streptomycin. 
Eppenberger et al. 
(1988) 
3h attachment period 
after >5h 
pretreatment period. 
Used 35mm petri 
dishes. 
BM 86-Wissler 
media with 4% 
FCS*' . 
37°C; 16% O2: 
5% CO2: 79% N2 
Streptomycin 
(100^g/ml)and 
Penicillin G (100 U/ml). Eckel et al. (1985) 
3h attachment period 
after pretreated 
overnight with 4% 
FCS* ' inM199 (37°C 
and 5% CO2). 
Used 60mm petri 
dishes. 
Ml99 media 0.2% B S A ^ insulin 
(lOnM). penicillin G 
(250|iM) and 
streptomycin (250 ^M). 
Piper et al. (1982) 
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2.4.2.2 Culturing conditions 
Glutamine and serum-free media supplemented with creatine, carnitine and taurine 
prolong the survival of elongated CM in culture (Volz et a/.. 1991). Glutamine was omitted 
from the culturing conditions a s this amino acid serves as a signal for proliferating 
fibroblasts (Claris Jr., 1976) and shown to develop the spherical shape of CM in serum-
free conditions (Piper a/., 1990). Taurine (2-aminoethanesulphonic acid) was 
supplemented in the culture media as it is found in mammalian tissues. In heart tissue, 
levels range 20-26|imoles.g*^ (wet weight), and this has been suggested to be equivalent 
to a concentration of at ^ O m M (Militante et a/.. 2000). Taurine is thought to modulate the 
movement of sodium ions across the sarcolemma (osmoregulation), modulate protein 
phosphorylation and calcium fluxes in heart tissue. Carnitine and taurine have a similar 
effect to creatine and together prevent cell rounding and contribute in replenishing 
intracellular ATP levels (Piper et a/.. 1990). 
Culture medium should be changed between 1-4h after plating the isolated cells (Piper et 
a/.. 1990). This ensures the removal of non-attached cells and other cell debris (Table 
2.1). The pH of the culture media was a s s e s s e d after observing the red colour of the 
supplemented media turn pink (under the culturing conditions used). The colour dye 
indicating pH qualitatively showed alkalosis in the culture media. The bicarbonate buffer 
system used was dependent upon 5% CO2. However, this buffer system did not appear to 
be effective and the addition of H E P E S to the culture media was thought to maintain a 
stable pH. This was perfomied by supplementing the culture media and adjusting to pH 
7.4 at 37°C. This resulted in more cells surviving (after being plated) a s observed prior to 
the first media change. The media change resulted in cell viability's of ca. ^70%, although 
with a marked loss of cell numbers. Supplementing culture media with H E P E S led us to 
use commercially available Medium 199 with H E P E S . The culture media was oxygenated 
prior to its use. However, this oxygenation was difficult to perform as it caused frothing of 
the culture media due to the presence of BSA. This frothy media is not recommended 
during cell culture (personal communication with Dr. Christine King, University of 
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Plymouth); therefore, the container holding the culture plates was oxygenated prior to 
incubating the plates. 
The findings of Eppenberger et a/. (1988) showed that cultured adult CM undergo 
extensive morphological transitions after 4d in culture to a less differentiated state. Small 
myofibrils were identified in the cells and these cells showed altered shapes and 
distribution of the myofibrils. The inclusion of serum increases the rate of differentiation in 
the cellular myosin profile (Nag & Cheng, 1986). This suggests that the cultured cells may 
have to be used within 4d (after being cultured) to maintain a consistent cell type. These 
morphological changes question the validity of published studies using these culturing 
conditions. 
2.4.2.3 Calcium in cell culture 
A gradual introduction of calcium is necessary to avoid the calcium paradox and to allow 
the intercalated disc region to recover from the cell dissociation process (Isenberg & 
Kldckner, 1980). The calcium (in the culture media) could contribute in restoring the 
extracellular structures found in the intercalated disk regions and may account for the 
aggregation of cells (observed here). 
2.4.2.4 Distribution of cultured cardiac myocytes 
One common observation was the absence of an uniform distribution of cells after plating 
isolated CM. Unattached cells tended to congregate towards the centre of each well. This 
could not be resolved either by gentle agitation of the culture plates, or by spreading the 
cells over the well area during plating. The layer of unattached cells may starve the 
attached viable cells by consuming oxygen and limiting oxygen for the attached viable 
cells, as CM are highly dependent upon oxygen (De Young et al., 1989). Furthemiore. CM 
do not like to be in contact with each other in culture, as either one or all the cells in 
contact die (personal communication with Dr. Richard Handy). Therefore, this led us to 
plate cells at lower densities, i. e. 2 x 10^ cells compared to 1 x 10^ cells. The cells plated 
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at a higher density showed a greater viability relative to those plated at a lower density 
after the 3h wash. These findings agree with Yasui et a/. (2000) who showed cell-cell 
interaction to be important for cell function and survival (Figure 2.1). 
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2.5 Discussion 
The low cell viability may have been caused by hypoxic injury resulting in the 
hypercontracture of isolated cells (Hohl a/.. 1982). These hypercontracted cells are 
shown to lack the mechanisms for normal calcium homeostasis (Allshire et a/., 1987). 
Oxygen utilization is increased in myocytes following the addition of calcium (Frangakis et 
a/.. 1980). The increasing presence of calcium may have raised the oxygen consumption 
of these cells. Therefore, it may be worthwhile to increase the oxygen levels gradually in 
parallel with the calcium levels. However, this may compromise cell viability by the 
*oxygen paradox'. 
Dead (rounded) CM may release pro-apoptotic factors during their hypercontracture that 
may be responsible for a low stability of the isolated viable cells. This suggests a 
threshold effect, where the loss of viability may trigger cell death by (necrosis or 
apoptosis) in the remaining viable cells. This could explain the requirement of high viability 
preparations of isolated cells, typically to exceed ^70% based on the numerous studies 
that have used this model. The preparation of high viable fractions may not release a 
lethal level of mediators responsible for producing death in neighbouring cells. 
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2.6 Conclusions 
Cell culture could not be used to maintain the viability of the isolated cardiac myocytes, 
possibly due to the poor viability obtained after their isolation. The discussed findings may 
serve as a reference for other workers who propose to use this model. The expenditure of 
resources and time led us to consider using another model. 
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Chapter Three 
Isolated Perfused Heart Model 
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3.1 Introduction 
The isolated rat heart preparation were evaluated a s an alternative in vitro model to 
investigate the cardiotoxicity of C O . In brief, this model should allow a rapid approach (at 
a lower cost) to examine cardiac changes compared to using isolated cardiac myocytes 
(Chapter 2). This chapter examined the possible use of this model to study the 
cardiotoxicity of C O . We have considered the appropriateness of the model; shown the 
technical feasibility in preparing this model; examined its validity; found suitable markers 
to determine tissue viability; and demonstrated a range of C O levels to investigate the 
toxicity of C O . 
3.1.1 Isolated Per fused Rat Heart Model 
Isolated perfused hearts allow biochemical, physiological function (i.e. contractile and 
electrophysiology), pharmacological, vascular biology, and tissue histology to be studied. 
These experiments are performed in the absence of other influencing factors such as 
organs/tissues, hormones, and neural control. Therefore, allowing changes to be 
examined that may otherwise be unobserved. Such cardiac changes include those that 
occur to maintain adequate oxygenation of tissues during chronic exposure to C O (1.4.1 
and 1.4.2). Isolated hearts are not usually perfused with blood. Crystalloid solutions are 
usually used for delivering oxygen and substrates, for example, the Krebs Henseleit buffer 
(KHB; Neely et a/., 1967). An absence of blood allows the direct effect(s) of C O to be 
studied in heart tissue under conditions lacking systemic hypoxia (due to the absence of 
carboxyhaemoglobin from blood). The loss of peripheral innervation may be rectified by 
using perfusion buffers with added chemicals such as neurotransmitters to approach in 
vivo conditions. 
Biochemical analysis can be performed on heart t issues by preparing tissue 
homogenates. This allows time course studies to be earned out (Yue et a/., 2002). 
Isolated rat hearts have been used to examine the effect of free radical producing systems 
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in situ (Chahine a/., 1997); to study ischaemia (Mousa et a/., 1987); and protein 
turnover (Morgan et a/., 1971; Rannels et a/., 1975). Hearts from numerous species can 
also be used by this model to evaluate species differences. However, the issues of cost, 
animal ethics and appropriateness have to be considered (Galinanes & Hearse, 1990a). 
Previous related work (using this model) mostly studied the effects of C O - and hypoxic-
hypoxia on the vasculature (McGrath & Chen, 1978; McGrath & Smith. 1984). Other work 
has shown histological changes to occur in the heart following C O poisoning (Kjeldsen et 
a/., 1974). The established use of isolated hearts to examine ischaemla/reperfusion (l/R) 
injury (1.6). and the postulated role of l/R-like injury in the cardiotoxicity of C O (1.7) favour 
its use for this study. 
Most models have limitation(s) that vary in degree with the nature of the conducted 
experiments. The advantage of removing other factors that influence tissue function in 
vivo yields preparations that dissociate from the in vivo setting. The lack of sympathetic 
and vagal tones can be compensated (to some extent) by artificially pacing the heart 
preparation. This requires the necessary hardware and could mask ventricular arrythmias 
that may arise from the treatment(s). This ex vivo preparation gradually deteriorates, 
however, it does allow studies for several hours. Rat hearts have a very short action 
potential duration and this can limit its value (in terms of extrapolating any findings to the 
human heart) in arrhythmogenic studies (Galinanes & Hearse, 1990b). The species used 
is important in any study considering extrapolating the findings from one species to 
another. 
3.1.2 Heart Preparations: Langendorff ve rsus Working Heart 
The isolated hearts can be prepared in two ways. 
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3.1.2.1 Langendorff preparation 
The Langendorff preparation comprises cannulating the aorta of the isolated heart prior to 
its perfusion with oxygenated buffer. The perfusion buffer Is delivered in a retrograde 
manner to the organ, by either constant pressure (60-100 mmHg) or flow (delivered by 
infusion or a peristaltic/roller pump). The perfusing buffer forces the aortic valves to close 
and the buffer perfuses into the coronary arteries. This perfuses the heart tissues via the 
coronary arteries before draining into the coronary sinus (Wexter & Walsh, 1996). The 
coronary drainage occurs in the right side of the heart from the pulmonary artery. Most of 
the present methods are adapted from the original design by Langendorff (1895). The 
Langendorff preparation was chosen due to its simplicity in setting up (relative to the 
working heart preparation; 3.1.2.2), and it is established in evaluating cardiac 
performance. This model does not require pacing as the working heart preparation. 
3.1.2.2 Working heart preparation 
This is more complex relative to the Langendorff preparation (described above). This 
preparation comprises ventricle filling prior to ejection through the aorta, i.e. the heart 
behaves as in vivo, hence its name. It is essentially a left heart preparation that conducts 
its own work whilst perfusing its own coronary system, and it is paced to maintain 
oxygenation close to the physiological range (Mousa et a/., 1987). This preparation 
requires the Langendorff preparation to be modified after the heart is stabilised following 
its isolation. This preparation has a greater expenditure of energy and subsequently a 
higher consumption of oxygen. These particular attributes are likely to render the wori<ing 
heart more susceptible to ischaemic injury (Galinanes & Hearse, 1990a). However, this 
preparation allows other indices of cardiac function to be determined, i.e. different filling 
pressures and afterioads (Neely et a/., 1967) relative to the Langendorff preparation 
(Galinanes & Hearse. 1990b; Grupp etaL, 1999). 
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3.1.3 A i m s & Object ives 
The aim to investigate the toxicity of C O in the heart appears feasible using the 
Langendorff heart preparation. It is envisaged that the isolated heart model will allow the 
effects of C O and hyperbaric oxygen treatment (HBOT) to be investigated to address the 
hypothesis (1.7). 
Specific objectives include: 
(a) to establish a protocol for using the Langendorff heart preparation; 
(b) to evaluate lactate dehydrogenase and creatine kinase as markers of tissue 
viability of the isolated heart preparation; and 
(c) to determine a suitable range of C O exposure to produce results that may be 
extrapolated for clinical use. 
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3.2. Material & Methods 
3.2.1. Isolation of Rat Hearts 
The heart was isolated following the /.p. administration of anaesthesia and heparin as 
described previously (in 2.3.1). 
3.2.2 Langendorff Perfusion 
The aorta was cannulated using surgical silk to attach the heart to the Langendorff 
apparatus for retrograde perfusion (Powell. 1984). Prior to perfusing the heart with the 
Langendorff apparatus, the cannulated fitting was tested by passing ice-cold cardioplegia 
(ca. 10ml), to ensure that the suture was secure to prevent the heart from detaching off 
the perfusion apparatus (as described in 2.3.1). This also ensured that no damage was 
caused to the aortic valve and removed some blood from the tissues. Observing blood 
perfuse out from the heart surface in the coronary ostia region during the slow infusion of 
cardioplegic indicates no damage to the aortic valve. The heart was attached to the 
Langendorff apparatus with the perfusion buffer flowing at O.lml.min'^ to prevent air 
bubbles entering the heart. Perfusion buffer (118mM NaCI. 4.7mM KCI. 1.2mM KH2PO4. 
1.2mM MgS04, 1.8mM C a C b . 20mM NaHCOs and 11 mM glucose) was constantly gassed 
with 21% oxygen, 5% carbon dioxide (balanced with nitrogen) to pH 7.4. The flow rate 
(FR) was increased gradually so as not to cause any damage to the aortic valve and 
coronary vasculature to 6ml.min'Vg'^ (wet weight). At this point the heart beats itself and 
this aids in removing unwanted blood from the tissues. The heart was maintained in a 
humid environment by placing cling-film over the chamber housing the isolated heart. 
Hearts that failed to beat within 30s were removed and discarded from the study. 
3.2.3 Experimental Design 
In brief, the hearts were exposed to C O and examined for any changes with the C O -
treatment. Hearts were isolated and perfused for ca. lOmin to remove blood and allow the 
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organ to stabilise following the excision procedure (pretreatment period). Hearts were 
perfused with buffer saturated with 95% oxygen and 5% carbon dioxide during this 
pretreatment period. C O exposure was started by perfusing hearts with buffer saturated 
with 0, 0.05, 0.1 or 0.2% C O (with 21% oxygen. 5% carbon dioxide, and balanced with 
nitrogen) for 30min, followed by a 90min CO-free period (by perfusing the hearts with 
petreatment perfusion buffer). Three hearts were used for each treatment with 0-0.2% 
C O . The heart rate and perfusate flow was determined in some hearts (3.2.4). The C O 
gas mixtures used were certified mixtures supplied from B O C G a s e s (Dorset). 
3.2.4 Heart Rate & Perfusate Flow 
The basal or pretreatment (I.e. pre-CO) heart rate (HR) was determined 5 minutes prior to 
treating the heart by perfusing equilibrated C O solution (3.2.3) and recording the HR at 
various timepoints during and after the C O exposure. The HR of the Isolated organ was 
detemriined by visually counting the number of heart beats during a 30s period and 
expressing the HR in beats.min'^ (bpm) at that timepoint. Perfusate flow (PF) out of the 
organ was determined (in some hearts) by measuring the collected volume of perfusate at 
various time points to a s s e s s the myocardial coronary function. Perfusate samples were 
collected from the heart at various time points and kept on ice (In 1.5ml eppendorf tubes) 
prior to assaying (3.2.5). 
3.2.5 Biochemical A s s a y s 
The spectrophotometric assays (below) were conducted using a H e ^ l O S p UV-vislble 
spectrophotometer (UNICAM) that was fitted with a temperature controlled cuvette holder. 
The activity of the mariners (and other analytes) In the perfusate were determined from the 
assays (below) and expressed per gram (wet weight of heart tissue) to normalise the data. 
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3.2.5.1 Lactate dehydrogenase (LDH) 
The LDH activity was measured after each perfusion in fresh perfusate samples that were 
placed on ice prior to determining the LDH activity (^1h after completing each perfusion). 
The perfusate sample (0.1ml) was added to 2.9ml of assay reagent (in a 3ml cuvette), 
rapidly mixed using a paddle and the initial decrease in absorbance at 340nm was 
recorded over 30s at 25°C. The assay reagent used comprised 50mM sodium phosphate 
buffer (pH 7.5) containing 0.6mM pyruvate (sodium salt) and 0.2mM NADH (final assay 
concentrations) that were added in powder form prior to use. Enzyme activity was 
determined by running known standard activities (0-5 U.ml"^) prepared from L-lactic 
dehydrogenase (Type XXXV) from porcine heart (Sigma). 
3.2.5.2 Creatine kinase (CK) 
The activity of creatine kinase was determined in stored perfusate samples using a 
commercial assay kit (catalogue number: 47-20, Sigma). The assay was perfonmed as 
described in the manufacturers instructions. 
3.2.5.3 Nitric oxide (NO) 
Nitric oxide was measured by determining its immediate breakdown product, nitrite (NO2*), 
using the Griess assay. This was perfonmed after each perfusion using the method in 
Yamamoto et al. (1998). 
3.2.5.4 Ferric reducing ability of plasma (FRAP) assay 
The F R A P assay was perfomned as described by Benzie & Strain (1996). 
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3.2.6 Data analys is 
The heart rate and assay measurements were performed in triplicate and showed good 
agreement. The data shown is the mean ± S E M of 3 hearts at each C O dose tested. No 
statistical analysis was performed in this preliminary study. 
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3.3 Results 
The Langendorff model was tested using a range of dissolved C O gas mixtures containing 
0, 0.05, 0.1 and 0.2% C O (in 21% O2 with 5% CO2 and balanced with N2). The heart is 
very sensitive to acid so an effective buffer was employed. The established bicarbonate 
buffering system was used in conjunction with 5% CO2 a s performed by other studies 
using isolated hearts (Galinanes & Hearse, 1990; Humphrey et a/.. 1987). 
Please note that no statistical analysis of the data was performed (in this chapter). The 
study was performed to examine whether the isolated heart model is a valid model to test 
our hypothesis (1.7). 
3.3.1 Heart Rate & Perfusate Flow 
Control hearts (with no added CO) appeared to beat constantly at a similar level and 
showed no visible colour change during the entire experimental period. The heart rate 
(HR) was not recorded to allow quantification of the control data for comparison to the 
other CO-treated groups. The 0.05% C O perfused hearts showed a decrease in HR after 
2min of C O perfusion as observed qualitatively. A negative inotropic response was 
observed in parallel with the chronotropic response. A decrease in perfusate (coronary) 
flow was observed by an increase in back pressure (seen by an increased volume of 
perfusing buffer in the bubble trap of the Langendorff apparatus). After the 30 minute C O 
perfusion period (with 0.05% CO) , the hearts displayed an increase in HR within 2min. 
and contractile recovery was further observed by 15min. However, the inotropic response 
did not recover to that observed (qualitatively) prior to C O exposure. No colour change 
was observed in hearts perfused with 0-0.1% C O . 
Hearts perfused with 0.1% C O showed similar changes in their inotropic and chronotropic 
responses as the 0.05% C O perfused hearts. The pre-0.1% C O HR was 168 ± 12 
beats.min*^ (expressed as the mean ± S E M ; from n = 3 hearts) at 5min prior to C O 
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exposure. The HR decreased during C O exposure to 146 ± 8 bpm at 27min of C O 
exposure (or 87 ± 5% of the pre-CO value). The HR increased during the CO-free period 
(after 30min of C O exposure) to 132 ± 20, 144 ± 28 and 160 ± 11 bpm at 31. 92 and 
122min. respectively. The pre-CO HR values were taken as 100% for each heart and 
other values of HR determined during and after the CO-treatment were expressed as a 
percentage of the pre-CO level for each heart (prior to averaging for the group). These HR 
values were equivalent to 79 ± 15%, 86 ± 19% and 95 ± 7% of the pre-CO level for 31, 92 
and 122min of the perfusion, respectively. Arrthymias were clearly observed when 
detenmining the HR following the C O exposure. These arrhythmias were seen as phases 
of irregular spasmic-like beating. 
The 0.2% C O perfused hearts also showed a similar decrease in HR (as the 0.1% C O -
treated group). The pre-CO HR was 198 ± 7 bpm and fell to 112 ± 34 bpm at 29min of C O 
exposure, then recovered over the 90min CO-free period to 190±3 bpm at 120min (Figure 
3.1). The HR for the 0.2% CO-treated group was 56 ± 15%. 87 ± 8% and 96 ± 2% (of the 
pre-CO level) at 29, 90 and 120min, respectively. However, no arrhythmias or 
vasoconstriction (Indicative of perfusion back pressure) were observed in these hearts. 
The perfusate flow (PF) was measured and decreased during the C O exposure period 
and increased gradually over the post-treatment period (Figure 3.1). The pre-CO P F 
(determined 5min prior to CO-treatment) was 5.62 ± 0.08ml.min'V The P F did not recover 
to the observed pre-CO levels. The P F was not detemriined for the 0.1% CO-treated group 
to compare between these CO-treated groups. 
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Figure 3.1 Heart rate and perfusate flow of isolated rat hearts exposed to 0.2% carbon 
monoxide (CO). Hearts were perfused with buffer saturated with 95% O2 and 5% CO2 
during the pretreatment period (ca. 10min). C O exposure was started by perfusing hearts 
with buffer saturated with 0. 0.05. 0.1 or 0.2% C O (with 21% oxygen. 5% carbon dioxide, 
and balanced with nitrogen) for 30min. followed by a 90min CO-free period (by perfusing 
hearts with petreatment perfusion buffer). Data shown is the mean ± S E M (n = 3 hearts). 
The black bar shows the period of C O exposure in perfused hearts. 
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3.3.2 T i s s u e Viability 
Lactate dehydrogenase (LDH) and creatine kinase (CK) are both intracellular enzymes. 
The release of LDH and C K into blood serum indicates cellular, tissue, or organ damage 
(Penney & Maziarka, 1976; Swaanenburg et a/., 1998). Their activities were detenmined in 
perfusate samples from hearts perfused with C O . Control hearts (0% C O ) had a constant 
release of LDH (<0.04 units.ml'Vg'^) during the experimental period. Hearts perfused with 
0.05% C O showed maximum LDH activity in the 30min perfusate samples followed by a 
decline (Figure 3.2). However, it remained elevated above the LDH activity of control 
hearts. Perfusions with 0.1% and 0.2% C O had similar LDH release profiles and showed 
no difference relative to the control hearts (0% C O ) . The C K activity had a similar profile 
a s the LDH release for the 0.1 and 0.2% C O groups, however, no elevation in C K activity 
was found for the 0.05% CO-treated group (Figure 3.3). The C K activity was not 
determined for the control hearts. 
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Figure 3.2 Release of lactate dehydrogenase (LDH) into the perfusate of CO-treated rat 
hearts (0-30min; black bar) followed by a 90min CO-free period. The LDH activity was 
determined (as described in 32 5 1, Materials & Methods) immediately after each 
perfusion was performed Same experimental conditions as described in Figure 3.1. The 
white circles, red squares, blue triangles and green upside-down triangles show the mean 
± S E M of three hearts for the 0, 0 05. 0 1 and 0.2% CO-treated groups, respectively. 
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Figure 3.3 Activity of creatine kinase (CK) in perfusate samples from CO-treated hearts 
The assays were performed using a commercial assay kit on perfusate samples that had 
been stored frozen (at -20°C for at least two days) prior to their analysis. Same conditions 
as described in Figure 3.2, although no control data was determined. 
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3.3.3 Nitrite 
Nitric oxide (NO) is produced after CO exposure in the brain tissue of rats (Ischiropoulos 
et a/.. 1996). To address this issue for heart tissue, we examined whether CO could 
produce its toxicity/morbidity from a production of reactive oxygen species (ROS) and/or 
reactive nitrogen species (RNS) Therefore, the possible production of NO was 
investigated by measuring its immediate breakdown product, nitrite (using the Griess 
assay: 3 2 5 3) The Griess assay was performed on perfusate samples taken on the 
same day as the perfusion No differences were observed between the control and CO-
treated hearts at the three doses used (Figure 3.4). 
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Figure 3.4 Nitric oxide levels were determined from the nitrite concentration (normalised 
per gram of heart tissue) in the perfusates of CO-treated hearts Same key and 
experimental conditions as described in Figure 3 2 
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3.3 4 Ferric Reducing Ability of Plasma (FRAP) 
To address our hypothesis (1.7). we need to examine for the production of reactive 
oxygen species (ROS) during and/or following CO exposure. The FRAP assay determined 
the antioxidant potential (in perfusate samples) from its ability to reduce ferric (Fe'") to 
ferrous iron (Fe"). Feme iron (at low pH) will form a complex with tripyridyltriazine (Fe'"-
TPTZ) that can be reduced (to ferrous iron) producing a stable coloured complex that is 
measured (/^ax at 593nm). If the production of ROS is elevated in the heart it may reduce 
the antioxidant capacity of the tissue(s). No qualitative differences were observed 
between the control and CO-treated hearts at the three doses used (Figure 3.5). The 
perfusate from the 0.05% CO-treated group showed an elevated level of antioxidant 
potential similar to the release of LDH, although it does not appear to be significant 
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Figure 3.5 Antioxidant potential of the perfusate of isolated rat hearts exposed to CO. The 
ferric reducing ability of plasma (FRAP) assay was used to assess the antioxidant 
potential (as deschbed in 3 2 5 4). 
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3.4 Discussion 
Pentobarbitone is a widely used anaesthetic that is a cardiovascular and respiratory 
depressant that can reduce the Intracellular level of high energy phosphates 
(Bretschneider, 1975). Tissue hypoxia could potentiate this loss of high energy phosphate 
when the heart was removed from the animal (Grupp et at., 1999). The maintenance of a 
high ATP to ADP ratio Is critical in determining tissue viability. The removal of the heart 
(after administering pentobarbitone) was performed quickly and followed by rapid 
perfusion to minimise global ischaemia in the heart. Stressed (frightened) animals have an 
altered honnonal blood chemistry (particularly catecholamines) that may influence the 
perfused heart at the biochemical and physiological level (Bolll ei a/., 1985; Bristow a/., 
1993; VIeeming et a/., 1989). Stressing the animals was avoided at all costs by keeping 
the animals in a quiet environment prior to anaesthesia and by minimising their handling. 
The animals were handled confidently and administered anaesthesia without causing 
them any visible distress following the experience gained (In Chapter 2). 
The levels of CO used (0-0.2%) are similar to those producing a broad range of blood 
[COHb] found during CO intoxication. Raub ef a/. (2000) showed equilibrium levels in 
blood COHb ranging from 2-80% following the steady-state exposure to air containing 
0.001-0.195% (10-1950ppm). These blood [COHb] produce a range of effects following 
CO exposure in vivo from subtle flu-like symptoms to death (Table 1.2), I.e. non-lethal to 
lethal. Therefore, using [CO] that reflect the spectrum of symptoms produced following CO 
poisoning ensured a clinically relevant dimension to the study. The level of CO may be 
lower than those cited due to the decreasing solubility of CO in solution with increasing 
temperature. The solubility of CO In water is 3.54. 2.14, and I.SSml.lOOml'^ at 0, 25, and 
37°C, respectively (Worid Health Organization, 1979). The use of plastic tubing 
throughout the perfusion apparatus may also reduce the [CO] through adsorption. Most of 
this loss was thought to arise from the lowered solubility with temperature (above) and the 
presence of other solutes in the perfusion buffer. The degree of loss of CO through 
solubility and adsorption was not determined. To minimise any loss of CO through 
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adsorption between the stock gas cylinder to the glass bottle (holding the CO-containing 
perfusion buffer); therefore, tubing that could withstand high pressure and not adsorb CO 
was found and ordered for later work (from Altec). Therefore, the [CO] used here reflect 
nominal values and not the actual level. 
The changes in mechanical function were assessed by measuring the heart rate (HR). 
The bradycardia (observed from the determined HR in 3.3.1) suggest a dose-dependent 
effect of CO at similar time-points for the 0.1 and 0.2% CO-treated groups. The absence 
of a blood compartment (as found in vivo) rules out the formation of COHb. Therefore, 
these changes in HR do not result from systemic hypoxia, or the decreased perfusing O2 
level during CO exposure relative to the pre-CO PO2 (discussed below). The 
vasoconstriction, anythmias and bradycardia observed in hearts perfused with 0.1 and 
0.2% CO may suggest a direct effect of CO. The perfusate flow (PF) may also have a 
dose-dependent relationship (similar to the HR). however, this remains to be determined. 
These changes in HR and PF are not discussed here as the primary purpose (of this 
chapter) is to evaluate the feasibility of using isolated hearts. However, this work does 
suggest a direct effect of CO on heart function (under the conditions used). 
The mariners used (lactate dehydrogenase and creatine kinase; LDH and CK, 
respectively) are established in cardiovascular research (Van Der Laarse et a/., 1979). 
These markers were used for two purposes: to dissect out the deterioration of the 
perfused organ with time and to examine the experimental effects of CO. Some release of 
LDH was found from control hearts and this leakage may indicate washout of LDH arising 
from tissue damage during heart isolation and/or deterioration of the Isolated preparation 
over time. The release of LDH during the 0.05% CO-treatment indicates some tissue 
damage produced by CO. The mechanlsm(s) responsible for producing the tissue 
damage (with 0.05% CO) are not discussed as this preliminary study was perfomned to 
evaluate the isolated heart model (1.8). However, the higher doses of CO (0.1 and 0.2%) 
showed no elevation in LDH activity (Figure 3.2). These findings suggest that sub-acute 
doses of CO ^0.05% CO may warrant further examination prior to making any conclusions 
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(Chapter 4). Furthermore the reduced PF observed in the 0.2% CO-treatment (above) 
may lower the activity of LDH (and also CK) by reducing the rate of release of these 
markers from the heart tissue(s). The increase in PF after the 0.2% CO-treatment could 
have occurred in the 0.05% CO-treated group (not determined here) and may account for 
the decrease in LDH activity following the CO-treatment (Figure 3.1). The absence of 
LDH activity (in the perfusate) from hearts exposed to ^ . 0 5 % CO suggests that the 
changes in PF may have masked any LDH release and could be determined more 
accurately by measuring the activity in perfusate fractions. 
The activity of CK in the perfusate samples did not allow any conclusions to be made as 
no control data was determined. The CK assays were performed at a later date after the 
experiments and this storage could have resulted in a loss of activity from the samples 
(Figure 3.3). The duration of storage at -20**C (prior to assaying for CK) in the samples 
was 2-3, 6, and 68-75 days for 0.10%, 0.20% and 0.05% CO. respectively. Any likely loss 
of CK activity may mirror the duration that the samples were stored at. Assuming there 
was a loss of activity with time, it suggests that there may have been a release of CK (as 
observed for LDH). Whether a dose-dependent release occured remains to be 
determined. Damage to the heart following CO exposure could be examined using 
sensitive markers of viability to indicate more specific tissue damage. Such markers 
include the troponins (Chapter 4) and myoglobin (Chapter 7) due to its specificity in 
showing early myocardial damage and its abundance in myocardial tissue, respectively 
(Ooi & Le May. 2000; Stokke et a/.. 1998). 
Inducible nitric oxide synthase (iNOS) is shown to be stimulated following 
ischaemia/reperfusion (l/R) and also after CO exposure (1.5). The role of nitric oxide (NO) 
during and/or after CO exposure may be ruled out in heart tissue at the levels of CO used 
here. The nitrite may have oxidised to nitrate (prior to measuring nitrite) and this may 
explain the absence of any difference in NO levels (as reflected by nitrite). However, this 
does not rule out iNOS. as NO may be found elevated in heart tissues following a period 
of induction post-CO exposure (Chapter 1). Therefore, this measurement will be excluded 
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in further studies, although its role in cardiac mortality following CO exposure cannot be 
eliminated. 
The antioxidant potential of perfusate samples showed no differences using the FRAP 
assay (3.2.5.4). Several flaws were identified in the method that could render it useless for 
this study. The use of acidic solutions (to maintain the solubility of iron) may prevent some 
antioxidants in reducing ferric iron. This change in pH may alter the redox potential and 
interfere with the antioxidant chemistry. Whether antioxidants were released from heart 
tissue (into the perfusate) cannot be concluded as used (or oxidised) antioxidants may not 
participate in the FRAP assay, unless they undergo redox recycling to their antioxidant 
state, i.e. become reduced. The FRAP assay is shown to detemriine the antioxidant 
activity in samples of plasma (Benzie & Strain. 1996). This could restrict the assay to 
using samples with a high content of antioxidants such as the plasma or heart tissue 
homogenates (relative to using perfusate samples). Conversely, other measurements 
such as the glutathione content may be determined to evaluate oxidative stress (Chapter 
5). 
The gases used here comprised 95% O2 (and 5% CO2) during the pre-CO stage that was 
changed to a CO-containing mixture (of 2 1 % O2 and 5% CO2 balanced with N2) during 
CO-treatment, followed by the pre-CO (CO-free) gas mixture. This use of gas mixtures 
(during CO-treatment) may have introduced a reduction in PO2 during the CO exposure in 
comparison to the basal (pre-CO) and the post-CO period (following CO-treatment); 
therefore, masking the effect(s) of CO by possibly introducing hypoxia. Using gases that 
remove this variable would have to be employed. Use of gas mixtures containing 2 1 % O2, 
5% CO2. 0-0.1% CO (balanced with nitrogen), i.e. maintain 2 1 % O2 throughout the entire 
perfusion would eliminate this en-or. The 0.05% CO-treated hearts showed the release of 
LDH into the perfusate (above) suggesting that CO may have a direct cardiotoxic effect 
irrespective of hypoxia produced following the changes in O2 levels during CO exposure. 
The absence of an elevated LDH activity in the perfusate of control hearts (0% CO) 
suggests that no hypoxia(-reoxygenation) injury may have occurred, therefore, ruling out 
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this introduction of hypoxia under the experimental conditions used. Conversely, no 
hypoxia may have been introduced as oxygen (at ^21%) was used throughout the 
experiments. 
Hyperbaric oxygen therapy (HBOT) following CO exposure may be studied by perfusing 
the heart preparations with buffer equilibrated with a greater content of dissolved oxygen, 
i.e. hyperoxic relative to the buffer equilibrated with 2 1 % O2. This appears to be a valid 
experimental model as hyperoxia of the blood is essentially what occurs during HBOT. 
Blood can carry 0.3ml of dissolved oxygen per 100ml under physiological conditions. I.e. 
inhaling air (21% O2) at sea level (one atmosphere). The inhalation of 100% O2 at 1 
atmosphere (atm) results in 1.5 ml O2 per 100ml blood, an increase by a factor of five 
(according to Henry's Law); at 3 atm (i.e. HBOT) increases the amount to 4.5ml O2. By 
using 95% O2 to perfuse the heart (and maintain the bicarbonate buffering with 5% CO2) 
may simulate these conditions, although the dissolved O2 content of the perfusing buffer 
may have to be detemnined to quantify the level of hyperoxia. Using different levels of O2 
may allow other levels of hyperoxia to be studied. The use of a high O2 level after CO 
exposure may indicate some positive effects of HBOT as shown by the increase in HR, 
PF and the decreased loss of LDH from the heart following CO-treatment. However, this is 
not conclusive as hyperoxia was used here prior to any CO exposure. 
Experimental hearts should be perfused with gas mixtures containing 2 1 % oxygen 
throughout the entire period to njte out hypoxia (above). This is not difficult to conduct 
(above), however, whether the heart preparation is able to use 2 1 % O2 remains to be 
determined as other organ studies use 95-100% O2 with 0-5% CO2 depending on the 
buffer used (McGrath & Martin, 1978). Examination of the oxygen consumption in vivo 
would appear to support the use of 2 1 % O2 in Langendorff perfusing hearts. Dissolved O2 
in the plasma Is used by the cells/tissues following its diffusion through the capillary walls. 
The content of dissolved O2 in the blood is 0.3ml per 100ml of arterial blood following the 
inhalation of atmospheric air. I.e. 2 1 % O2 (1.3 and above). Considering that this model 
comprises an isolated heart, it should be able to sustain itself using 2 1 % O2 (as other 
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compartments such as the tissues and blood are not present). Taking the above into 
consideration, it appears likely that the heart preparations using 2 1 % O2 throughout are 
likely to work and has been confirmed (in Chapter 4). Using 2 1 % is also more clinically 
relevant and strengthens the use of this model for our purposes. 
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3.5 Conclusions 
The Langendorff isolated heart preparation was used to evaluate and validate its use for 
investigating the cardiotoxicity of CO. This preliminary study identified some 
improvements (3.4) that support its use to address the hypothesis (1.7). The levels of CO 
used were chosen by examining the literature values and the symptoms produced (given 
in Chapter 1). The 0.05% CO dose produced tissue damage, however, the higher 
concentrations of CO may have had their toxicity masked due to an inaccurate sampling 
method. As the isolated heart was exposed to CO, the chosen concentrations of CO gas 
mixtures may exceed (theoretical) blood levels that could surpass death. Therefore, using 
a lower concentration of CO such as 0.01% CO may prove to be suitable for this study. 
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3.6 Further Work 
3.6.1 Nitric oxide 
A fluorometric assay with increased sensitivity and including nitrate reductase may be 
more suitable to detect any production of NO (Misko et a/., 1993). Alternatively, tissue 
homogenates could be prepared from heart tissue to eliminate the above issue of 
sensitivity. A recent method that continually monitors NO released from perfused hearts 
may be used (Tsukada et a/.. 2003). 
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Chapter Four: 
Cardiotoxicity of CO During Normoxia 
- Physiological Changes 
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4.1 Background 
Previous work has shown ultrastructural changes in rabbit hearts after exposing live 
animals to CO (Kjeldsen et a/., 1974). There are also studies that have reported changes 
in tissue viability following CO exposure (Penney & Maziarka, 1976) and some studies 
have assessed cardiac function using isolated hearts from rats exposed to CO. However, 
at present no studies have been found examining tissue biochemistry with physiological 
changes (in structure and function) following the CO exposure. This study will incorporate 
the necessary work to provide a detailed insight to elucidate the mechanism(s) of CO 
toxicity in the heart. 
Other studies used chronic exposure to CO and showed that significant changes occurred 
following CO exposure (1.4.1). Such changes include an increased haematocrit content, 
cardiomegaly, and other changes in the levels of various blood enzymes. Many of these 
changes were attributed to CO-induced hypoxia, therefore, the direct effect of CO in 
myocardial tissue is masked by other influencing variables (Chapter 1). For example, a 
cardiotoxic chemical species (or modified biomolecules) produced by other organs (such 
as the liver) following chronic exposure to CO may be responsible for the cardiotoxicity of 
CO. These early studies that examined chronic CO exposure failed to account for the 
associated heart failure that at present appears to be a direct effect of CO. Previous 
chronic studies also used non-lethal doses that were lower than the doses found in severe 
cases of acute CO poisoning. 
Studies are routinely performed solely examining the physiological changes without 
considering any biochemical changes. Our model used isolated rat hearts to assess the 
cardiotoxicity of acute CO poisoning, however, the blood component is missing and the 
organ is perfused using a modified Krebs-Heinshelt buffer (KHB; 3.2.2). Therefore, blood 
(or systemic) hypoxia cannot occur as CO cannot bind to haemoglobin (in erythrocytes). 
This model allowed the examination of CO directly in the heart and was performed by 
dissolving the CO-containing gas mixture into the buffer that perfused the isolated organ. 
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The novel aspect is that nomnoxic conditions were used throughout, i.e. all perfusions 
with CO were conducted in the presence of 21% oxygen. Biochemical measurements 
were also undertaken to look for evidence of a reperfusion-like injury to investigate the 
hypothesis (1.7). This chapter presents the physiological findings from this study (and 
Chapter 5 shows the biochemical aspects). 
110 
Chapter 4 Cardiotoxicity of CO During Normoxia - Physiological changes 
4.2 Materials & Methods 
4.2.1 Isolation & Langendorff Preparation 
Isolation of rat hearts and the Langendorff preparation were carried out as described 
previously in 3.2.1 and 3.2.2, respectively. No heparin was administered to the 
unconscious animal. (The reasons for not administering heparin in this study are stated in 
5.2.3). Isolated hearts that showed arrhythmia's immediately or other visible signs of the 
calcium paradox after being perfused were discarded. 
4.2.2 Experimental Protocol 
This was performed exactly as described by Patel a/. (2003). In brief, hearts were 
perfused for 15 minutes to wash out contaminating blood. The basal physiological 
parameters (4.2.3; heart rate and coronary flow) were determined over the next 15 
minutes. Exposure to CO was started by perfusing with buffer that was saturated with 0, 
0.01 and 0.05% CO (0, 100 and 500ppm, respectively) for 30 minutes, followed by a 90 
minute CO-free period. Note, the perfusing buffer was constantly saturated with 2 1 % 
oxygen and 5% carbon dioxide (balanced with nitrogen). The heart ventricle was then 
blotted and weighed prior to snap-freezing for biochemical analysis (Chapter 5). 
Some hearts were perfused with perfusion buffer supplemented with antioxidants. The 
antioxidants were perfused during the pretreatment period (i.e. whilst establishing basal 
levels of heart rate and coronary flow over 15min; 4.2.3) and during the 30min exposure to 
CO. The antioxidants used were TroloxC and ascorbic acid, at 0.2mM and ImM, 
respectively. The stock solution of ascorbate was prepared and added to the perfusion 
buffer before the start of the antioxidant perfusion. The inclusion of ascorbate required 
greater buffering in the perfusion buffer and was supplemented with lOmM HEPES. Other 
heart perfusions were performed that involved taking hearts immediately off the 
Langendorff apparatus after the basal parameters had been determined or after being 
treated with 0 and 0.01% CO (for 30 min). 
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4.2.3 Physiological Parameters 
Heart function was evaluated by monitoring the heart rate (HR; 4.2.3.1) at various fixed 
time points. This was perfomied to examine any change{s) in cardiac performance and 
investigate any direct effects of CO on the heart. The coronary flow (CF; 4.2.3.2) was 
measured to assess changes in coronary vasculature produced as a result of CO 
exposure. The time points used were -15 to -10, -10 to -5, -5 to 0, 0-5, 5-10, 10-15, 15-20, 
20-25. 25-30. 30-35. 35-45. 45-60. 60-80. and 80-120 minutes. 
4.2.31 Heart rate (HR) 
The heart rate (in beats.min'^) was determined by counting the number of heart beats in a 
30 second period three times around the midpoint of each time fraction (above). The 
mean HR was detemiined in each timepoint for each heart. 
4.2.3.2 Coronary Flow (CF) 
The coronary flow (CF) was determined from the volume collected (ml) over the time 
period for each fraction (in minutes) and normalised per gram of heart tissue (wet weight). 
The collected perfusate was immediately placed on ice for biochemical analysis (5.2.3). 
4.2.4 Changes in Heart Weight (HW) 
Prior to cannulating the heart (for Langendorff preparation; 4.2.1) the heart was blotted 
and quickly weighed to detennine the pre-perfusion HW. Following the perfusion the heart 
was quickly removed from the Langendorff apparatus, taken off the cannula and weighed 
to detemriine the post-perfusion HW. 
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4.2.5 T i s s u e Water Content 
The water content was determined in heart tissue from the difference in wet and dry tissue 
weights. Hearts were immediately taken off the perfusion apparatus following the 
experiment (4.2.2 and 4.2.4). The ventricle tissue was obtained (firstly, by removing the 
atrial and vascular tissue) using a scalpel, then some tissue (ca. 30-1 OOmg wet weight) 
was rapidly removed from the top portion of the ventricle mass opposite the apex. The 
remaining ventricle mass was gently blotted and weighed prior to being snap frozen and 
stored at -80°C (5.2.4). The removed portion of ventricle tissue was weighed (after gentle 
blotting) to give the wet weight (WW). The pieces of tissue were dried by incubating in an 
oven and drying to constant weight (at 80°C over 11 days). The tissue water content was 
expressed as a percentage (determined using (WW-DWA/W\/)x100%, where DW Is the 
dry weight). 
4.2.6 Metal Ion Ana lys is 
Dried ventricle tissue (from above; 4.2.5) was reconstituted in 2ml nitric acid (70%, 1.42 
S G ; Fischer Chemicals Ltd) in a fume hood and heated at 55°C (for lOmin) to dissolve the 
dry tissue. The following electrolytes: sodium (Na*), potassium (K*). calcium (Ca^*), 
magnesium (Mg^^), iron (Fe), copper (Cu^^). and manganese (Mn) were quantified using 
inductively coupled plasma mass spectrometry ( ICP-MS). The analysis was perfonmed 
using a PlasmaQuad PQ2+ Turbo ICP-MS with the following default lens setting: 
extraction 1.00-2.00; collector 7.70; lens 1 7.70; lens 2 5.40; lens 3 5.00; lens 4 3.85; and 
pole bias 4.60-5.50. The instrument was calibrated using appropriate metal solutions, and 
indium (lOOng.ml"^) as the blank. The sample preparation and electrolyte analysis was 
performed by Mr. Leonard Hawkins (as part of a final year undergraduate project). 
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4.2.7 Osmolarity 
The osmolarity of the perfusate were measured to evaluate any changes in the electrolyte 
content of heart tissue (4.2.6) following CO-treatment. The frozen perfusate samples were 
thawed on ice prior to determining its osmolarity. 
4.2.8 Histology 
Two to four tiny pieces (ca. 2-4mm length) of ventricle tissue from each heart were 
removed and immediately placed in 3% glutaraldehyde in 0.1 M sodium phosphate buffer 
for primary fixation (1h at 4°C). In brief, the pieces were then washed twice with buffer 
(5min each). Secondary Fixation was performed using 1% osmium tetraoxide (OSO4) in 
buffer (for 1h at 4*'C) prior to washing three times with buffer. T issue pieces were 
dehydrated using successive incubations (10min each) in ethanolic solutions (30, 50, 70, 
90% and absolute alcohol). The samples were then infiltrated with Spurr's resin in a 
graded manner prior to polymerisation in embedded blocks of resin. Ultra-thin sections 
(ca. 100nm) were prepared using a Reichert ultramicrotome and collected onto copper 
support grids for routine staining for contrast by Dr. Roy Moat (Electron Microscopy Unit, 
University Of Plymouth, UK). 
4.2.9 Data Ana lys is 
All data shown is expressed a s the mean ± S E M or S D with the number of hearts (n) 
cited for each group. Unless otherwise stated the Student's t test was used for statistical 
comparisons of the means using StatGraphics 5.0 software. 
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4.3 Results 
4.3.1 Genera l Observat ions 
The rat hearts were excised, cannulated and mounted on the Langendorff perfusion 
apparatus as quickly as possible in order to minimise tissue ischaemia (as discussed in 
Chapter 2 and 3). Isolated perfused hearts that beat regularly and showed no visible 
signs of the calcium paradox (Chapter 2) were used. The total number of hearts (or 
animals) used solely for this work including unsuccessful hearts were 40. The number of 
successful perfusions (used here and Chapter 5) were 36. The weights of the hearts used 
in the perfusions are presented in Table 4.1. Also shown are the body weights (BW) of the 
animals used from which the hearts were taken, and these were determined in 
unconscious animals prior to excising the heart. The start-stop perfusions were conducted 
using nine hearts (three in each group) and had a mean body and heart weight of 292 ± 
38 and 1.53 + 0.19 (mean ± S D ) . respectively. 
The region of the heart surrounding the coronary arteries was observed to swell up during 
the CO-free period in hearts exposed to C O . However, control hearts showed no sign of 
swelling. Some CO-treated hearts showed an increase in the volume of perfusion buffer in 
the bubble trap (placed above the heart to prevent air bubbles entering the heart). From 
the 0.01% and 0.05% CO-treatment, respectively, four and two hearts showed an 
increase in the volume of after C O exposure. This increase in buffer volume occurred at 
different periods after the CO-treatment. In general, these identified hearts appeared to 
have an increase in back pressure before their decline in heart rate (HR). Some hearts 
from the preliminary study (Chapter 3) also showed this increase in volume, however, 
those CO-treated hearts showed this trend either during and/or after the C O exposure. 
Control hearts had regular heart beat and showed no altered HR. Most of the CO-treated 
hearts displayed signs of arrhythmias indicated by fibrillation and irregular heart beat. 
Eight hearts (of ten) showed arrhythmias at some periods with 0.01% CO-treatment; 2. 3 
and 3 hearts showed these signs during CO-treatment. during and after CO-treatment. 
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and only after C O exposure, respectively. All hearts treated with 0.05% C O showed signs 
of arrythmia at some point: 3, 1 and 2 hearts showed these signs during CO-treatment, 
during and after CO-treatment, and after C O exposure, respectively. 
The coronary ostias region of the heart was close (in proximity) to the atria in control 
hearts indicating no swelling. A swollen appearance in the vasculature was observed in all 
hearts after the period of CO-treatment. However, this could not be presented here as this 
observation was not quantified or recorded. Two of the hearts (out of six) exposed to 
0.05% C O had two to three small red areas resembling haemmorhagic zones. These focal 
regions were found predominantly around the apex of the heart (after the perfusion). No 
tissue specimens were taken from these areas for histological examination. 
Group (n) Body weight (grams) Heart weight (grams) 
0% CO (3) 261.33 + 5.35 1.37 ± 0 . 1 0 
0% CO + AO (3) 258.23 ± 3.91 1.30 ± 0 . 0 7 
0.01% CO (yo) 246.21 ± 1 1 . 9 0 1.51 ± 0 . 1 1 
0.05% CO (6) 229.73 ± 1 1 . 0 9 1.42 ± 0 . 1 0 
0.05% CO + AO (5) 278.08 ± 7.82 1.61 ± 0 . 1 5 
0% CO; Omin 284.80 ± 39.07 1.43 ± 0 . 0 5 
0% CO; 30min 308.67 ± 44.94 1.69 ± 0 . 2 6 
0.01%; 30min 283.77 ± 38.97 1.46 ± 0 . 1 0 
All (36) 261.70 ± 3 0 . 2 1 1.48 + 0.15 
Table 4.1 The body and heart weights of adult male Sprague-Dawley rats In each 
treatment group. This includes the CO-treated groups, antioxidant (AO) perfusions, and 
start-stop perfusion. The data shown Is expressed as the mean ± S D for each group with 
the number of hearts in each group {n). 
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4.3.2 Heart rate (HR) 
The basal heart rates of the perfused hearts ranged from 78-274 beats.min'^ for the hearts 
perfused with or without antioxidants (AO). The mean heart rate (HR) for the pretreatment 
period are shown in Table 4.2. To allow comparisons to be made between the CO-treated 
groups: the three pretreatment HR levels were expressed as a mean pretreatment HR 
and the other HR were expressed as a percentage of the mean pretreatment level (taken 
as 100%) for each heart. The data were expressed a s the mean ± S D for each group 
(Figure 4.1). 
Control hearts beat regularly and had no significant deviation to the pretreatment (basal) 
HR. The CO-treatment had a negative chronotropic effect. Hearts treated with 0.01% C O 
showed a decline and a recovery in HR during the 30min period. These hearts had a 
decline in the CO-free perfusion period. Those hearts exposed to 0.05% C O showed a 
similar decrease, however, there were no signs of recovery during the CO-treatment and 
the mean HR were similar to the 0.01% exposed levels at the end of the perfusion. The 
decline in HR showed no significant differences to the control hearts (0% C O ) throughout 
the perfusions. The control antioxidant group had no difference to the control group 
without AO, however, the CO-treatment had a negative chronotropic effect that was 
augmented with the antioxidants. 
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Time Heart rate (beats min* ) 
(min) 0% C O 0% CO 0.01% C O 0.05% C O 0.05% C O 
(n = 3) with AO {n = 3) (n = 10) (n = 6) with AO (n = 5) 
-12.5 191 ± 6 9 189 ± 1 4 131 ± 19 142 ± 32 151 ± 4 2 
-7.5 185 ± 6 2 1 8 3 ± 1 1 132 ± 18 142 ± 29 160 ± 53 
-2.5 186 ± 7 5 184 ± 15 135 ± 2 0 144 ± 30 163 ± 5 5 
Table 4.2 The pretreatment heart rate (HR, in beats.min^) of isolated perfused rat hearts 
Hearts were perfused in a retrograde manner through the aorta using a Langendorff 
apparatus at 6ml.min \ g ^ (wet weight). The hearts were perfused with a modified Krebs-
Henseleit buffer at 36.9°C (see Materials & Methods for the composition of the perfusion 
buffer). The buffer was equilibrated with a certified gas mixture containing 21% oxygen, 
5% carbon dioxide, balanced with nitrogen and gassed constantly with this mixture for the 
entire perfusion period to establish pH 7.4. Hearts were perfused for 15min to wash out 
blood and allow the organ to stabilise from the excision procedure The basal HR (or 
pretreatment HR) were determined over another 15min period prior to commencing the 
carbon monoxide (CO) treatment. Some hearts were treated with antioxidants (AO): 
TroloxC and sodium ascorbate were included in the perfusion buffer (at 0.2 and ImM, 
respectively) during the 15min equilibration (basal) period and during the exposure to C O . 
The C O exposure (for 30min) used normoxic conditions with 0% C O {n = 3 hearts; 
controls), 0% C O with AO (n = 3 hearts; AO controls). 0 01 and 0.05% C O (r? = 10 and 6 
hearts, respectively) and 0.05% C O with AO {n = 5). Normoxic conditions were used 
throughout the entire perfusion using gas mixtures with varying nitrogen levels to 
compensate for the different C O level (0 to 0.05%). Hearts were treated by switching the 
buffer with a pre-equilibrated buffer containing the desired C O concentration. The time to 
attain this new equilibrium was ca. 2min. Following the 30min C O exposure, hearts were 
perfused for 90min to a s s e s s the post-CO HR; not shown. The data shown is the mean ± 
S O for n hearts in each group 
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Figure 4.1 The heart rate of isolated rat hearts exposed to carbon monoxide (CO) by 
perfusion using a Langendorff perfusion apparatus. Hearts were perfused in a retrograde 
manner through the aorta using a Langendorff apparatus. The hearts were exposed to 0, 
0.01 and 0.05% C O and 21% O2 (balanced with N2) for 30 minutes followed by a CO-free 
gas mixture (90 min) by perfusion Some hearts were perfused with antioxidants (AO; 
0.2mM TroloxC and 1mM sodium ascorbate) during the pretreatment period (15min) and 
during the C O exposure (30min). The black bar denotes the period that hearts were 
exposed to C O , whereas, the blue bar shows when AO were perfusing the hearts. Same 
conditions as described in the legend for Table 4.1. The mean basal (or pretreatment) HR 
were taken as 100% and the HR expressed as a percentage of the determined basal HR. 
The data shown is the mean ± S E M with the number of hearts (n) used in each group 
depicted in the figure. No significant differences were found at the 95% confidence level 
between the controls (with or without AO) and the CO-treated groups. 
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4.3.3 Coronary Effluent 
The coronary flow (CF) was determined to a s s e s s any change in the perfusion of hearts 
exposed to C O . The tenms coronary flow (CF) and perfusate flow (PF) is used 
interchangeably as exemplified in other literature, however, some readers may disagree 
with this. The isolated hearts were perfused using a calibrated pump that was validated 
before and after completing the study (not shown). All the hearts were perfused at 
6ml.min'\g'^ (see 4.2.1) and the mean pretreatment C F are shown in Table 4.3. These 
values were transformed as performed for the heart rates (described in 4.3.2) and shown 
in Figure 4.2. The C F declined significantly in a dose-dependent manner after the C O -
treatment relative to the control group (Figure 4.2). The 0.05% CO-treated group had a 
significant decline in cumulative C F over the CO-free perfusion period relative to the 
control group (not shown) and is expected from the observed decline in C F . The inclusion 
of A O prevented the decline in C F produced after the 0.05% CO-treatment (Figure 4.2). 
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Time Coronary flow (ml.min Vg^ wet weight of heart) 
(min) 0% C O 0% C O 0.01% C O 0.05% C O 0.05% C O 
(n = 3) with AO (n = ( n = 1 0 ) (n = 6) with AO (n = 
3) 5) 
-12 5 5.61 ±0 .22 6.87 ± 0.11 5.73 ± 0 . 3 0 5.61 ± 0 23 7.12 ±0 .41 
-7.5 5.56 ± 0 . 1 9 6.87 ± 0. 11 5.75 ± 0 . 3 3 5.60 ± 0.24 7.15 ±0 .38 
-2 5 5.56 ±0 .14 6.87 - 0. 11 5 74 ± 0.33 5 59 ± 0.23 7.14 ± 0 40 
B 
Time Cumulative volume of perfusate (ml.g^ wet weight of heart) 
(mm) 0 % C O 0 % C O 0.01% C O 0.05% C O 0.05% C O 
(n = 3) with AO (/? = 3) (n = 10) (n = 6) with AO [n = 5) 
0 84 ± 2 103 1 86 ± 1 84 ± 0 107 ± 3 
30 250 ± 3 308 ± 1 256 ± 4 250 ± 1 322 ± 7 
120 745 - 10 919 - 4 739 ± 13 708 ± 13 9 5 3 : 2 6 
Table 4.3 The coronary flow (OF) of isolated rat hearts perfused with carbon monoxide 
(CO) with or without antioxidants (AO). Hearts were treated as described earlier (in Table 
4.1 and Figure 4.1) and perfused at a flow rate of 6ml min Vg^ (wet weight). The C F was 
determined by measuring the collected volume of perfusate (or coronary effluent) in the 
perfusion fractions and normalising this volume per gram (wet weight) of heart tissue [A). 
The times stated above (in min) represent the midpoint of the time fractions used in the 
experiments: -15 to -10, -10 to -5. and -5 to 0 minutes The data shown is the mean ± S D 
for n hearts in each group (B) The cumulative volume of perfusate following C O -
treatment with or without antioxidants (AO). The perfusate were collected from hearts 
exposed to C O in the time fractions (under the same conditions as described previously) 
and the volume of perfusate was measured prior to any biochemical analysis. The 
cumulative volume were normalised (as described above) and the mean ± S E M 
expressed for each group of treated hearts. 
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Figure 4.2 The coronary flow (CF) of isolated rat hearts exposed to C O with or without 
antioxidants (AO). The same experimental conditions were used as described in Figure 
4.1. The black and blue bar denotes the period that hearts were perfused with C O (30min) 
and AO (45min). respectively. The pretreatment C F values were taken as 100% with the 
other measurements expressed as a percentage of the basal levels. The number of hearts 
used in each group is the n number shown in the figure (above). The data shown is the 
mean ± S E M for the hearts in each group. The asterisk (*) and hatched symbol (#) 
indicate a significant difference using ANOVA multivariate analysis at the 95% confidence 
level between the controls (with or without AO) and 0.01% C O groups, respectively. 
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4.3.4 Heart Weights & T i s s u e Water Content 
The hearts were weighed prior to and after the perfusion to estimate changes in wet 
weight following C O exposure. All the groups had an increase in mean heart weight (HW) 
after being perfused compared to their pre-perfusion HW (Table 4.4). The increases were 
not significantly different to the control group (with or without AO). The water content of 
the ventricle tissue from perfused hearts (without AO) were detemiined by drying the 
tissues to constant weight (Table 4.4). No significant difference were found in these 
groups relative to the controls. 
Measurement 0% C O 0% C O 0.01% C O 0.05% C O 0.05% C O 
(n = 3) with AO ( n = 1 0 ) (r7 = 6) with AO 
(r7 = 3) (n = 5) 
Pre-perfusion 1.37 ± 0 . 1 0 1.30 ± 0 . 0 7 1.51 ± 0 . 1 1 1.42 ± 0 . 1 0 1.61 ± 0 . 1 5 
HW 
Post-perfusion 1.57 ± 0 . 1 1 1.44 ± 0 . 1 0 1.68 ± 0 . 0 9 1.50 ± 0 . 0 8 1.77 + 0.08 
HW 
Increase in 15.00 ± 7 . 5 0 10.72 ± 12.56 11.58 ± 3 . 4 7 5.97 ± 5.26 10.62 ± 5 . 8 8 
HW (%) 
Tissue water 82.5 ± 0.9 nd 83.0 ±1 .4^ 82.3 ± 2.7 nd 
content (%) 
Table 4.4 The wet heart weights (HW) before their perfusion and after the 30min C O 
exposure and CO-free (90min) perfusion period. The post-perfusion water content (%) 
were determined by drying preweighed ventricle tissue (taken from perfused hearts) to 
constant weight. The data shown is the mean ± S D for the hearts in each group; and nd is 
not detemiined. ^The n number of hearts was 8 (and not 10) through no collection and 
loss of the tissue sample. 
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4.3.5 T i s s u e Electrolyte Content 
The electrolyte content was determined in the dried ventricle tissue of perfused hearts 
(described in 4.2.6). The electrolyte content were measured using ICP-MS for the 
following metals: sodium, potassium, calcium, magnesium, iron, copper, and manganese. 
The data shown below (in 4.3.5.1-4.3.5.8) is the mean ± S D from 3, 3, 8, 6 and 5 hearts 
for the 0% (controls), 0% with A O (AO control), 0.01 and 0.05% C O , and 0.05% C O with 
AO (0.05% CO+AO) groups, respectively. 
4.3.5.1 Sodium 
The sodium content in the dried ventricle tissue of each treatment group were 8497 ± 
1116, 9014 ± 2366, 6217 ± 1757, 9537 ± 2211. and 5891 ± 1178 ng.g ' (dry weight) for 
the control (n = 3 hearts). AO control (3). 0.01 {n = 8) and 0.05% C O (n = 6), and 0.05% 
CO+AO groups, respectively. There were no significant differences in the levels of sodium 
between the control and CO-treated groups ± AO. Although the sodium content in the 
0.01% C O and 0.05% CO+AO groups were lower relative to the other groups. The ratio of 
sodium to potassium content was also determined (see 4.3.5.8). 
4.3.5.2 Potassium 
The potassium content in the dried ventricle tissue for each group were 12672 ± 1483. 
12629 ± 2562, 7827 ± 1492. 13680 ± 2839. and 6516 ± 2328 ng.g'^ (dry weight) for the 
control, AO control. 0.01 and 0.05% C O . and 0.05% CO+AO groups, respectively (with 
the same n numbers as cited above for sodium). There were no significant differences 
between the CO-treated (± AO) groups relative to the control, however, the 0.01% C O and 
0.05% CO+AO groups were lower as the sodium content (above). The ratio of sodium to 
potassium content was determined (see 4.3.5.8). 
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4.3.5.3 Calcium 
The calcium content of the dry ventricle tissue were 1735 ± 331. 1475 ± 310. 1284 ± 148, 
1864 ± 275, and 1688 ± 429ng.g*^ (dry weight) for the control. A O control. 0.01 and 0.05% 
C O , 0.05% CO+AO groups, respectively. The 0.01% CO-treated hearts had a lower 
calcium content. No significant differences were found in the CO-treated hearts (± AO) 
relative to the control. 
4.3.5.4 Magnesium 
The level of magnesium ("Mg) in the dry ventricle tissue were 1041 ± 146, 1053 ± 154, 
817 ± 79, 983 ± 188, and 756 ± 137 |ig.g'^ (dry weight) for the control, AO control. 0.01 
and 0.05% C O , and 0.05% CO+AO groups, respectively. No significant differences were 
found in the CO-treated hearts ± AO relative to the control group. The analysis using ICP-
MS also determined the levels of ^®Mg and these were similar to the "Mg levels (not 
shown). 
4.3.5.5 Iron 
The determined content of iron measured the total iron pool. i.e. Fe^* (ferrous) and Fe^* 
(ferric). The iron level in the dry tissue were 205 ± 73, 353 ± 101, 315 ± 42, 372 ± 95 and 
349 ± 136 ^g.g'^ (dry weight) for the control, A O control, 0.01 and 0.05% C O . and 0.05% 
CO+AO groups, respectively. The increased iron content of hearts exposed to C O had no 
significant difference relative to the control group. The control A O group also had an 
increase in iron content compared to the control group (with no AO) , however, this 
increase was not statistically significant (at P < 0.05). 
4.3.5.6 Copper 
The copper content in the dry ventricle tissue were 63 ± 34, 27 ± 5, 34 ± 2, 31 ± 6. and 34 
± 13 |ig g*' (dry weight) for the control. A O control, 0.01 and 0.05% C O . and 0.05% 
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CO+AO groups, respectively. The two C O exposed groups without A O had copper levels 
that were not significantly reduced compared to the control group. The control A O group 
had a lower copper content than the control group without A O (above). The AO appear to 
produce a similar change as C O for heart ventricle tissue, i.e. reduce the copper content. 
4.3.5.7 Manganese 
The level of manganese In the control group was unquantlfiable (at -16 ± 9 ng.g'^ dry 
weight). This level was considered negligible compared to the values for the AO control, 
0.01%. 0.05% C O . and 0.05% CO+AO treated groups of 20 ± 6. 4 ± 3. 7 ± 3. and 12 ± 4 
ng.g*^ (dry weight), respectively. The antioxidant (AO) treatment increased the level of 
manganese in the heart ventricles, however, no significant difference were found between 
the treated groups relative to the control group 
4.3.5.8 Sodium/potassium and calcium/magnesium ratios 
A change in the ratio of sodium to potassium content may indicate cellular fluxes within 
the tissues. The ratio of sodium to potassium (Na*/K*) Is determined from the tissue 
contents (above) and were 0.67 ± 0.01, 0.71 ± 0.04, 0.78 ± 0.12, 0.70 ± 0.14, and 1.00 ± 
0.40 for the 0 (control). AO control, 0.01 and 0.05% C O , and 0.05% CO+AO groups, 
respectively. The C O ± AO-treatment showed an increased ratio, although this were not 
significant. The ratio of calcium to magnesium was determined similarly as for NaVK* to 
evaluate any fluxes of these ions In heart tissue following the exposure to C O . The ratio of 
calcium to magnesium (Ca^V^Mg^*) were 1.67 ± 0.28. 1.41 ± 0.28. 1.58 ± 0.18. 1.92 ± 
0.23, and 2.39 ± 1.13 for the 0 (control), AO control, 0.01 and 0.05% C O . and 0.05% 
CO+AO groups, respectively. These values showed no significant difference between 
each treatment group compared to the controls and may suggest that no sodium or 
calcium loading occurred. The 0.05% CO+AO treatment increased this ratio, however, it 
were not signficant. 
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4.3.6 Osmolarity of Heart Perfusate 
The osmolarity (a measure of the osmotic pressure) of the collected perfusate was 
determined (at a later date). The perfusate samples for each fraction were stored frozen 
prior to measuring its osmolarity. The mean osmolarity for each treatment group is shown 
in Table 4.5>*. No significant differences (in osmolarity) were found between the C O -
treated and control groups, nor between the two C O exposed groups. The osmolarity of 
the perfusion buffer were also measured before the start and after the perfusions (Table 
4.5B). No significant differences were found in the osmolarity between the two groups. 
The perfusate osmolarity was not determined for hearts perfused with antioxidants. 
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Time Osmolarity (mmol.kg'^) 
(min) 0% C O 0.01% C O 0.05% C O 
(n = 3) ( n = 1 0 ) (n = 6) 
-12,5 257 ± 25 270 ± 17 275 ± 1 8 
-7.5 283 ± 13 258 ± 19 278 ± 6 
-2.5 261 ± 28 266 ± 22 278 ± 3 
2.5 262 ± 39 268 ± 30 280 ± 7 
7.5 255 ± 35 261 ± 24 279 ± 1 3 
12.5 283 ± 5 270 ± 17 278 ± 5 
17.5 282 ± 12 264 ± 1 5 275 ± 11 
22.5 254 ± 2 8 253 ± 32 253 ± 36 
27.5 266 ± 18 265 ± 18 277 ± 9 
32.5 288 ± 5 259 ± 32 266 ± 20 
40 262 ± 24 258 ± 35 260 ± 31 
52.5 265 ± 33 269 ± 19 262 ± 23 
70 264 ± 4 4 237 ± 47 274 ± 6 
100 286 ± 2 260 ± 36 268 ± 11 
Osmolarity of 0% C O 0.01% C O 0.05% C O 
perfusing buffer ( n = 3 ) ( r7=10) (r? = 6) 
(mmol.kg"^) 
Pre-perfusion 261 ± 4 3 269 ± 27 279 ± 4 
Post-perfusion 278 ± 2 1 270 ± 22 280 ± 3 
Table 4.5 Osmolarity in the coronary perfusate of rat hearts exposed to C O (A). The 
collected perfusate was stored at -20''C (after noting the necessary measurements and 
taking sample aliquots for biochemical analyses) prior to determining the osmolarity. The 
samples were thawed and kept on ice to minimise any evaporation to reduce inaccurate 
measurements. The osmolarity of the perfusion buffer before and after perfusing the 
hearts with C O is also shown in (B) , pre- and post-perfusion, respectively. The data 
shown is the mean ± S D for the number of hearts {n) in each treatment group. 
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4.4 Discussion 
The carbon monoxide (CO) treatment had a direct effect on the heart rate (HR) of isolated 
perfused rat hearts. C O exposure reduced the HR in the CO-treated hearts relative to the 
control group (not exposed to CO) . A decrease in HR during C O exposure was also 
shown by McGrath (1984) using the Langendorff preparation. Their findings showed an 
immediate decline in HR during the CO-treatment, however, this decrease was 
significantly dose-dependent. Normoxic conditions were used during the experimental 
period using perfusion buffer equilibrated with 21% oxygen, whereas, McGrath (1984) 
used different levels of C O (0-95%) balanced with oxygen. The different level of oxygen 
used during C O exposure may have contributed to the reduced HR resulting from 
introducing hypoxia (as addressed previously in 3.4). The HR post-CO exposure was not 
reported by McGrath (1984) to compare with our findings. 
C O is shown to reduce the cerebral energy metabolism during C O exposure in vitro 
(Rogatsky et al., 2002). This could suggest that a reduction in HR during and after C O 
exposure may be caused by a reduction in the cardiac energy metabolism. The further 
reduction in HR during the exposure to 0.05% C O with AO may be due to the inhibition of 
cytochrome c oxidase (or Complex IV). C O binds to the reduced haem centre of 
(fen'o)cytochrome as (Piantadosi. 1987) and could suggest a reduction of Complex IV by 
ascorbate (from the AO-treatment). C O can behave as a reductant. although this is 
reported to be 'far too slow' to inhibit cytochrome c oxidase (Morgan et a/.. 1985). Early 
damage to mitochondrial function occurs during myocardial ischaemia (Kay et a/., 1997) 
and may contribute to the cardiotoxicity following severe C O poisoning in vivo where the 
incidence of hypoxia may be more likely than in the conditions used here. Whether any 
disruption in myocardial energetics occurred at the cytosolic or mitochondrial level needs 
further investigation to clarify the nature of events in C O poisoning and the heart rate. 
An increased sodium content in heart tissue is shown to depress the contractile activity 
during anoxia (McGrath & Bullard. 1970). The decrease in HR could suggest that tissue 
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loading of sodium occurred in the heart during and/or following C O exposure. The 
contraction of rabbit papillary muscle disappear after ischaemia (Dekker et a/., 1996) 
suggesting that the CO-treatment may have resulted in ischaemia responsible for the 
decreased HR. This ischaemia-induced contracture is shown to increase the intracellular 
calcium. However, neither increase in sodium or calcium were found here (discussed 
below). 
The intoxication of C O in vivo is shown to produce tachycardia to compensate for the 
depressed oxygen tension of the blood (1.4.1). However, bradycardia was observed In 
isolated hearts exposed to C O . The absence of these in vivo homeostatic mechanisms 
suggests a direct effect of C O in the isolated heart under normoxia. The bradycardia 
observed here is also shown in severe c a s e s of C O poisoning where heart block is found 
to occur (Shafer et a/.. 1965). Low levels of COHb (as low as 9% In blood) are associated 
with death following cardiac arrhythmia's (Dolan. 1985). The observed incidence of 
arrhythmia's in the hearts following CO-treatment (4.3.1) suggest that heart failure may 
have occurred If a longer period of CO-treatment and/or CO-free period were used. A 
major cause of death associated with acute C O intoxication Is cardiac arrhythmia (Dolan. 
1985). C O exposure produced an irregular beating of the heart similar to that described by 
Ehrich a/. (1944). These workers also found changes in the electrocardiogram ( E C G ) 
such as a decreased amplitude of the T-wave. inversion of the T-wave. elevation of the R-
T segment, and later atrioventricular (AV) heart block. These E C G changes following C O 
poisoning are also found to occur during anoxia (Ehrich et a/., 1944; Middleton et a/., 
1961). The observed irregular heart beats and fibrillation cannot conclude these were 
arrhythmia's as no E C G recordings of hearts were taken following C O exposure. 
However, it may be reasonable to associate those other findings with these found to 
suggest that C O may have resulted in anoxia (or Ischaemia) within the myocardium. 
Although C O may have a different cardiotoxic mechanism than that of 
ischaemia/reperfusion (l/R) Injury, the observed reduction In HR were similar to that of 
globally ischaemic hearts (over the same period as the C O exposure, i.e. 30 minutes). 
These findings may support a mechanism of l/R-like injury in the cardiotoxicity of C O . 
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However, ischaemia is not shown to reduce the HR in either isolated heart preparation 
(Chambers etaL, 1991). 
In wVo a wide variation in blood PCO2 and pH can affect the susceptibility of the heart to 
fibrillation (DeBias et a/., 1976). The altered HR in hearts (exposed to C O ) cannot be 
explained by changes in PCO2 (or pH) as these were constant throughout the perfusions. 
The chronotropic changes and arrhythmia's/fibrillation's may be due to an impaired 
coronary perfusion of the contractile components. The exposure to 0.01% C O in monkeys 
(for 6h) produced T-wave inversions that increased in incidence when infarcted monkeys 
were similarly exposed to C O . The energy requirements of the myocardium are greatest in 
the subendocardial layer of the LV, therefore, the inner wall is most likely to shown signs 
of reduced contractility in LV dysfunction (Einzig ei a/., 1980). Patients with LV dysfunction 
(failure) have been shown to have an accompanying endothelial dysfunction and an early 
reduced myocardial perfusion during the transition from LV dysfunction to heart failure (de 
Jong et a/., 2003). The negative chronotropic response may Indicate left ventricular 
dysfunction and the reduced coronary flow after C O exposure suggests that it could 
produce heart failure in this manner. 
The in vivo positive chronotropic change following C O exposure arises from homeostatic 
changes to maintain adequate oxygenation of the tissues (above). Although an in vivo 
human study using humans exposed to high levels of C O (of 3.56%) found no significant 
increase in HR (Stewart et a/., 1973). The isolated heart may amplify any cardiac changes 
shown here as no other tissue compartments were present. Therefore, the findings from 
this study may be extrapolated to an in vivo setting associated with exposure to lethal 
levels of C O (Chapter 3). The use of a working heart preparation Instead of the 
Langendorff preparation could have produced different results due to differences In 
myocardial energetics (3.1.2). Investigation of the change In HR during l/R (1.6) with both 
preparations of isolated rat heart has shown that the Langendorff preparation is more 
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resistant to ischaemia than working hearts in the time taken to attain a similar negative 
chronotropic level (Galinanes & Hearse, 1990b). 
The observed order of events suggests that C O has a negative chronotropic effect that is 
produced before reducing the coronary flow ( C F ; 4,3.3). The permanently reduced HR 
following the 0.05% C O exposure suggests that some irreversible damage may have 
occurred in the contractile apparatus of the heart and account for the decreasing C F 
observed post-CO. Some hearts in the 0.01% CO-treated group had a recovery, whereas 
others showed a depressed HR with no sign of recovery post-CO suggesting an 
irreversible effect of CO. Histological change(s) in these tissues remain to be determined 
to identify any component(s) of the impaired heart activity. These changes appeared to be 
irreversible in this study, however, McMeekin & Finegan (1987) reported this impairment 
to be reversible using one patient. 
The altered HR (following the C O exposure) may suggest an early causal role of heart 
failure by C O (SzatkowskI ei a/.. 2001). The appearance of microscopic focal lesions were 
observed in the myocardium of adult rats exposed to 0.05% C O in air (Thomas & 
O'Flaherty. 1982) and supports the direct in vivo effect of C O that has been illustrated on 
several occasions in this study. Myocardial lesions as haemorrhage foci were observed in 
the ventricle tissue (4.3.1) and also shown In other c a s e s of acute C O poisoning (Marek & 
Piejko, 1972). Necrosis is found in the reperfused canine myocardium after prolonged 
Ischaemia (Becker et a/., 1999). Necrosis could have occurred In some of the myocytes 
and produced the contractile changes, however, this remains to be confirmed (in the 
ventricle tissue) using electron microscopy. These observed zones were predominantly 
found in the outer wall of the ventricle and support the transmural gradient driven by the 
perfusion through the coronary arteries (Griggs Jr. et a/., 1972). The lack of coronary 
obstruction (as found using coronary angiogram) in a patient exposed to acute C O 
(Marius-Nunez. 1990) appears to rule out the no-reflow phenomenon and supports the 
Increased permeability of the coronary vasculature a s a possible cause of the depressed 
coronary flow. 
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The change in HR by C O is similar to that reported for tobacco smoking and may be 
associated with the clinically recognised tobacco angina (Ayres et a/. . 1970). Smoking 
tobacco produces initial tachycardia and shows a common flattening of the T-wave of the 
E C G trace (Oram & Sowton, 1963). The contractile changes described here may have 
resulted in an altered E C G recording during the period of C O exposure. Furthermore, the 
inverted T-waves found in ischaemia/reperfused hearts (Kolb, 2002) have been observed 
by other workers examining myocardial function following C O poisoning (McMeekin & 
Finegan, 1987). This may suggest that similar mechanisms and/or possible CO-induced 
ischaemia could be responsible for producing the CO-assoclated morbidity in heart tissue. 
Although the work of De Bias et ai (1976) showed an increased P-wave amplitude and T-
inversion In the hearts of monkeys exposed to 0.012% C O (for 24 weeks), they concluded 
this was a result of non-specific myocardial stress rather than ischaemia (World Health 
Organization, 1979). 
The changes in HR following the exposure to C O may be accounted for by ischaemia 
possibly at an intracellular level. Myocardial Ischaemia as In a heart attack can kill cardiac 
cells (Sussman, 2001) and produce an altered ventricular function that can reside in two 
conditions: hibernating and stunned. The hibernating myocardium refers to viable 
myocardium that has become Impaired following ischaemia, however, It is akinetic and 
may recover its function after adequate revascularisation (Siebelink et a/., 2000). The 
hibernating myocardium represents left ventricular dysfunction and can persist for several 
months to years (Kloner et a/., 1989). The stunned myocardium represents a prolonged 
myocardial depression (Luss et a/., 2002). The myocardium can be salvaged by coronary 
reperfusion that exhibits transient postischaemic contractile dysfunction and lasts for 
hours to days (Patel et a/., 1988). The 0.05% CO-treated group had a depressed HR after 
C O exposure and may indicate a stunned myocardium. The 0.01% CO-treated group of 
hearts showed a recovery during the C O exposure, although the decline in the post-CO 
period may be attributed to a hibernating myocardium that may have shown recovery at a 
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later stage. Myocardial blood flow is impaired in the hibernating myocardium (Luss et al., 
2002) and stunned myocytes show an impaired transport of calcium (Kloner et al., 1989). 
The coronary flow (CF) had a dose-dependent decline after the CO-treatment and 
suggests that C O may have direct effect(s) on the coronary vasculature. The coronary 
microvessels play a significant role in the determining the supply of oxygen and nutrients 
to the myocardium by regulating the C F conductance and substance transport (Komaru et 
al., 2000). A similar reduction in blood flow is shown for rat lungs subjected to l/R (Vural & 
Oz, 2000). However, previous studies using whole animals exposed to C O , specifically 
rats, have shown that C F is increased in isolated perfused hearts taken from rats exposed 
to C O (Lin & McGrath, 1989; McFaul & McGrath, 1987). This is thought to be an adaptory 
response that occurs in vivo to maintain adequate oxygenation of the heart. 
Heparin immediately increases the levels of hepatocyte growth factor (HGF) and this has 
a role in angiogenesis and growth of the collateral vessels (Matsumori et al., 1998). Using 
heparin may have masked the changes observed in C F and could play a crucial rote when 
examining the findings of other studies investigating the effects of ischaemia and C O in 
vivo. However, it is unlikely that any released H G F (if heparin had been administered) 
could evoke the described changes (above) in the period prior to perfusing the isolated 
heart. 
The work by Bischoff et al. (1969) investigated the myocardial ultrastnjcture in dogs, 
rabbits and rats maintained at high altitude (4.300m for 5 months) and showed that the rat 
appeared to be the most resistant species by showing minor changes (Kjeldsen et al., 
1974). In light of this, the direct effect of C O on the coronary vasculature (found here) may 
be significant in man and could contribute to atherosclerosis, if not reversed before 
causing any myocardial damage. Work by McGrath & Smith (1984) showed that C F 
increased dose-dependently with C O levels below 50%, however, their study was limited 
by the introduction of hypoxia unlike here. Collateral flow is reduced following myocardial 
reperfusion after an ischaemic episode (Becker et al., 1999), therefore, supporting the 
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notion (1.7) that intracellular hypoxia may have o c c u r e d following C O exposure In the 
presence of normoxia. Ischaemia has been shown to reduce the coronary vasodilator 
reserve (Fernandez et ai, 2002) and suggests that the depressed C F after C O exposure 
may have arisen following intracellular Ischaemia (produced from C O binding with 
myoglobin and limiting the diffusion of oxygen Into the myocardial tissue). Isolated rat 
hearts subjected to global ischaemia (by clamping the aortic cannula for thirty minutes) 
have also shown a decline in C F after the ischaemic episode (Galinanes & Hearse, 
1990a). 
The arterioles, venules and capillaries of rabbit hearts exposed to 0.018% C O in vivo (for 
two weeks) showed similar swollen characteristics (Kjeldsen a/., 1974). This swelling 
was possibly due to the absence of elastic membranes in the observed region. These 
workers also found a small accumulation of erythrocytes and thrombocytes and inferred 
petechiae, however, this tissue damage may have been caused by an inflammatory 
response. The autopsy of human hearts following acute C O poisoning showed acute 
circulatory failure in 45% of deaths (Marek & Piejko, 1972). Histological examination of 
these myocardial specimens showed similar changes of hyperaemia and lesions in the 
muscle fibres. Endothelial damage is attributed to the oedema found in the muscles of C O 
poisoned c a s e s (Finley et a/., 1977). Endothelial cells may be sensitive to C O (Brenner & 
Wenzel, 1972) and the underperfusion of muscle tissue may contribute to the 
myonecrosis observed in C O poisoning. 
The presented findings and evidence (above) suggest that C O intoxication may produce 
oedema. The vasodilatory effect of C O Is possibly a direct effect and the nonmoxic 
conditions here rule out the Involvement of any ischaemia-lnduced vasodilation. Rats that 
survived cyanide treatment showed no oedema, whereas C O produced significant 
cerebral oedema (Salkowski & Penney, 1995). The direct effect of C O must be considered 
in C O toxicity as oedema (produced through vasodilation) may be mistaken for cell 
swelling and Indicate cell/tissue damage. The presence of a swollen vasculature appeared 
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to be largest for the 0.05% CO-treated hearts relative to the 0.01% C O group at the end of 
the perfusion period. 
The profile of the C F post-CO may indicate some early damage prior to eventual heart 
failure through the cessation of myocardial perfusion. However, it has been shown that a 
reduced coronary blood flow of 60% lowered the oxygen consumption by 30%, 
accelerated the rate of glucose utilisation and increased the levels of lactate (Neely et a/., 
1975). The reduction in C F could impair the oxygenation of the heart itself (depending on 
the dose and duration of C O exposure). The likely vasodilation following C O exposure 
found here may be mistaken in vivo as a compensatory mechanism to deliver more 
oxygen to the vasculature. The presence of excess fluid could limit the availability of 
oxygen (also other essential nutrients and impair the removal of waste) from the increased 
diffusion space produced between the capillary bed and localised tissues (Kjeldsen et ai, 
1974). This may also be a protective measure to limit the delivery of C O within the 
myocardium. These myocardial changes are not restricted to the vasculature as other 
workers have also shown swelling in mitochondria and a complete disintegration of 
myofibril substructures. These swollen mitochondria have associated deposits of glycogen 
following acute C O poisoning and are suggested to represent myocardial cells incapable 
of using energy substrata (Tritapepe et a/., 1998). Blood flow determines the degree of 
oxygenation to the tissues in vivo. A reduction in oxygen availability In heart tissue could 
produce chemical ischaemia and may contribute to the no-reflow phenomenon or a 
myocardial infarct. One case has described an AMI attributed to acute C O poisoning 
(Ebisuno et a/., 1986). Serum enzymes, electrocardiogram and technetlum-99m 
pyrophosphate scintigrams led these workers to conclude an AMI. In another similar case , 
the coronary arteriograms one week later showed no significant narrowing suggesting 
reversible coronary dysfunction (Marius-Nunez, 1990). It may be reasonable to state that 
C O may affect the coronary vessels to an extent that produces a direct AMI, although this 
needs further Investigation (Chapter 8). 
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The work of Adams et al. (1973) showed that the coronary blood flow increased linearly 
with COHb in conscious dogs that were breathing 0.15% CO-air mixture for 30 minutes 
(through a tracheostomised preparation). These workers also found no significant 
changes in PO2, PCO2 and pH during the exposure to C O , therefore, the presence of the 
air mixture may have ensured chemical normoxia here. Despite the contrary change in C F 
by these workers compared to our findings, vasodilation was attributed to their observed 
increase in C F . Vasodilation of the coronary vasculature may be a direct effect of C O that 
continues to persist after the C O exposure and could be responsible for the oedema. 
Vascular C O is thought to inhibit vasoconstrictors by a mechanism involving stimulation of 
the tetraethylammonium (TEA)-sensitive potassium channel that is independent of cGMP 
(Kaide et al., 2001). The likely vasodilation of the coronary vasculature by C O could 
account for the reduced perfusate flow. However, the dose-dependent effect of C O was 
present after C O exposure had ceased. The recently reported production of NO and the 
hydroxyl radical during reperfusion after ischaemia (M^czewski & Berfsewicz, 2003) may 
suggest that NO may produce vasodilation and/or endothelial damage (initiated by the 
hydroxyl radicals) in the coronary vasculature. The swelling of capillary endothelial cells is 
reputed to be a sign of ischaemic injury (Chiavarelli et al., 1988) and suggests that the C O 
exposure in this study may have produced ischaemia (possibly by binding to intracellular 
myoglobin as no haemoglobin was present). 
Based on the above evidence it is possible that C O exposure may produce a condition 
similar to myocardial infarction from the reduced delivery of oxygen to the myocardium 
that could eventually lead to heart failure. This highlights the severity of C O poisoning in 
people who have a cardiac disorder or are unknowingly predisposed to developing 
coronary disease (Schart et al., 1974). A primary factor in the rate of development and 
size of a myocardial infarct (produced from occlusion of the coronary artery) is the 
coronary collateral circulation (Maxwell et ai, 1987). The change in C F following the 
exposure to C O could account for the CO-induced AMI described in several c a s e s 
(above). 
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Oedema Is reported to occur when using perfusion buffers of low osmolarlty and Is also 
shown to decrease LV filling (Starr et at., 1999). Using crystalloid solutions of low 
osmolarity to perfuse hearts can induce myocardial oedema (Stanr et a/.. 1999; Takoudes 
e^ a/.. 1994), however, no significant differences were found In the osmolarlty of the 
perfusing buffers of the CO-treated hearts relative to the control group. This suggests that 
the oedema characterised as swelling in the vasculature may be produced directly 
following the exposure to C O . Coronary constriction in open-chest dogs also showed no 
changes in the tissue water content relative to control animals that were cannulated 
without constriction (Griggs Jr. et a/.. 1972). This suggests that the depressed C F could 
not be responsible for lowering the perfusate osmolarity and producing oedema. The 
normal osmolarity of the blood ranges from 290-310 mOsm.l"^ and taking a normal level 
as 310 mOsm.r^ (Starr et a/., 1999) suggests that the osmolarity of the perfusion buffer 
used may be marginally lower here. This could account for the increase In wet weight (by 
inducing oedema) in hearts following their perfusion. However, the absence of oedema in 
the coronary vasculature of control hearts suggests that oedema may be a direct effect of 
C O . The water content (ca. 82%) of ventricle tissues were similar to that reported by 
Amirhamzeh et al. (1997) of 81% who used a perfusion buffer (called Pleglsol; 289 
mOsm.r^) with similar osmolarity. The nonsignificant Increase in water content in all 
treated groups could suggest that this Is attributed solely to the minor hypotonic nature of 
the perfusing buffer. This may have influenced the degree of oedema observed following 
the C O exposure and may suggest that the dietary Intake of salt could influence the 
coronary response following C O exposure. The vasodilatory effect of C O may be 
responsible for the reported lowering of blood pressure (Penney & Chen, 1996). The 
decreased gain in HW following CO-treatment (relative to control group) may suggest 
some loss of the myocardial content occurred and could indicate tissue damage produced 
by C O (Chapter 5). An Increase in water content was anticipated In light of the swelling 
observed In hearts exposed to C O , however, this absence may suggest that the loss of 
myocardial content following C O could be greater than the gain in HW (4.3.4). 
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In brief, a significant flux of one electrolyte will produce other electrolyte fluxes, especially 
when specific cellular ion exchange mechanism(s) are Impaired such a s In heart failure 
(Schwinger a/., 2003). Some changes that occur in ischaemia/reperfused hearts have 
been mentioned here to discuss the findings (4.3.5) in light of the hypothesis (1.7). The 
electrolyte content was determined using inductively coupled plasma m a s s spectrometry 
( ICP-MS) to examine any flux(es) in heart tissue exposed to C O . The electrolytes 
measured are of physiological Importance and by comparing suitable ratios it Is possible 
to determine any ion fluxes due to C O poisoning. 
The work of G6linas et al. (1992) also used ICP-MS to determine the normal inorganic 
content (of various elements) In several tissues of Sprague-Dawley rats Including the 
heart. Although their work did not cite the type of heart tissue used In detemrilning the 
electrolyte distribution, i.e. heart ventricle tissue was used here; and their values were 
used as a comparison to identify any ion flux(es) following the exposure to C O in the 
isolated heart. The electrolyte content determined by G^linas et al. (1992) for the heart 
was 68, 220, 0.13, 12, 5, 0.25 and 0.02 mg.g'^ {wet tissue) for sodium, potassium, 
calcium, magnesium, Iron, copper, manganese, respectively. The results (shown in 4.3.5) 
were expressed per gram of dry tissue with the water content of the tissues ca . 82% 
(4.3.4). The electrolyte levels were proportional to those of G^iinas et al. (1992). 
The major electrolytes in heart tissue are sodium (Na), potassium (K), magnesium (Mg) 
and calcium (Ca). These metal ions play a vital role in the contractile function of the heart. 
The sodium/potassium ratio can provide information regarding the conduction of action 
potentials responsible for regular contractions in heart tissue. It has been shown that 
potassium levels declined significantly in the LV tissue (of hearts) from cadavers of C O 
poisoning (Marek & Piejko. 1972). This loss of potassium from the myocardium is found in 
failing hearts following ischaemia, whereas hearts that recovered from total Ischaemia 
showed a gain of potassium (Humphrey et al., 1987). The magnesium/calcium ratio can 
provide useful data on excitation-contraction coupling In myocardial perfonnance. Many 
studies have reported that the plasma concentration of magnesium Is associated with 
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cardiovascular diseases such a s ischaemia. arrhythmias and hypertension (Murphy et a/.. 
1991). A low intracellular [magnesium] can cause significant dysfunction in cardiac 
myocytes in the absence of any other disease state(s) (Griffiths, 2000). 
An increased sodium and calcium content and decreased potassium and magnesium 
content is established in the myocardium of Isolated rat hearts subjected to 
ischaemia/reperfusion (l/R) injury (Kamiyama et a/., 1996; Humphrey et a/., 1987; 
McGrath & Martin, 1978). Similar fluxes are found in the serum following the exposure to 
high-altitude for simulating hypoxia (Christensen et a/., 1975). However, their study failed 
to consider the effects of dehydration in their electrolyte changes. The depletion of 
magnesium and potassium (with sodium loading) is shown to be responsible for cardiac 
arrhythmia's and death (Guiderl et a/.. 1975). The findings here do not substantiate the 
observed arrhythmia's in some CO-treated hearts. High Intracellular levels of sodium can 
inhibit some enzyme systems, particularly those involved In glycolysis (Lockwood, 1963). 
Intracellular loading of sodium during anoxia can depress cardiac activity (Hercus et a/.. 
1955; McDowall et a/., 1955). The extrusion of cellular sodium is increased In the 
presence of extracellular bicarbonate. The perfusion buffer contained 20mM sodium 
bicarbonate (4.2.1) that may have reduced any sodium loading of the tissues. However, 
the role of bicarbonate in reperfusion-induced arrhythmias Is ruled out (Zhu et a/., 2003). 
The absence of these changes (as described for l/R injury) do not support the in vitro 
cardiotoxicity of C O to proceed through an l/R like Injury (mechanism) under the 
conditions used here. A lack of change in the sodium content is shown In hearts taken 
from victims of C O poisoning at autopsy (Marek & Plejko, 1972). Myocardial levels of 
potassium are reduced from 61.5 ± 4.9 to 50.0 ± 7.0 mequiv.kg"^ (to ca. 80%) in lethal 
c a s e s of acute C O poisoning (Marek & Piejko, 1972). Much of the potassium Is 
transported into cardiac myocytes across their membranes by an active transport 
mechanism Involving the membrane bound Na*-K*-ATPase (Mousa a/., 1987). 
However, no increase in potassium were found here following C O exposure (relative to 
the control group). 
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However, any electrolyte changes may have taken place during and/or immediately 
following the exposure to C O , and then returned to control levels by the end of the 
experimental period (4.6.3). Furthermore, these electrolyte changes may only occur in 
infarcted tissue with minor changes in the surrounding boundary tissue relative to normal 
tissue in infarcted hearts (Polimeni & Al-Sadir, 1975). The appearance of haemorrhaged 
zones (petechiae) found in some hearts treated with 0.05% C O could suggest that these 
zones had some tissue damage produced by C O . Regions of myocardial necrosis appear 
as diffuse haemorrhages in the peri- and endocardium following C O exposure (Ehrich et 
al., 1944) along with degenerative changes in individual fibres (World Health Organization, 
1979). These degenerative changes in individual fibres may arise due to the functional 
arrangement and architecture involving gap junctions that relay the transient electrolyte 
changes along the muscle fibres and compromise the contractile activity in this way (Ruiz-
Meana et al., 1999). Any electrolyte changes in these damaged zones remain to be 
determined. Myocardial scar tissue (verified by histology) has shown that the electrolyte 
changes described for l/R injury occur in these damaged region(s) and these changes 
could alter the overall myocardial picture (Lehr a/., 1972). The observed focal zones 
(possibly of necrosis) may have been too small (in size and distribution) to have produced 
any significant changes found similar to l/R injury, however, these findings indicate a 
direct cytotoxic effect of C O on the myocardium for the 0.05% C O dose. The absence of 
minor change(s) in sodium content may be due to other means of passive transport that 
could have compensated for any electrolyte changes. 
The influx of calcium (as established in l/R injury) was not found here. This influx is shown 
to occur during the repertusion phase following ischaemia (Kloner et al., 1989). Although 
rats administered verapamil (a Ca^^-channel blocker) before and/or during acute exposure 
to 0.24% C O showed no protective effect (Penney & Chen. 1996). The influx of calcium is 
also shown to produce nitric oxide in aortic endothelium (Koyama et ai, 2002). However, 
the presence of low levels of calcium (ImM) has been shown to be detrimental in the 
stability of the isolated working heart preparation (Chambers et al., 1991) with the optimal 
[calcium] being 1.2mM (Yamamoto al., 1984). Elevated intracellular calcium levels have 
141 
Chapter 4 Cardiotoxicity of CO During Normoxia - Physiological changes 
been found to occur after overloading the blood with salt (Mahboob a/., 1997). 
Therefore, using a slightly hypotonic perfusing media (discussed above) may have had a 
protective effect by possibly reducing the influx of calcium a s found In l/R Injury (Haigney 
et al., 1994). The intracellular loading of calcium into the tissue surrounding the coronary 
arteries and vasculature cannot be ruled out as the sodiunn/calclum exchanger (NCX) Is 
also present in the tissues of the coronary arteries (Budel & Beny, 2000). If calcium 
loading were found to occur (following CO-treatment) In the coronary arteries it could 
suggest a tissue-specific effect of C O within the heart. Whether an intracellular 
overloading of calcium precedes or contributes to the CO-lnduced vasodilation remains to 
be determined. The possibility of calcium loading in the coronary arteries may suggest 
that an l/R injury could have occurred in light of the depressed coronary flow after C O 
exposure through an altered contraction of the arteries. These findings may also suggest 
that intracellular hypoxia occurred here. However, if any electrolyte changes did occur 
during the eariy CO-free period and returned to the control values found at the end of the 
experimental perfusion period, this may suggest that a reversible transition In these 
changes was evoked by C O . The decline in perfusate flow (after the exposure to CO) 
failed to show any recovery and may suggest that a reversible loading of calcium is not 
possible and/or may not be involved In the observed coronary dysfunction. 
The iron (Fe). copper (Cu) and manganese (Mn) content showed changes that may be 
attributed to the CO-treatment. The iron content in the rat heart ventricle tissue was 
elevated whereas the copper content was lowered (both In a dose dependent manner). 
The manganese content followed a similar trend as the Iron. The changes are discussed 
in light of their role(s) in heart tissue. 
Iron is the most abundant transition metal in the human body (ca. 4-5 grams) and Is 
essential for oxygen transport. DNA synthesis and electron transport (Conrad a/., 
1999). However, it Is tightly regulated in vivo to ensure no free iron exists 
(Balagopalakrishna et al., 1999). Iron is stored as ferritin and complexed with other 
biomolecules, and only a small portion of iron (ca. IfoM) Is loosely bound and detachable 
142 
Chapter 4 Cardiotoxicity of CO During Normoxia - Plrysiological changes 
(Higson e^ a/., 1988). Although iron deficiency may upregulate certain Inflammatory 
mediators such as COX-2 (Tanji et a/., 2001), it is also involved in cardiac hypertrophy 
and mitochondrial enlargement with copper deficiency (Goodman a/., 1970). The 
increase in iron content could precede oxidative stress (and possibly contribute to 
releasing the cellular content from the tissues a s described in Chapter 7). The role of Iron 
as a cofactor for nitric oxide synthase (NOS; Halliwell & Gutteridge, 1999) may produce 
an upregulation of NOS and could have contributed to the decline In perfusate flow (via 
NO mediated vasodilation and/or coronary dysfunction through oxidative stress). The 
elevated Iron may precede an increased production of NO, however, the reason(s) for this 
increase in iron by C O remains unknown. Iron and copper can produce the hydroxy! 
radical via the Haber-Weiss reactions In the presence of the reduced (cationic) forms, Fe" 
(ferrous) and Cu' , respectively. Iron overioad is a well-known cause of myocardial failure 
and is thought to occur through iron-catalysed free radical generation that damages the 
myocardium and alters cardiac function (Bartfay et al., 1999) suggesting that acute 
exposure to C O may initiate heart failure through oxidative stress (1.7). Significantly 
elevated levels of cytotoxic aldehydes is found In heart tissue of iron-loaded mice (Bartfay 
et al., 1999), however, as no other significant electrolyte fluxes were found the likely 
cause of Iron overload by C O remains undetermined. 
Copper is required to maintain normal iron metabolism and can increase the oxidation of 
Hb and Mb (Halliwell & Gutteridge. 1999). It is also required as a cofactor for cytochrome 
c oxidase and copper zinc superoxide dismutase (CuZnSOD) . The chelating property of 
copper ions for the intracellular antioxidant (or reductant) glutathione (GSH) could suggest 
that more G S H may be available for cellular protection. This could also suggest that 
oxidative stress occurred as a result of the C O exposure (Chapter 5). Conversely, the 
decline in copper content could suggest that oxidative stress occurred and depleted the 
Intracellular content of copper-bound G S H . Coincidentally, iron and copper have an 
inverse relationship in which these two metals depend on each other in normal 
metabolism (Harris, 1994). An Increase in iron content and a fall in the copper content of 
the hearts exposed to C O were found here. 
143 
Chapter 4 Cardiotoxicity of CO During Normoxia - Physiological changes 
No difference in the manganese content of the CO-treated groups and the controls were 
found here. However, the level of manganese in the control group was negative and 
suggests It was below the detection limit of the analytical method used ( ICP-MS). The 
manganese content appeared to rise in the CO-treated hearts and Is visible if the control 
group is assigned a level of zero and the other values adjusted accordingly (ca. 20 and 23 
ng.g"^ for 0.01 and 0.05% C O hearts, respectively). Manganese in cells and tissues is 
predominantly localised in mitochondria a s a cofactor for superoxide dismutase (SOD). 
S O D catalyses the dismutation of superoxide to hydrogen peroxide (Halliwell & 
Gutteridge, 1999). When the supply of copper Ion falls the activity of copper zinc S O D 
(CuZnSOD; cytosolic SOD) is reduced, however, more manganese S O D (MnSOD) Is 
synthesised to maintain a similar total activity of S O D . Coincidentally, the copper content 
had fallen in ventricle tissue following C O exposure, whereas the manganese levels 
appeared to rise relative to the control group. This may suggest an incidence of oxidative 
stress in the ventricles of CO-treated hearts. Oxidative stress through the production of 
R O S can disrupt ion channels and cell/tissue homeostasis (Kuzuya et a/., 1993; 
Ziegelstein et a/., 1992), however, no ion fluxes were found here. 
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4.5 Conclusions 
Perfusing isolated rat hearts with C O altered the heart rate (relative to the cxjntrol group) 
and produced an incidence of arrhythmias. The presence of 21% oxygen (in the perfusing 
buffer may rule out systemic hypoxia and could suggest a direct effect of C O in the heart. 
The decline In coronary (or perfusate) flow in a dose-dependent manner after C O 
exposure under these conditions suggests that an l/R-like injury may have resulted from 
C O exposure. The reduced heart rate and the swelling of the vasculature may indicate 
different effect(s) of C O in the ventricle and vasculature tissues, respectively. Therefore, 
the cardiotoxicity of C O may arise through several effects from tissues within the heart, 
and these may contribute to the CO-associated morbidity that arise following C O 
poisoning. The lack of electrolyte fluxes that are found in other studies examining l/R 
injury in heart tissue appears to rule out the hypothesis that the cardiotoxicity of C O 
precedes through an l/R like injury (1.7). However, other changes do occur in hearts 
subjected to l/R and an absence of the electrolyte fluxes do not rule out the postulated 
hypothesis. Further measurements to evaluate the possible production of intracellular 
hypoxia and oxidative stress are necessary to test the postulated hypothesis (1.7). 
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4.6 Further Work 
4.6.1 Osmolarity 
A hyperosmotic perfusing media (infused during reperfusion) has been shown to improve 
the stunned myocardium arising after ischaemia In Isolated rat hearts and reduce the 
intracellular calcium overload (Sun & Lin, 1990). The uses of hypo- and hypertonic 
intravenous cocktails remain to be Investigated in light of preventing further cardiac 
damage following acute C O poisoning. This may ensure satisfactory reduction in the 
degree or incidences of the cardiac morbidity(s) associated after acute exposure to C O 
and determine whether dietary factors such a s salt intake could influence C O poisoning. 
4.6.2 C h a n g e s in t issue electrolyte content 
The possibility of electrolyte changes occurring in heart ventricle tissue during the C O 
exposure remains to be investigated. This issue could be addressed by using the same 
isolated heart preparation and removing these perfused hearts at various times during and 
after following the exposure to C O . This would determine any electrolyte flux(es) that may 
have nonnalised (to control levels) after the 90 minute CO-free period and confimri 
whether l/R like changes took place to support the hypothesis. The electrolyte contents 
could be detemiined in the perfusate samples to identify any fluxes within the tissues that 
may have appeared as nonsignificant. 
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5.1 Background 
The work described (in Chapter 4) showed physiological changes consistent with 
ischaemia/reperfusion (l/R) injury and other findings that were not. The physiological 
changes were found using isolated hearts exposed to C O in the presence of nonnoxia. 
These changes show a direct effect of C O that may not otherwise be observed in vivo. 
The underlying biochemistry is important to identify any changes within the myocardium to 
fulfil the aims of the study (1.7). This chapter presents the biochemical findings and 
ascertain whether intracellular hypoxia (hypoxia^) and/or oxidative stress occun-ed in the 
heart during C O exposure. 
148 
Chapter 5 Cardiotoxicity of CO During Normoxia - Biochemical changes 
5.2 Materials & Methods 
5.2.1 Isolation & Langendorff Preparation 
The isolation of rat hearts and their Langendorff preparation was performed as described 
previously (4.2.1 and 4.2.2. respectively). No heparin was administered to the 
(unconscious) animals as heparin decreases the levels of assayed troponin I (Gerhardt et 
a/.. 2000; and 5.2.3). 
5.2.2 Experimental Protocol 
This was perfonned as described in the previous chapter (4.2.2). 
5.2.3 C a r d i a c Markers of Viability 
The perfusate samples (for determining the tissue viability) were kept in heparin-free 
tubes placed on ice during the experiments. The samples were delivered for analysis <1h 
after completing the perfusion. Lactate dehydrogenase (LDH), creatine kinase (CK) and 
troponin I (Tnl) are used as mariners in cardiology. LDH and C K activities in the collected 
perfusate fractions were assayed on the day by Triphasic Laboratories (Plymouth, UK) 
using commercial diagnostic kits and automated analysers (Beckman). The control hearts 
with or without AO (n = 3) and 0.05% CD-treated group with A O had their LDH and C K 
activity determined in house using a commercial diagnostic kit from Sigma. The perfusate 
from the CO-treated groups (0.01, 0.05 and 0.10% C O ) were assayed by Triphasic Ltd. 
The use of LDH and C K to detennine tissue viability were described in 3.2.4. Heparin is 
not compatible with the LDH and C K assays used (personal communication with Jane 
Dickinson. Triphasic Laboratories, Plymouth. UK). No heparin was administered to the 
animal following anaesthesia as it has also been shown to contribute in angiogenesis and 
increase collateral blood flow (4.4; Matsumori et a/.. 1998; Shulman. 2000). 
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Troponin I (Tnl) is a very specific marker in assessing cardiac function, and its activity was 
detenmined in four perfusate fractions: pretreatment period (in the - 5 to 0 min fraction), 
during C O exposure (10 to 15 min), post-CO (30 to 35 min) and post-recovery treatment 
(80 to 120 min). Only one detennination per sample (from each fully perfused heart) was 
assayed for Tnl. The assay was conducted by Triphasic on samples that had been frozen 
at -SO^'C (prior to thawing on ice) before being assayed a s described above. The samples 
for troponin analysis were frozen before their determination a s a prerequisite of the 
diagnostic assay (personal communication with Jane Dickinson, Triphasic Laboratories 
Ltd, Plymouth. UK). A study by Heeschen a/. (2000) has shown no significant reduction 
in troponin concentrations for plasma samples anticoagulated with sodium heparin, 
however, this is contradictory to the findings by another study (Gerhardt a/.. 2000). 
5.2.4 Preparation of Rat Heart Ventricle T i s s u e Homogenate 
The preweighed frozen rat heart ventricle tissue was homogenised as described by 
Rouet-Benzineb et a/. (1999); although tetrahydrobiopterin were not included in the 
homogenisation buffer (HB). Briefly, the 10% (w/v) homogenates were prepared by 
mincing the tissue in HB using scissors, followed by a Potter-Elvehjem glass-Teflon 
homogeniser (5 passes per gram of wet weight tissue). Ice-cold HB comprised 250mM 
Tris-HCI. ImM EGTA. ImM phenylmethylsulphonylfluoride (PMSF) , 10|ig/ml pepstatin A 
and 10ng/ml leupeptin (to pH 7.4 using 4M KOH). The homogenate (10% w/v) was 
collected and centrifuged at 1500g (5min). The supernatant was centrifuged (1500g, 
5min) and at 8000g for 15 minutes. The supernatant (homogenate) was immediately 
deproteinised for later analysis (5.2.5). 
5.2.5 Deproteinisation of Homogenates 
This was performed immediately on freshly prepared homogenate samples (5.2.4) to 
prevent the oxidation of various analytes by neutral pH, air and cellular proteins. Care 
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must be taken as perchloric acid (HCIO4) is a strong oxidising acid. Two volumes of ice-
cold 8% HCIO4 (analytical reagent; BDH Chemicals Ltd, Poole) were added to one volume 
of homogenate. The contents were gently mixed by inversion and kept on ice (15min) with 
occasional mixing prior to centrifugation (2000fif for 10 min) to remove the protein. The 
supernatant was snap-frozen and stored (at - 8 0 X ) in 0.5-1 ml aliquots (in microeppendorf 
tubes) for later analysis (5.2.7). Any exposure of the deproteinised extracts to air were 
kept to a minimum to prevent the oxidation of some analytes. Samples for glutathione 
analysis had 2^ 1 of 2-vinylpyridine (VP) added to 100^1 of deproteinised extract. These 
were mixed by vortexing before storing at -80**C for later analysis (5.2.7.5). 
5.2.6 Protein Determination 
The protein content of the perfusates (5.2.3) and tissue homogenates (5.2.4) were 
determined (to express the enzyme activity in specific units of activity). The protein assay 
kit was supplied by BioRad Laboratories (Hemel Hempstead), and used according to the 
manufacturers instructions based on the method of Wiechelman et ai (1988). 
5.2.7 Other Biochemical Measurements In Heart T i s s u e 
The following assays (below) were performed using a spectrophotometer (3.2.5). 
5.2.7.1 Lactate 
The lactate content was detenmined in deproteinised homogenate extracts (5.2.5) using a 
commercial Sigma Diagnostic kit (Lactate 826-B; Lot 120K6030) according to the 
manufacturers instructions based on the method of Gloster & Harris (1962). 
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5.2.7.2 Pyruvate 
The pyruvate content was detenmined in deprotelnised homogenate extracts (5.2.5) using 
commercial Sigma Diagnostic kit (Pyruvate 726; Lot 031K6054) according to the 
manufacturers instructions based on the method of Bucher et al. (1963). 
5.2.7.3 Glucose 
The glucose content was determined in deproteinised homogenate extracts (5.2.5) using 
commercial Sigma Diagnostic kit (115-A; Lot 100K6112) according to the manufacturers 
instructions based on the method of Bergmeyer (1963). 
5.2.7.4 Glycogen 
The glycogen levels in deproteinised homogenate extracts (5.2.5) were determined by 
measuring the glucose content (5.2.7.3) after hydrolysing the glycogen according to the 
method of Keppler & Decker (19xx). In brief, the pH of the deproteinised extract was 
adjusted to pH 4.5 for optimal activity of the amyloglucosldase (as pH > 4.8 would inhibit 
the hydrolysis) and incubated at 40°C for 2h (final activity of 24 U.ml"^) prior to stopping 
the enzyme by adding perchloric acid. 
5.2.7.5 Glutathione 
Deproteinised rat heart ventricle homogenates (5.2.5) were used to determine the tissue 
glutathione levels. The assays were perfonned using a modified method described by 
Griffith (1980). The acidic deproteinised extracts (SOOjol) were neutralized with Ice-cold 
16% KOH In 0.12M Tris-base buffer (52|il), centifuged at 13,000g (2mln) to remove the 
Insoluble potassium perchlorate. The supernatant was carefully removed and placed on 
ice prior to analysis. A worthing assay reagent was freshly prepared prior to use by mixing 
reagents A, B and C (at room temperature). All assay reagents were prepared in lOOmM 
Na*-phosphate buffer with 1mM Na*-EDTA (pH 7.4 at 25*'C) and stored in the fridge 
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before use: A, 0.4mM NADPH; B, 4mM 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB); and C , 
50 U.mr^ glutathione reductase (GR) . Standards of reduced and oxidized glutathione 
( G S H and G S S G ) were prepared in 5.3% perchloric acid prior to use and assayed as 
described. Final assay concentrations of reagents (in 1ml final volume) were 0.2mM 
NADPH, 0.4mM DTNB, and 0.5 U.mr^  G R . The working range of the assay was 
determined as 0-25nM from the linear range of the standards used (200^1 samples). All 
samples were kept on ice prior to analysis. Appendix A gives details of the assay method 
and other tests performed to implement the assay. 
5.2.8 Data analys is 
Performed as described in 4.2.9. 
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5.3 Results 
5.3.1 T i s s u e Viability 
The viability of the isolated perfused hearts were a s s e s s e d by measuring the activities of 
markers released into the perfusate. Three mariners were used to a s s e s s the viability of 
heart tissue: lactate dehydrogenase (LDH), creatine kinase (CK) and troponin I (Tnl). The 
activity of LDH was determined in the collected perfusate fractions (after measuring the 
volume to detemriine the coronary flow; 4.2.3.2) and nonmalised to the wet weight of the 
tissue (Table 5.1A). To allow comparisons to be made between the groups; the mean of 
the three pretreatment (basal) values were taken a s 100% and the activity of the other 
fractions were expressed relative to the mean basal level. The mean data from each 
treatment group is shown in Figure 5.1. No significant difference in LDH activity was 
found at P < 0.05 in any of the groups relative to control levels, although the CO-treatment 
did increase the loss of LDH from the heart. The activity of C K was determined in the 
same perfusate samples that LDH was assayed. The pretreatment CK activity 
(nonmalised) are shown in Table 5.16; and shown as a mean percentage of the 
pretreatment level as performed for the LDH data to compare between groups (Figure 
5.2). The CO-treated hearts had an increased activity of C K compared to the controls, 
however, no significant differences were found. The enzyme activities in the perfusates of 
the start-stop experiments (where hearts were perfused for a specified duration and C O 
exposure) were not determined. 
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Table 5.1 (overleaf) The basal activity of lactate dehydrogenase (LDH) and creatine 
kinase (CK) in the perfusate of rat hearts exposed to carbon monoxide (CO) in the 
presence of antioxidants (AO). The perfusate was collected and stored on ice before 
measuring the activity of LDH on the same day. Isolated hearts were perfused in a 
retrograde manner through the aorta using a Langendorff perfusion apparatus at 6ml.min' 
(wet weight). The hearts were perfused with buffer at 36.9°C (see Materials & 
Methods for the composition of the perfusion buffer). The buffer was equilibrated with a 
certified gas mixture containing 21% oxygen (O2), 5% carbon dioxide (CO2), balanced with 
nitrogen (N2) and gassed constantly with this mixture for the entire perfusion period to 
establish pH 7.4. Hearts were perfused for 15min to wash out the remaining blood and 
allow the organ to stabilise from the excision procedure. The basal (or pretreatment) 
activity of LDH (A) and C K (B) were then detemiined over three five-minute fractions (over 
15min period) prior to commencing the carbon monoxide (CO) treatment. The C O 
exposure (for 30min) used normoxic conditions with 0% (n = 3 hearts; controls), 0% with 
AO (n = 3 hearts), 0.01% (n = 10 hearts). 0.05% (n = 6 hearts) and 0.05% C O with A O {n 
= 5 hearts). Normoxic conditions were used throughout the entire perfusion period using 
gas mixtures with varying nitrogen levels to compensate for the different C O levels (0-
0.05%). Hearts were treated by perfusing with buffer that was pre-equillbrated with C O . 
The time to attain this switch-over was ca . 2min. After the 30min C O exposure hearts 
were perfused for 90min to a s s e s s any functional recovery post-CO. The data shown is 
the mean ± S D for n hearts in each group. 
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Time 
(min) 
LDH activity (units.r .g"^  wet weight of heart) 
0% C O 0% C O 0.01% C O 
(n = 3) with A0(r? = 3) ( n = 1 0 ) 
0.05% C O 0.05% C O 
(n = 6) with AO (n = 5) 
12.5 
-7.5 
-2.5 
0.22 ± 0.04 
0.22 ± 0.04 
0.19 ± 0 . 0 4 
0.05 ± 0.02 
0.04 ± 0.01 
0.04 ± 0 . 0 1 
45 ± 1 6 
40 ± 1 7 
39 ± 1 8 
22 ± 1 6 
1 8 ± 11 
14 ± 6 
0.06 ± 0.02 
0.06 ± 0.02 
0.06 ± 0.05 
8 
Time C K activity (units.rTg^ wet weight of heart) 
(min) 0% C O 
(n = 3) 
0% C O 
with A O (n = 3) 
0.01% C O 
( n = 1 0 ) 
0.05% C O 
(n = 6) 
0.05% C O 
with AO (n = 5) 
-12.5 30 ± 5 3 5 ± 19 3 0 ± 16 1 0 ± 7 29 ± 1 8 
-7.5 26 ± 7 2 9 ± 14 2 9 ± 15 11 ± 7 36 ± 2 0 
-2.5 26 ± 7 2 7 ± 12 2 8 ± 14 1 0 ± 8 36 ± 2 6 
Table 5.1 The table legend is on the previous page. 
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Figure 5.1 (overleaf) Nonnalised activity of lactate dehydrogenase (LDH) and creatine 
kinase (CK) in the perfusate (coronary effluent) from isolated hearts perfused with carbon 
monoxide (CO). Hearts were perfused in a retrograde manner through the aorta using a 
Langendorff apparatus. The hearts were exposed to 0, 0.01 and 0.05% C O and 21% O2 
(balanced with N2) for 30 minutes followed by a CO-free gas mixture (90min) by perfusion. 
Some hearts were treated with antioxidants (AO): TroloxC and sodium ascorbate were 
included in the perfusion buffer (at 0.2 and ImM, respectively) during the 15min 
pretreatment (basal) period and during the C O exposure. The C O exposure (for 30min) 
used normoxic conditions with 0% C O (n = 3 hearts; controls), 0% C O + AO (n = 3 hearts; 
antioxidant controls), 0.01% C O (n = 10 hearts), 0.05% C O (n = 6 hearts) and 0.05% C O 
+ A O (n = 5 hearts). The data points show the activity of LDH (top panel) and C K (bottom 
panel) in the collected perfusate fractions. The black and blue bar denote the period that 
hearts were exposed to C O (for 30min) and A O (45min), respectively. S a m e conditions as 
described In the legend for Table 5.1. The mean enzyme activity was determined from the 
three pretreatment fractions and taken as 100%, with the activity of LDH and C K for the 
other perfusate fractions expressed a s a percentage of the mean basal activity for each 
heart. The data shown is the mean ± S E M with the number of hearts (n) used in each 
group shown in the figure. The timepoints overieaf (in minutes) represent the midpoint of 
the perfusate fractions that were collected during each perfusion to determine the tissue 
viability: -15 to -10, -10 to -5, -5 to 0, 0-5. 5-10, 10-15. 15-20, 20-25. 25-30. 30-35. 35-45. 
45-60. 60-80 and 80-120 minutes. 
157 
Chapter 5 Cardiotoxicity of CO During Sormoxia - Bi(Khemical changes 
0 
</) 
CD 
.E 03 
o ^ 
> ^ c 
N CD 
O O 
> Q. 
»«— 
O O 
•o 
E 
200 
180 
160 
140 
120 
100 
80 
60 
40 
20 
0 
240 
220 
200 
180 
160 
140 
120 
100 
80 
60 
40 
20 
0 
Lactate dehydrogenase 
-O - 0% CO (n = 3) 
# 0% CO-^AO (n = 3) 
A 0.01% CO {n = 10) 
• 0 05% CO (n = 6) 
• 0 05% CO+AO (n = 5) 
15 0 15 30 45 60 75 90 105 
Creatine kinase 
15 0 15 30 45 60 
Time (min) 
75 90 105 
Figure 5.1 The figure legend is on the previous page 
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The troponin I (Tnl) activity was determined in the same samples (after storage for ca . 6.5 
weeks at -SO^C prior to their measurement; 5.2.3.2). The normalised pretreatment data is 
presented in Table 5.2. The rate of release of Tnl (Table 5.2) was detennined by 
calculating the total amount of Tnl in each perfusate fraction and expressing the amount 
released per minute. No significant differences were found between the CO-treated hearts 
and the controls. The activity of Tnl for the 0.05% CO-treated group has shown the mean 
data from 5 hearts (compared to the 6 hearts cited for the LDH and C K data) as the 
samples for one heart were misplaced (by the laboratory performing the enzyme assays) . 
Perfusate Troponin I (Tnl) activity in ng.rVg"^ (wet weight) 
fraction (Rate of Tnl release in ng.min'Vg'^) 
(min) 0.00% C O 
(n = 3) 
0.01% C O 
( n = 1 0 ) 
0.05% C O 
(n = 5) 
-5 too 5.42 ± 0.83 3.43 ± 1.08 0.72 ± 0.72 
{0.041 ±0.005) (0.030^^0.009) (0.005 ±0.005) 
10 to 15 5.58 ± 2.09 9.04 ± 2.86 18.70 ± 14.35 
(0.043 ±0.016) (0.079 ± 0.025) (0.132 ±0.101) 
30 to 35 2.68 ± 0.24 12.26 ± 3 . 8 8 0.85 ± 0 . 8 5 
(0.020 ±0.002) ( 0 . ) 0 5 ^ 0.033) (0.007 ±0.007) 
80 to 120 3.55 ± 1 . 2 7 9.25 ± 2.92 0.55 ± 0.34 
(0.028 ±0.011) (0.077 ±0.024) (0.004 ±0.002) 
Table 5.2 The activity of troponin I (Tnl) a s a maricer of tissue viability were detennined in 
perfusate samples of hearts perfused with C O . Four detenminations were made for each 
heart perfused: pretreatment (-5 to Omin). mid-exposure to C O (10 to 15min). immediately 
post-CO exposure (30 to 35min) and at the end of the perfusion (in the 80 to 120min 
fraction). The activity of Tnl was normalised to gram of heart tissue (wet weight) in the 
treated hearts. The rate of Tnl release was determined by deriving the normalised 
absolute amount in the specified time fraction and dividing this value by the duration (in 
minutes) of the fraction to obtain a final rate. The time in bold text denotes the period that 
hearts were exposed to C O , i.e. 0 to 30 minutes. The data shown is the mean ± S E M with 
the number of hearts (n) used in each group. 
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The rate of release of the markers were determined to a s s e s s when the C O exposure 
caused a loss of tissue viability. This was determined similarly (as perfomried above for 
the troponin I data) for LDH and C K and is shown in Table 5.3 and 5.4, respectively. The 
profiles for the rate of release min^or the activity of the markers In the perfusate fractions 
(not shown) and appeared to be increased with CO-treatment, however, no significant 
differences were found. 
Time Rate of LDH release (units.min"\g"^ wet weight of heart) 
(min) 0.00% C O 0.00% C O 0.01% C O 0.05% C O 0.05% C O 
(n = 3) with AO (n = 3) ( n = 1 0 ) (n = 6) with AO (n = 5) 
-12.5 0.0017 ±0.0004 0.00O44± 0.00019 0.39 ±0.14 0.18±0.14 0.00064 ± 0.00022 
-7.5 0.0017 ±0.0004 0.00040 ± 0.00007 0.35 ±0.15 0.14 ±0.09 0.00064 ±0.00030 
-2.5 0.0014 ±0.0004 0.00034 ± 0.00009 0.34 ±0.16 0.12 ±0.06 0.00063 ± 0.00055 
2.5 0.0014 ±0.0004 0.00029 ±0.00011 0.46 ± 0.30 0.14 ±0.14 0.00084 ± 0.00054 
7.5 0.0013 ±0.0003 0.00024 ±0.00011 0.44 ± 0.32 0.14 ±0.16 0.00079 ±0.00055 
12.5 0.0013 ±0.0005 0.00024 ±0.00010 0.49 ± 0.32 0.16 ±0.21 0.00084 ± 0.00056 
17.5 0.0013 ±0.0003 0.00023 ±0.00012 0.42 ± 0.27 0.13±0.15 0.00085 ±0.00056 
22.5 0.0013 ±0.0003 0.00029 ±0.00012 0.38 ± 0.24 0.17±0.11 0.00078 ±0.00053 
27.5 0.0013 ±0.0003 0.00024 ± 0.00007 0.32 ± 0.26 0.11 ±0.10 0.00073 ± 0.00043 
32.5 0.0012 ±0.0004 0.00023 ± 0.00009 0.29 ±0.19 0.25 ± 0.43 0.00066 ± 0.00042 
40 0.0011 ±0.0004 0.00024 ± 0.00005 0.25 ±0.18 0.10 ±0.07 0.00059 ±0.00038 
52.5 0.0011 ±0.0001 0.00021 ±0.00003 0.23 ±0.14 0.08 ± 0.06 0.00051 ±0.00031 
70 0.0007 ± 0.0002 0.00017 ±0.00003 0.21 ±0.11 0.08 ± 0.04 0.00047 ±0.00023 
100 0.0006 ±0.0001 0.00018 ±0.00005 0.18±0.10 0.06 ± 0.07 0.00045 ±0.00025 
Table 5.3 Rate of lactate dehydrogenase (LDH) release from CO-treated hearts perfused 
with or without antioxidants (AO; same conditions as previously described). The times 
show the midpoint of the collected perfusate fractions (as given in Figure 5.1). The time in 
bold text denotes the period that hearts were exposed to C O , i.e. 0 to 30 minutes. 
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Time Rate of CK release (units.min"\g"^ wet weight of heart) 
(min) 0% CO 0% CO 0.01% CO 0.05% CO 0.05% CO 
(n = 3) with AO {n = 3) (n=10) (/7 = 6) with AO (n = 5) 
-12.5 0.23 ± 0.05 0.32 ±0.18 0.25 ±0.13 0.08 ± 0.06 0.35 ±0.23 
-7.5 0.20 ± 0.07 0.26 ±0.13 0.25 ±0.12 0.09 ± 0.06 0.43 ± 0.28 
-2.5 0.20 ± 0.07 0.24 ±0.12 0.25 ±0.12 0.08 ± 0.07 0.45 ± 0.36 
2.5 0.20 ± 0.05 0.23 ±0.10 0.36 ± 0.25 0.10 ±0.09 0.40 ± 0.35 
7.5 0.17 ±0.02 0.22 ±0.10 0.43 ± 0.36 0.12 ±0.14 0.45 ± 0.49 
12.5 0.17 + 0.07 0.21 ±0.13 0.44 ± 0.41 0.14 ±0.21 0.57 ± 0.43 
17.5 0.17 + 0.02 0.17 ±0.10 0.37 ±0.36 0.10 ±0.13 0.58 ± 0.42 
22.5 0.15 ±0.03 0.19±0.12 0.30 ± 0.29 0.08 ± 0.08 0.58 ± 0.44 
27.5 0.15 ±0.07 0.19±0.12 0.26± 0.28 0.06 ± 0.06 0.53 ±0.39 
32.5 0.17 ±0.02 0.17 ±0.10 0.25 ± 0.26 0.05 ± 0.05 0.39 ± 0.43 
40 0.12 ±0.02 0.15 ±0.13 0.20 ±0.21 0.05 ± 0.05 0.40 ±0.31 
52.5 0.12 ±0.02 0.15 ±0.13 0.21 ±0.17 0.05 + 0.03 0.38 ± 0.30 
70 0.10 + 0.07 0.13±0.12 0.18 ±0.15 0.04 ± 0.05 0.23 ± 0.30 
100 0.11 ±0.02 0.09 ±0.14 0.17 ±0.13 0.06 ± 0.09 0.31 ±0.25 
Table 5.4 Rate of creatine kinase (CK) released from hearts treated with CO in the 
presence of antioxidants (AO). The times show the midpoint of the collected perfusate 
fractions (as given in Figure 5.1). The time in bold text denotes the period that hearts 
were exposed to CO, i.e. 0 to 30 minutes. 
161 
Chapter 5 Cardiotoxicity of CO During Normoxia - Biochemical changes 
The cumulative activities of LDH and CK in the perfusate fractions were detemiined. The 
figures were expressed as a percentage of the mean pretreatment level to allow 
comparisons to be made (as perfomied previously). The control hearts showed an 
exponential decline in the activities of LDH and CK during the perfusion (Figure 5.2). The 
hearts treated with CO showed an elevated level, although this was not significant and the 
0.01% CO group appeared to release more LDH and CK than the 0.05% CO-treated 
hearts. The AO control group had a lower loss of LDH and CK and these were not 
significantly different to the control group. Hearts treated with 0.05% C O in the presence 
of AO showed a similar loss in cumulative activity for both LDH and CK relative to the 
0.05% CO-treatment without AO. However, the CO-treatment increased the loss of LDH 
and CK from hearts during CO exposure, whereas the AO-treatment reduced the loss (of 
LDH and CK) after the CO-treatment. None of the described changes were significant. 
The cumulative activity of troponin 1 (Tnl) were not determined using the four perfusate 
fractions. 
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Figure 5.2 Cumulative activities of lactate dehydrogenase (fop pane/) and creatine kinase 
{bottom panel) in the perfusates of CO-treated hearts perfused with or without 
antioxidants (AO). The data shown is expressed as a percentage of the mean 
pretreatment level (determined from the -15 to 0 minute fractions). The data shown is the 
mean ± S E M with the number of hearts (n) used in each group shown in the figure. The 
black and blue bar denote the penod that hearts were exposed to CO (for 30min) and AO 
(45min), respectively. 
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5.3.2 Other Tissue Measurements 
5.3.2.1 Lactate & Pyruvate 
The lactate and pyruvate content were detemiined in the homogenates from ventricle 
tissue of isolated hearts exposed to CO. Lactate and pyruvate levels ranged from 0.061-
0.83 ^moles.mg*' protein and from 0-1.43 nmoles.mg'^ protein In 10% ventricle 
homogenates (with no significant differences), respectively (Table 5.5). The 
lactate/pynjvate ratio (UP) expressed as the mean ± S D were 343 ± 101. -1987 ± 929, 
285 ± 725, 563 ± 237, and 409 ± 800 for 0% (control; n = 2), 0% + AO (AO control; n = 3). 
0.01% (n = 10), 0.05% CO {n = 4), and 0.05% CO+AO (n = 4) groups, respectively. The 
UP ratio showed no significance differences between treated hearts relative to the 
controls. The negative UP ratio for the AO control may suggest some depletion of 
pynjvate by the antioxidants. The n numbers differ here as some ratios could not be 
determined due to a couple of zero values for the pyruvate content (one heart from the 
0%. 0.05% CO. and 0.05% CO + AO groups). 
The start-stop perfusions had some hearts immediately removed from the perfusion 
apparatus before and after the 30min perfusion with 0.01% CO. The lactate content 
before any treatment (at / = Omin) were 43 ± 6 jimoles.g'^ (mean ± SD); and the content 
after 30min of perfusion with 0 and 0.01% CO were 39 ± 2 and 39 ± 3 nmoles.g"\ 
respectively. There were no significant difference between these values; and also for the 
pyruvate data (below). The pyruvate content before any treatment (at t - Omin) were 0.26 
±0.16 pmoles.g'^ (mean ± SD) and the content after 30min of perfusion with 0 and 0.01% 
CO were 0.31 ± 0.06 and 0.36 ± 0.04 nmoles.g"\ respectively. The specific content of 
lactate and pyruvate from these start-stop perfusions is shown in Figure 5.3. The 
pyruvate content increased over the 30min treatment period, then declined over the next 
90min similar to the lactate profile that had an almost linear relationship with time. 
164 
Chapter 5 Cardiotoxicity of CO During Normoxia - Biochem ical changes 
Treatment 
(n) 
Lacfafe 
(^moles.g"^ wet tissue) 
Pyruvate 
(^moles.g'^ wet tissue) 
0.00% CO (3) 18.83 ±0.98 0.038 ± 0.020 
0.00% CO + AO (3) 18.59 ±0.71 -0.012 ±0.05 
0.01% CO (70) 17.68 ±2.00 0.022 ±0.011 
0.05% CO (5) 21.80 ± 1.37 0.033 ±0.010 
0.05% CO + AO (5) 10.61 ±3.58 -0.001 ±0.011 
Table 5.5 The contents of lactate and pyruvate were determined in the homogenates of 
ventricle tissue prepared from isolated rat hearts exposed to CO with or without 
antioxidants (AO; under the same conditions as described previously). The absolute 
amount of lactate and pyruvate (in ^moles) is expressed per gram of tissue (wet weight). 
The data shown is the mean ± S E M and no significant differences were found. 
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Figure 5.3 Time course of the lactate and pyruvate content in ventricle tissue 
homogenates from isolated rat hearts treated with CO. The black bar denotes the period 
that hearts were exposed to CO (for 30min). The data shown is the mean ± S E M . 
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5.3.2.2 Glucose 
The glucose content was determined in the deproteinised ventricle homogenate extract 
and expressed per mg of protein in the tissue homogenate (Table 5.6). The AO in the 
0.05% CO-treated group significantly increased the glucose content compared to the AO 
control group (Table 5.6). 
5.3.2.3 Glycogen 
The glycogen content is expressed as the equivalent unit of liberated glucose. This was 
detemiined in samples (as above; in 5.3.2.2) by hydrolysing the glycogen to glucose units 
(using amyloglucosidase) and subtracting the initial glucose level that was present before 
hydrolysis (5.2.7.4). No significant differences were found between the groups, however, 
the antioxidants appeared to lower the glycogen content (Table 5.6). 
Treatment 
(n) 
Glucose 
(nmoles.g"^ wet tissue) 
Glycogen 
(l^moles glucose.g"^ wet tissue) 
0.00% CO (3) 4.33 ± 1.78 33.52 ± 2.49 
0.00% CO + AO (3) 3.09 ± 0.41 23.11 ±5.58 
0.01% CO (70) 3.75 ± 0.99 26.31 ± 5.07 
0.05% CO (5) 4.49 ± 1.32 35.52 ± 9.38 
0.05% CO + AO (5) *8.26±1.26 23.63 ± 2.20 
Table 5.6 The absolute content of glucose and glycogen determined in homogenates of 
ventricle tissue from rat hearts exposed to CO with or without antioxidants (AO). The 
glucose content was detenmined in acidic deproteinised samples and the glycogen 
content was expressed as an equivalent glucose content following its hydrolysis with 
amyloglucosidase (see Materials and Methods for details). The data shown is the mean ± 
S E M with the number of hearts (n) used in each group shown in the figure. * The asterick 
indicates a significant difference (at P < 0.05) between the marked group and the control 
AO group, i.e. treated with 0% CO with antioxidants. 
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5.3.2.4 Glutathione 
The glutathione levels were determined in deproteinised samples of rat heart ventricle 
homogenate prepared from isolated hearts perfused with CO ± antioxidants (AO). The 
CO-treated hearts had a significantly decreased content of glutathione and the AO 
showed a protective effect (by preserving some of the CO-induced depletion of 
glutathione). These results were published (Patel et a/.. 2003) and are shown (on pages 
293-297). The depletion of glutathione was found to occur after the CO exposure from the 
start-stop perfusions (Table 5.7). 
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Treatment GSH G S S G Reduced/Oxidised 
(n) (limoles.g'^ wet tissue) (^moles.g'^ wet tissue) ratio (GSH/GSSG) 
0.00% CO 0.375 ± 0.007 0.075 ±0.003 5.01 ± 0.30 
(3) 
0.01% CO 0.070 ± 0.007 0.027 ± 0.005 3.97 ±1.19 
(10) 
0.05% CO 0.050 ±0.010 0.015 ±0.002 3.82 ±1.19 
(5) 
1 
Time and GSH G S S G Reduced/Oxidised 
Treatment (nmoles.g'^ wet (nmoles.g'^ wet ratio (GSH/GSSG) 
(n = 3) tissue) tissue) 
t = Omin; 0.591 ± 0.070 0.036 ±0.016 31.59 ±5.43 
0% CO 
f= 30min; 0.406 ± 0.082 0.033 ±0.021 13.92 ±9.15 
0% CO 
i - 30min: 0.431 ±0.071 0.003 ± 0.003 73.17 ± 18.49 
0.01% CO 
6 
Table 5.7 The absolute content (in ^ o l e s per gram of wet tissue) of the reduced (GSH) 
and oxidised glutathione (GSSG) was determined in rat heart homogenates prepared from 
isolated perfused hearts treated with CO under nonmoxia {top part, A). The bottom part, B, 
is the glutathione content in homogenates taken from ('start-stop') hearts that were 
removed from the Langendorff apparatus at the stated time and CO-treatment (under 
normoxic conditions used throughout). The data shown is the mean ± SEM with the 
number of hearts (n) used in each group shown in the figure. The reduced to oxidised 
ratio was detemnined for each heart and is expressed as the mean ± SEM for each 
treatment group. No significant differences were found. 
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5.3.3 Protein Concentration of Rat Heart Ventricle Homogenate 
The protein concentration in the tissue homogenates prepared from isolated perfused rat 
hearts exposed to CO were determined to assess any Intracellular loss from heart tissue 
and CO-treatment. The protein concentrations were measured (using a commercial 
diagnostic kit) and is shown in Table 5.8 {top part. A). No significant difference was found 
between the treated and control groups, although the 0.01% CO-treated group had a 
lower protein content. The protein concentration for the start-stop perfusion is included in 
Table 5.8 {bottom pari. B). 
Treatnnent Protein concentration 
in) (mg.ml"^  homogenate) 
0.00% CO (3) 5.24 ± 0.22 
0.01% CO (70) 4.74 ±0.15 
0.05% CO (5) 5.36 ±0.21 
Time 
(n) 
Protein concentration 
(mg.mr^ of homogenate) 
0.00% Omin (3) 4.95 ±0.51 
0.00% 30min (3) 4.75 ±0.21 
0.01%30min (3) 5.03 ± 0.67 
Table 5.8 The protein concentrations of ventricle homogenates prepared from isolated 
perfused rat hearts exposed to CO. The ventricle tissue was taken from the experimental 
heart and homogenised prior to determining the protein in the 10% homogenates (see 
Materials and Methods). The protein concentrations shown are from {A) the CO-treated 
groups and (B) the start-stop perfusions. The data shown is the mean ± S E M with the 
number of hearts {n) used in each group shown in the figure. No significant differences 
were found. 
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5.4 Discussion 
The activities of lactate dehydrogenase (LDH). creatine kinase (CK) and troponin I (Tnl) in 
the perfusate of isolated perfused rat hearts were measured to assess the viability of heart 
tissue exposed to CO. The activities of CK and LDH were detenmined in fresh perfusate 
samples kept on ice prior to their detennination as storage at 20°C results in a significant 
loss of CK activity (Swaanenburg et a/., 1998). The high sensitivity of the troponins (and 
myoglobin) make them useful for detecting early acute myocardial infarction relative to 
LDH and CK (Stokke a/., 1998). The activities of LDH, CK and Tnl were increased 
following the CO-treatment in the perfusate of control hearts. The level of activities (of 
these measured markers) min-ored their rate of release into the perfusate (out of the 
heart) and declined over time suggesting that no significant damage occun'ed in the 
control hearts (under the conditions used). It may be reasonable to suggest that CO 
exposure produced subtle tissue damage, othenwise no increase in enzyme activity may 
have been found. 
The decreasing activity of LDH and CK may indicate some washout produced from early 
injury (in control hearts). This injury could arise during the removal of the heart (from the 
rat) prior to its perfusion (Rodrlguez-Sinovas et a/., 2003). Excision of the heart results in 
ischaemia of the organ from the temporary loss of blood supply prior to oxygenation (by 
perfusion). It is possible that this may produce oxidative stress (1.5) as a result of some 
ischaemia/reperfusion (l/R) injury (1.6) induced whilst preparing this model. The activities 
of LDH and CK were highest in the pretreatment perfusate than in later fractions (Figure 
5.1). Some readers may disagree with using the isolated Langendorff preparation in 
favour of a working heart. However, no significant differences were shown in the leakage 
of CK between the two preparations when used to examine ischaemia (Galinanes & 
Hearse, 1990a). The degree of CO-induced ischaemia here (if any) is anticipated to be 
less than the ischaemia produced by global ischaemia. Therefore, the levels of CK and 
LDH activities cannot compare the extent of the tissue damage by either treatment. The 
different levels of oxygen used in other studies (95% O2) compared to this study (21% O2) 
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could contribute to some of the differences found and cannot offer suitable enzymic data 
for comparison to evaluate whether the injury arises following indirect CO-induced 
ischaemia and/or solely from CO. 
Young adult rats exposed to 0.15% CO in air for two hours show elevated activities of 
LDH and CK (in serum) of 117 and 132% above control at two hours postexposure, 
respectively (Penney & Maziarka. 1976). Their study also found different rates and 
periods of enzyme release. An immediate release of CK were shown and the release of 
LDH was delayed post-CO. The elevated activities of LDH and CK (in the collected 
perfusate samples here) could not be compared quantitively to other studies as these 
used blood samples (Barabfes et a/,, 2000; Dolan, 1985; Penney & Maziarka. 1976). Their 
elevated activities cannot be attributed solely to heart tissue as the blood compartment 
could indicate damage from other tissues/organ(s). whereas we examined heart tissue. 
The immediate elevated activity of LDH (and CK) during CO exposure does not support 
the hypothesis as the reperfusion period is shown to induce the release of LDH from rat 
hearts (Rodriguez-Sinovas et a/., 2003). The increased perfusate activity of CK may 
suggest that myocardial necrosis occurred during CO exposure. Myonecrosis is reported 
in patients of CO poisoning (Shapiro a/.. 1989). However, no correlation is found 
between the levels of CO exposure and CK detemiined in the serum (Shapiro et a/.. 
1989), similar to the observed activities of CK (and LDH) in the perfusate of 0.01 and 
0.05% CO-treated hearts. Glucose is shown to reduce the release of cytosolic enzymes 
from heart tissues following ischaemia (Hearse & Humphrey, 1975). The inclusion of 
glucose in the perfusion buffer may have offered some myocardial protection here. The 
lack of association in the loss of tissue viability with dose of CO is discussed below. 
The established role of free radicals (1.5) in l/R injury (1.6). particularly the reactive 
oxygen species (ROS) may blind the true extent of tissue damage as some ROS can 
lower the activity of CK. The activity of cytosolic CK (in rat heart) is decreased by ROS 
and is thought to arise from the oxidation of a cysteine residue involved in substrate 
binding at the active site (Genet et a/.. 2000). It is possible that any intracellular production 
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of ROS may precede the loss of cellular viability and that some CK measured in the 
perfusate could be inactivated (described above). This could account for the unexpected 
low activity of CK in perfusate of rat hearts exposed to 0.05% CO relative to the 0.01% 
CO-treated group. However, ROS production is shown to occur predominantly in the 
reperfusion period of l/R injury (Grupp ef a/., 1999; Halliwell & Gutteridge. 1999). 
Therefore, the rise in CK (and LDH) activity in the perfusates taken during CO exposure 
could be from the direct effect(s) of CO, possibly at some other cellular target(s) involved 
in maintaining cellular integrity. CO is shown to depress the specific activity of LDH and 
glucose-6-phosphate in cultured heart cells (Brenner & Wenzel. 1972). Chronic CO 
exposure increased the M-subunit of LDH in adult rats (Penney et a/., 1974). however, 
Brenner & Wenzel (1972) found a decrease in this subunit. The use of semm in culture by 
Brenner & Wenzel (1972; above) may account for some of these differences, as serum is 
shown to alter the isoforms of cultured heart cells (Van Der Laarse et a/.. 1979). The 
exposure of adult male rats to 0.05 and 0.1% CO in air produced an elevated activity of 
CK (MB isofonn) in the plasma (Thomas & O'Flaherty. 1982). In the heart, the 
mitochondrial CK activity arises from the sarcomeric Isofonn (Hammerschmidt a/., 
2000). The activity of several isoforms of myocardial CK is shown to be altered following 
P-adrenergic stimulation and this is thought to precede the failing heart. The observed loss 
of CK may impair myocardial energy metabolism and lead to heart failure (morbidity) in 
this manner. 
The release of CK and LDH did not reflect or associate with any of the trends found in the 
physiological changes following CO exposure (Chapter 4). Fortunately, for this study 
another specific marker of cardiac viability was used, i.e. troponin I (Tnl). In hindsight, the 
author suggests measuring the troponin levels in all the perfusate fractions (TnT or Tnl; 
Ooi & Maddock, 2000) and the activity of LDH/CK in the ventricle homogenates. In vivo 
Tnl is primarily released into the plasma as a binary complex with troponin C and later 
occurs as a distribution of several forms (Gerhardt ef a/.. 2000; Ueda et a/., 2001). The 
activities (and rates of release) of perfusate LDH and CK were maximal during the 10-15 
minute period of CO exposure (Figures 5.1). Therefore, the 10-15min fraction were used 
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for Tnl analysis, with the following fractions: pretreatment fraction (-5 to Omin); fraction of 
observed maximal CO damage (10 to 15min); immediately post-CO (30 to 35min); and at 
the end of the perfusion, i.e. final perfusate fraction (at 80 to 120min). 
The troponins (Tn) comprise of three sub-groups: I, C and T (Sato ef a/., 1998; Zhao et 
a/., 2000). These are currently the best markers in clinically diagnosing any muscle 
damage in heart tissue using blood samples taken from patients. Troponin I is found in the 
serum of ca. 30% of patients with severe heart failure (Benamer et a/., 1999; La Vecchia 
ef a/., 2000). Although, perfusate samples were used to determine the level of Tnl. serum 
must be free from plasma othenwise falsely elevated Tnl concentrations can arise 
(Nosanchuk, 1999). Troponin T (TnT) is regarded as the most reliable marker out of the 
three in establishing cardiovascular damage (Johansen ef a/., 1998) and analytically costs 
more than measuring Tnl levels (personal communication with Jane Dickinson, Triphasic 
Laboratories, Plymouth, UK). The higher sensitivity of TnT is thought to be due to a 
difference in the cross-reactivity of antibodies to Tnl and TnT (Bertinchant ef a/., 2003; 
Heeschen ef a/.. 2000). However, Tnl may have a similar prognostic value as TnT 
(Meckel ef a/., 1998). However, Tnl may not always suggest myocyte injury in patients of 
congestive heart failure (Kamblock, 2002). The extrapolation to the human heart is 
possible as the troponin assays have been validated In rats using an isolated heart model 
(Fredericks ef a/.. 2001). 
The loss of intracellular material from perfused hearts exposed to CO were difficult to 
associate with the overall loss of measured mariners (i.e. LDH, CK and Tnl). The CO-
treated groups showed greater activity in the perfusate and rates of release relative to the 
control group, however, the 0.01% CO-treated group had a greater loss of viability than 
the 0.05% CO group (result not significant). This may account for the lower protein 
content in ventricle tissue from 0.01% CO-treated hearts (5.3.3) and could suggest that 
most damage may have occurred in this group. 
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Both groups of CO-treated hearts had an increased level of Tnl in perfusate samples 
during and immediately after exposure to CO (compared to controls). These results 
support the LDH and CK data and suggest that CO exposure (under nonnoxic conditions) 
produced cadiac damage as shown by the loss of intracellular material (or viability) 
compared to controls. This is supported by the increased rate of Tnl released from CO 
exposed hearts relative to controls. The rate of release during CO exposure, immediate 
post-CO period and in the last CO-free perfused fraction were elevated relative to the 
basal levels. These rates of release were greater than the time-matched decline found for 
the control hearts and indicate that CO toxicity in vivo may not be caused solely from a 
lack of oxygen (from COHb formed during CO exposure). CO may have its own 
cardiotoxic effect(s) that may be potentiated by CO-induced hypoxia in vivo. The release 
of Tnl (and presumably TnT) could predict an adverse cardiac outcome in the long-term 
(de Filippi et a/., 2000) and may suggest that cardiac morbidity occurs in hearts exposed 
to CO. The dose-dependent decline in coronary flow (shown in Chapter 4) may be 
associated with the loss of Tnl following CO exposure (Table 5.3) and could suggest 
diffuse coronary disease and/or a worse outcome to follow the initial damage found 
(Fuchs a/.. 2002). 
Experimental ischaemia producing intracellular hypoxia (hypoxia,) is shown to produce a 
loss of troponins from the myocardial infarcted zones, with the greatest loss occurring in 
the periphery of the infarcted zones (Fishbein et a/., 2003). This loss of troponin (produced 
by ischaemia) preceded tissue necrosis and could suggest that ischaemia may have 
occurred in the hearts exposed to CO. The troponins are involved in the contractile 
function of the heart. The deletion of TnT can lead to diastolic dysfunction and ventricular 
arrhythmias (Frey a/., 2000). The loss of Tnl could account for the depressed HR 
(shown in Chapter 4). Cases of reported myocardial infarctions (Ml) produced following 
the exposure to CO were described in Chapter 4 (Ebisuno et a/., 1986). The troponins 
correlate closely with the size of infarct (Metzler et a/., 2002). The elevated levels of Tnl 
could suggest a direct effect of CO inducing a Ml, Furthermore, this may be potentiated 
through the reduced coronary perfusion (shown by the depressed perfusate flow after CO 
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exposure in Chapter 4). The zone(s) of focal haemmorhaging found in the ventricle tissue 
following 0.05% CO-treatment (Chapter 4) also showed an increased release of Tnl, and 
may highlight a possible region of infarcted tissue. However, the increase was not 
significant to the other 0.05% CO-treated hearts that showed no zones of damaged tissue. 
The degree of intracellular hypoxia (by COMb fonnation) is unlikely from the ratios of the 
gases that the hearts were exposed to. The dissolved diatomic oxygen utilised by 
cytochrome c oxidase (in the mitochondrial ETC) is delivered by the diffusive gradient 
between the blood and mitochondra. Myoglobin facilitates this delivery of oxygen to the 
mitochondria and this is inhibited in the presence of CO, however, this inhibition requires 
lethal levels of CO (Wittenberg & Wittenberg. 1993). A ratio of the partial pressure of CO 
(Pco) to the partial pressure of oxygen (P02) of at least six can inhibit the diffusion of O2 
from Mb to cytochrome c oxidase (Piantadosi, 1996); whereas, a PC0/P02 of one would 
bind CO to all the Mb. Whether hypoxia, was partly responsible for the described changes 
in Chapter 4 has to be detemiined (discussed below). The reduced myocardial steady-
state O2 consumption by NO is comparable to CO suggesting that CO may stimulate 
cGMP production within the myocardium (Gong et a/.. 1999). The possible production of 
cGMP may have a role in the chronotropic responses observed through its inotropic 
modulating properties. Myoglobin is also thought to be involved directly in mitochondrial 
respiration by the 'myoglobin-mediated oxidative phosphorylation' and somehow 
participates in respiration without facilitating the diffusion of oxygen to the mitochondria 
(Wittenberg & Wittenberg, 1993). These direct effects of CO suggest that CO may have a 
widespread role within the myocardium than once thought. The tissue(s) of the heart 
damaged by CO-treatment remain to be identified. However, in light of the discussed 
changes (in Chapters 4 and here) the endothelial cells may be a possible target of CO. 
The direct toxicity of CO towards endothelial cells were shown in bovine pulmonary artery 
endothelial cells exposed to 0.001 to 0.01% CO (Thom a/.. 2000). 
The lactate and pyruvate content of the tissues were determined to examine whether 
intracellular hypoxia (hypoxia,) had occurred in hearts exposed to CO. The measurements 
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of myocardial lactate and pyruvate serve a s indicators of oxidative metabolism (Ayres et 
a/., 1970). During glycolysis, a flux from pyruvate to lactate occurs under anaerobic 
conditions, whereas pyruvate is channeled into the Kreb's cycle under normal conditions, 
i.e. normoxia. Hypoxia, and the associated increase in intracellular [lactate] can lower the 
binding affinity of myoglobin for oxygen under moderately acidic pH (Giardina et a/., 
1996). A reduced myocardial oxygen consumption and/or anaerobic nnetabolism follows 
lactate production. The measured pyruvate content were not as effective in evaluating the 
intracellular conditions relative to the lactate measurements. The lactate to pyruvate (L/P) 
ratio is a more reliable indicator of the degree of intracellular oxygenation than the 
pyruvate content. The L/P ratio were compared using the determined content of each 
analyte (5.3.2.1). The L/P ratios support the above and also suggest that no oxygen 
limiting conditions occurred inside cells/tissues from the normoxic CO-treatment used 
here. 
Lactate levels in the blood mirror the tissue concentration in vivo, therefore, the lactate 
levels were expected to fall in the perfused organ following washout occuring to 
equilibrate with the perfusion buffer. The results (in Table 5.5) showed that the level of 
lactate in ventricle tissue were slightly elevated with increasing C O exposure, however, no 
significant differences suggest that no hypoxia, occurred in CO-treated groups at the end 
of the perfusion (5.3.2.7). This is in contrast to the elevated blood lactate found in rats 
exposed to 0.24% C O that occun-ed during and after the C O exposure (Penney & Chen, 
1996). Therefore, the lactate content was determined in ventricle tissue from hearts used 
in the start-stop perfusions (Figure 5.3). The start-stop heart perfusions (exposed to 
0.01% C O ) showed no elevation in the lactate content of ventricle tissue. This may 
suggest that the C O exposure to isolated rat hearts during normoxia did not produce 
intracellular hypoxia in the ventricles. The intracellular partition coefficient between C O 
and O2 is shown to be 36 from NMR signals (Glabe et a/., 1998). Under the assumption 
that the levels of COMb and Mb02 is proportional to the partial pressures of C O and O2 
(Pco and P02. respectively); and considering the partition coefficient (taken as 36) gives 
0.017 and 0.086 for the intracellular COMbiMbOj ratio for 0.01 and 0.05% C O , 
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respectively. Glabe et at. (1998) found an increase in the level of lactate to suggest 
inhibition of the mitochondrial E T C occurred when C0Mb:Mb02 >1.5. 
Other workers have reported that the effects of C O are not solely attributed to systemic 
hypoxia through the formation of COHb. Basset & Fisher (1976) showed that lactate and 
pyruvate production increased when isolated rat lungs were ventilated with C O (Lin & 
McGrath, 1989). Their increase in lactate suggests that intracellular hypoxia may be 
produced by the formation of COMb in the presence of normoxia. However, the ratio of 
lactate to pyruvate in the blood was unchanged in conscious dogs exposed to 0.15% C O 
through a permanent tracheostomy (Cramlet et a/.. 1975). Any increase in the level(s) of 
lactate could be masked during and/or after the exposure to C O as lactate (and amino 
acids) can be used in the synthesis of glycogen to maintain glycolysis by glycogenolysis 
(Fournier a/., 2002). However, glucose can maintain a linear anaerobic increase in 
lactate (Hohl a/., 1982). Using the changes In lactate content to measure the degree of 
hypoxia, may not rule out hypoxia, in the atria (not detemnined), and could implicate 
hypoxia, for the changes in coronary flow (in Chapter 4). An increased or decreased P02 
is shown to elevate the lactate levels In tachycardic hearts (Neill et a/.. 1973) suggesting 
that hypoxia may not increase the level of tissue lactate, and that the contractile state of 
the tissues may determine such biochemical changes (Salkowski & Penney. 1995). 
The production of reactive oxygen species ( R O S ) is established in l/R injury (described 
previously in 1.5 and 1.6). The inactivation of glycolysis (in P388D1 cells) by hydrogen 
peroxide also inhibited the uptake of glucose and the production of lactate (Hyslop et a/.. 
1988). The absence of any change in ventricle lactate levels could suggest that oxidative 
stress may have occurred following the exposure to C O in isolated hearts (see later). The 
role of R O S producing myocardial injury is established from many studies using 
antioxidants (AO). Many chemicals having antioxidant properties (by indirectly increasing 
the endogenous AO capacity and/or directly participating in scavenging R O S ) and were 
identified from studies using cell culture and isolated hearts (Chen & Tappel. 1995; Facino 
et a/.. 1999; Massey & Burton. 1990; Yim & Ko. 1999). Some obvious points are not 
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discussed here as they were previously mentioned elsewhere (Patel et ai, 2003; shown 
on pages 293-297). The perfusion of AO before and during CO-treatment were used for 
two reasons. Firstly, if oxidative stress were involved in the cardiotoxicity of C O , the model 
used should not be subjected to oxidative stress following organ isolation (as it would not 
be suitable due to the reduced tissue AO capacity). Secondly, preconditioning may arise 
in the hearts after their excision and this may not provide an accurate picture of events in 
CO-treated tissues, particularly if oxidative stress were involved in the cardiotoxicity of 
C O . The isolated hearts were treated with AO before and during the C O exposure as this 
period also appeared to produce the cardiac changes observed after C O exposure, for 
example, the depressed coronary flow (Chapter 4). Similarly, ketamine (a NMDA-receptor 
antagonist) administered before and during acute 0.24% C O exposure had a protective 
effect in reducing blood lactate in female rats (Penney & Chen, 1996). The period of AO 
intervention (used here) were similar to other studies examining l/R injury in the heart 
(Persoon-Rotherl a/.. 1990; Walker et a/., 1998). Vitamin C and TroIoxC were selected 
as the antioxidants as they are water soluble analogue and established in the literature 
(Arrigoni & De Tullio, 2002; Niki, 1987; and Shang et a/., 2003). Glutathione contributes 
significantly to cellular/tissue antioxidant defence (Krieter et a/., 1994; Reiners Jr. et a/., 
2000). The glutathione levels were determined to examine for oxidative stress in the heart 
tissue exposed to C O . Other markers of lipid peroxidation (to support CO-induced 
oxidative stress) such as malondialdehyde were not determined due to its artifactual 
production during homogenisation (Cordis et a/., 1995; Gutteridge, 1981; Verbunt et at., 
1996). The glutathione levels in rat heart ventricle tissue following C O exposure had a 
significant depletion (shown on pages 293-297) suggesting that oxidative stress occurred 
after C O exposure (Patel ef a/., 2003; and Table 5.7). The depletion of cellular 
antioxidants can also indicate anoxia (Blokhina et a/., 2000). however, this is unlikely 
under our experimental conditions and our biochemical data suggests no hypoxia 
occurred (Table 5.5 and Figure 5.3). 
The depletion of other myocardial antioxidants cannot be ruled out, particularly as a 
hierarchy of antioxidants is shown to exist (Dhalla et ai, 2000; Haramaki a/.. 1998; 
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Palace ef a/., 1999). Ascorbate is more effective than TroloxC as an antioxidant (AO) in 
the cardiac microvasculature (Molyneux et a/.. 2002). Furthermore, ascorbate is the 
primary A O in myocardial injury (Haramaki et a/.. 1998) and this could suggest that 
ascorbic acid (vitamin C ) may be the key A O that preserved the glutathione depletion, by 
supplementing the endogenous antioxidant content (of ascorbic acid). If this were shown, 
it may suggest that R O S were responsible for depleting the glutathione content. 
Additionally, using H E P E S buffer (with the A O perfusions) could have prevented or 
contributed in preserving the glutathione content, a s H E P E S is shown to scavenge 
hydroxyl radicals (Grootveld & Halliwell. 1986). Some depletion of glutathione could have 
occurred through leakage as shown by a minor loss of tissue viability, however, the loss of 
glutathione found here far exceeded that of the tissue viability (above). The likelihood of 
R O S being responsible in reducing the activities of LDH and C K were not detemnined and 
may not account for the difference between loss of glutathione and tissue viability. 
Therefore, the CO-treatment could have depleted the glutathione (possibly with the 
production of R O S ) and/or by other unknown mechanism(s) through direct or indirect 
mode(s). 
The role of NO in C O poisoning could produce R N S (Chapter 1) that may account for the 
oxidative stress found here. Nitric oxide is shown to deplete G S H by forming S -
nitrosoglutathione (Miglani a/., 2003). This may be likely as the production of NO after 
C O exposure is shown (Chapter 1). The reaction of NO with thiol-containing compounds 
(producing S-nitrosothiols; Foresti et a/., 1997) could have depleted the myocardial 
glutathione (possibly after the production of NO following C O exposure). Therefore, the 
inclusion of ascorbate (in the AO-treatment) may have indirectly preserved glutathione 
depletion in this manner and not necessaily by scavenging R O S . R O S are shown to 
promote intercellular endothelial gap formation (Schafer et a/., 2003) and could be 
responsible for the in-eversible swelling (found after CO-treatment in Chapter 4). Taken 
together, these could suggest an additive role of NO and R O S in the cardiotoxicity of C O . 
TroloxC can scavenge the hydroxyl radical and superoxide species with a reported ICso of 
1.15 and ImM, respectively (Walker et a/., 1998) and suggests that ascorbate may have 
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significantly contributed to the A O effect as 0.2mM TroloxC was used here (i.e. <IC5o). The 
depletion of glutathione could not be responsible for the depressed HR as the 
physiological change in HR occurred before the oxidative stress. In contrast, Ganafa et al. 
(2002) showed the depletion of glutathione increased the HR of male Sprague-Dawley 
rats. 
The regulation of extracellular calcium by glycolysis is shown (Aasum ef a/., 1998), 
however, any altered glycolysis (by oxidative stress following C O exposure) did not 
produce any Intracellular changes in calcium content (Chapter 4). Although any changes 
in the calcium content that occurred during the C O exposure may have returned to the 
control levels found after the 90 minute CO-free (recovery period). Lactate is shown to 
modulate the production of superoxide in bovine cardiac myocytes (Mohazzab-H. et al., 
1997). Although the use of intracellular lactate as a measure of hypoxia, has been 
addressed, an early study by Huckabee (1958) showed that the production of lactate by 
tissues is not aftributed to hypoxia. His study showed that the changes in blood lactate 
were due to the equilibria between pyruvate and lactate in the tissues. 
Huckabee (1958) showed that the infusion of glucose or pyruvate into the blood produced 
a secondary increase in the lactate levels of the tissues before changes in the blood 
(when hypoxia was absent). Their study also showed that the inhibition of glycolysis (with 
iodoacetate) produced a rise in blood pyruvate. This may suggest that the lactate content 
should have been determined in the coronary effluent of the perfused isolated hearts 
exposed to C O (5.6.1) to provide an accurate account of the changes. The increase in 
pyruvate following the exposure to 0.01% C O could suggest that sonne glycolysis may 
have been impaired by oxidative stress (above). However, the rise in (pyruvate] was not 
significant to the time-matched control level and may not be fully attributed to the inhibition 
of some component(s) of the Kreb's cycle resulting in the accumulation of pyruvate from 
glycolysis. The a-ketoglutarate dehydrogenase complex (in the Kreb's cycle) regulates 
mitochondrial function and cellular calcium (Huang et al., 2003) and its inhibition (by C O ) 
may be ruled out as no changes in calcium content were found (in Chapter 4). 
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Furthermore, the absence of glutathione depletion during the C O exposure period 
supports the evidence indicating an absence of hypoxia, (above); as hypoxia is shown to 
decrease the tissue content of glutathione in rat hearts (Park et a/., 1991). 
The content of glucose and glycogen were determined to examine any glycolytic fluxes 
that may have occun-ed in the ventricle tissue of hearts exposed to C O . Glycolysis 
supports cellular function by the production of ATP under anaerobic conditions and the 
glycolytic end-products (such as lactate) are thought to detemriine the extent of ischaemic 
cell damage (Bradamante et a/.. 2000). The blood glucose level is reported to correlate 
with the HR (Iwakura et a/., 2003). Therefore, this may be expected to show a lower level 
of glucose (in light of the depressed HR) in tissues exposed to C O (Chapter 4). However, 
no differences in the level of glucose or glycogen were found here in the ventricle tissue 
between CO-treated and control hearts. TroloxC (at 0.2mM) is shown to increase the HR 
and C F in perfused isolated rat hearts (Bell6-Klein et at., 1997). However, these 
contradictory findings were not found here in the control A O group of hearts, similarly to 
the findings of Walker et at. (1998) and cannot be explained. The positive chronotropic 
effect of TroloxC also reduced the glycogen content in their hearts from a higher 
consumption of energy (Bell6-Klein a/.. 1997). The AO-treated groups (here) showed a 
similar level of glycogen that appeared to fall (Table 5.6), and may suggest a higher 
consumption of glycogen without any concomitant increase in HR. 
Ischaemia produces an elevated level of glucose in porcine hearts subjected to an hour of 
regional ischaemia (Elvenes et a/., 2002) possibly to maintain anaerobic metabolism. As 
the depletion of glucose was not observed between the CO-treated and control hearts, it 
is reasonable to assume that gtycogenolysis may have occurred to provide glucose for 
glycolysis. However, glycogenolysis did not appear to have occurred as no glycogen 
depletion were found in CO-treated hearts compared to the control group (5.3.2.3). The 
perfusion buffer contained 11mM glucose during the whole perfusion period. This could 
have provided a sufficient level of glucose to maintain the adequate production of A T P by 
glycolysis if intracellular hypoxia was produced by C O (via the formation of COMb). This 
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may be possible as perfusing glucose is shown to protect isolated rat hearts subjected to 
anoxia (Hearse & Humphrey, 1975; Hoht et a/., 1982). Mild to moderate ischaemia 
produces a marked increase in glucose uptake and usage by inducing the translocation of 
a glucose transporter using protein kinases, however, severely ischaemic myocardium 
loses its ability to extract more glucose from the blood (Egert et a/.. 1997; Sun ef a/., 
1994). These changes are protective and associated with preserved myocardial function, 
a decreased release of myocardial enzymes and an improved recovery during 
reperfusion. The inclusion of glucose may account for the unchanged levels of glucose 
found in the ventricles of CO-treated hearts compared to controls. This may also explain 
the lack of glycogenotysis following C O exposure. Further work could repeat this study in 
the absence of glucose in the perfusion buffer of hearts exposed to C O and examine any 
differences in the degree of tissue damage (see 5.6.2). No difference in the tissue levels 
of glucose are anticipated to be found between the hearts of different ages treated with 
C O as ageing shows no change in the myocardial utilisation of glucose (Kates et ai, 
2003). However, the age difference in the cardiotoxicity of C O may reveal some significant 
changes and remains to be detemiined. Rats exposed to 4% C O (for 4 minutes) showed 
no change in the plasma level of glucose (Hattori a/., 1990). However, their level of C O 
is expected to be lower than the levels delivered solely to the heart, and may be expected 
to produce no significant change despite their reduced A T P content in the myocardium. 
No change in the glycogen content was found and could suggest that C O may interfere 
with the glycolytic pathway in a subtle manner to produce other changes not measured 
here. 
The role of glucose in preserving myocardial function following l/R was reported (above) 
to have a protective effect (Hearse & Humphrey, 1975). However, the activity of 
glutathione reductase (GR) in isolated rat hearts perfused with glucose is decreased 
during ischaemia (DeGroot et a/., 1995). Oxidative stress produced after C O exposure (in 
the heart ventricle tissue) could indicate a reduced activity of G R that may result in the 
depletion in glutathione (through loss of oxidised glutathione and/or other glutathione 
conjugates), however, this would have to be determined. The lactate and pynjvate data 
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suggested that no intracellular hypoxia occurred during C O exposure, therefore, it may 
suggest that C O in the presence of glucose could directly affect G R . 
A heart with limited energy can pump up to the limits of its energy supply (Wittenberg & 
Wittenberg, 1993), therefore, it would be expected to be observed as a diminished 
maximum rate. These workers also showed that greater than 4 0 % COMb in isolated rat 
cardiac myocytes decreased the mean steady-state respiratory uptake of oxygen in these 
heart cells. Contractile activity is directly related to glycolytic A T P synthesis (Bradamante 
et a/., 2000), although myocardial recovery is possible when the depletion of ATP and 
creatine phosphate (^  95%) occurs in myocytes (Bonz et a/., 1998). No change in the 
content of glucose and glycogen found for the CO-treated hearts (relative to the control 
group) may suggest that the glycolytic activity was not altered, therefore indicating that 
hypoxia, may not be responsible for the reduced HR (shown in Chapter 4). The influence 
of the glycolytic pathways could be investigated using glycogen-depleted hearts, although 
this may show glycogenolysis and it could also produce metabolic hibernation. 
Glycogenolysis may be related to the contractile recovery of postischaemic myocardium, 
however, this requires glycolysis during early reperfusion to support the cellular house 
keeping activities (Bradamante etai, 2000). 
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5.5 Conclusions 
The use of normoxic conditions, i.e. isolated hearts perfused with a buffer equilibrated with 
21% 02 may exceed the oxygen content delivered to the heart in wVo resulting in findings 
that indicate an absence of intracellular hypoxia. The isolated rat heart preparation has 
demonstrated some direct effects of C O that could be masked at the m wVo level. The 
effects of C O shown (here and the previous chapter) suggest that the changes in heart 
rate and coronary flow (in Chapter 4), and the loss of tissue viability may be produced 
directly by C O . The discussion here raised findings that suggest no intracellular hypoxia 
had occurred, however, the in vivo scenario may be different and would have to consider 
the blood compartment. Hypoxia in the blood (following the in vivo exposure to C O ) could 
possibly contribute to an elevated intracellular Pco to P02 ratio (5.4) and potentiate the in 
situ formation of carboxymyoglobin (COMb). This may shift the intracellular C0Mb:Mb02 
to exceed 1.5 indicating hypoxia, (Glabe et a/., 1998), therefore, possibly decreasing the 
heart rate of the heart through an impaired mitochondrial E T C . The role of oxidative stress 
in the heart following C O poisoning may indicate that a different mechanism (versus an 
l/R-like injury) occurs as no ischaemia (intracellular hypoxia) were found. 
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5.6 Further Work 
5.6.1 Intracellular Hypoxia & Lactate 
To examine the degree of intracellular hypoxia by measuring the levels of 
carboxymyoglobin (COMb) in isolated perfused rat hearts exposed to C O (under our 
experimental conditions). The COMb content may be determined in the stored ventricle 
tissue homogenates as C O is not lost from frozen tissue (Sokal et a/., 1984). The COMb 
content could be detemiined using spectroscopy under the assumption that the COMb 
complex is stable as carboxyhaemoglobin (COHb) by blocking the dissociation of C O by 
oxygen using sodium hydrosulphite (Na2S204; Rodkey et a/., 1979). However, Wittenberg 
& Wittenberg (1993) showed that C O dissociated rapidly from myoglobin, particulariy 
when C O is removed from the ambient solution. If this is the c a s e , the degree of 
intracellular hypoxia (by the formation of COMb) may not be determined so easily and 
could consider using fresh tissue homogenates exposed to C O . It is possible that no C O 
may bind in tissues (complexed to Mb), although this could be tested by measuring the 
level of C O in the tissue homogenate samples (Harper Jr., 1952). C O exposure produced 
the release of LDH, CK and Tnl (5.4.1), however, any loss of myocardial myoglobin (Mb) 
could limit the degree of oxygen delivered to the mitochondria. Therefore, it may be useful 
to detenmine the Mb content of the homogenate samples (also in the atrial tissue) to 
evaluate any toss of Mb following C O poisoning (Reynafarje, 1963). 
The activity of monoamine oxidase (MAO, using phenylethylamine as the substrate) can 
be used as a probe for examining the oxygen gradients in heart cells (Katz et a/., 1984). 
Intracellular hypoxia (by a limited diffusion of oxygen to the mitochondria via the possible 
formation of intracellular COMb) during C O intoxication could be determined indirectly in 
the CO-treated heart tissue by rapid homogenisation prior to measuring the MAO activity. 
The lactate content was not determined in the atrial tissue. Any hypoxia in the atrial tissue 
was not determined due to discarding the tissues (in 5.4). In hindsight, the author would 
propose measuring the lactate content in the atrial tissue from rat hearts exposed to C O . 
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The lactate and pynjvate content may also be determined in fresh perfusate to evaluate 
any changes in the (ef)flux of the tissue content. 
5.6.2 Substrate Supplementation For Isolated Hearts E x p o s e d T o C O 
The presence of glucose may limit the cardiotoxicity of C O . Glucose could be omitted 
during the perfusion with C O and/or supplemented in the CO-free period to evaluate its 
role in C O poisoning. 
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Chapter Six: 
Mitochondria & Oxidative Stress in CO Poisoning 
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6.1 Introduction 
Hyperbaric oxygen therapy/treatment (HBOT) is widely used in clinical medicine and is 
important in the treatment of C O intoxication (1.2 and 1.3). HBOT is highly effective in 
treating patients after C O poisoning; it can produce an elevated clearance of C O from the 
blood, with a rapid loss of symptoms of C O toxicity. However, this treatment results in 
oxidative stress as shown by the elevation in markers of oxidative damage (Bearden et 
al., 1999; Dennog et al., 1999). The role of reactive oxygen species ( R O S ) in l/R injury is 
established (Becker & Ambrosio, 1987; Entman et al., 1992; Maulik et al., 1998). In 
general, a longer duration of ischaemia produces more oxidative stress during reperfusion 
resulting in a greater degree of reperfusion-injury. The precise nature of events occurring 
under these conditions is not clear due to the involvement of many cellular components. 
Mitochondria are organelles whose *power house' role is to produce A T P for cellular work 
via the electron transfer chain ( E T C ; Cadenas & Davies, 2000). In heart tissue, virtually all 
the ATP is produced by mitochondria (Borutaite et al., 1996). Mitochondria are the major 
sites of R O S production via the E T C (Staniek & Nohl, 2000). The role of mitochondria in 
initiating cell death by releasing mitochondrial pro-apoptotic factors also makes this 
organelle of particular interest in tissue dysfunction. With this in mind (pro-apoptotic 
factors) and the high abundance of mitochondria in heart tissue, it is reasonable to 
assume a possible role of mitochondria in producing heart dysfunction following C O 
poisoning. The binding of C O to cytochrome c oxidase (or Complex IV) in the E T C is 
another reason for investigating this organelle. The role of mitochondria under hypoxic 
conditions is not fully understood and mitochondrial dysfunction is found in ischaemic 
myocardial tissue (Kay et al., 1997). Previous studies have shown that C O binding to 
cytochrome c oxidase results in the inhibition of the respiratory chain (5.4). This inhibition 
of the E T C can result in R O S production when oxygen is present, from oxygen interacting 
with reduced electron carriers. 
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6.2 Aim & Objectives 
The role of mitochondria in C O toxicity is not fully known. Inhibition of cytochrome c 
oxidase is well established, but its catalytic cycle during C O poisoning in the presence of 
oxygen Is not known (Morgan et a/., 1985). The aim were to investigate the effect of C O in 
the presence of oxygen, on possible R O S production from mitochondria during and/or 
after C O exposure and normoxia (as hypothesised in 1.7). Another aim was to investigate 
the role of mitochondria in possible R O S production during (re)oxygenation and HBOT 
following C O poisoning. Mitochondria from rat heart ventricles were chosen to associate 
the findings of the previous work (shown in Chapters 4 and 5). 
Specific objectives include: 
(i) the isolation of coupled mitochondria from fresh rat heart ventricle tissue; 
(ii) the use of hydrogen peroxide (H2O2). the dismutation product of superoxide (O2"), 
as an indicator of superoxide radical production from mitochondria to evaluate if 
R O S production occurs during/after C O exposure; and 
(iii) the assessment of the effect of hyperbaric oxygenation on R O S production using 
different levels of oxygen after C O exposure. 
The hyperbaric conditions may be simulated using custom made pressure vessels (2.3.4). 
However, it is possible that the elevated pressure(s) may have a direct effect on the 
mitochondria. We therefore used different oxygen fractions (at nonmobaric pressure) to 
simulate the increased partial pressure of oxygen (P02) in the blood that occurs during 
HBO exposure (as described in 1.3.1). 
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6.3 Materials & Methods 
6.3.1 Isolation of Rat Heart Mitochondria (RHM) 
The isolation procedure was performed as described by Staniek & Nohl (2000; who used 
a modified method described originally by Mela & Seitz, 1979). Briefly, rat heart 
mitochondria (RHM) were isolated from male Sprague-Dawtey rats (250-270 grams) 
following an acclimatization period >24h. The beating heart was rapidly excised after 
being anaesthesized (4.2.1). Hearts were immediately transferred into ice-cold isolation 
buffer prior to removal of unwanted tissue (thymus, lungs and atria). The isolation buffer 
(IB) contained 0.3M sucrose, 20mM triethanolamine (TEA) and ImM E G T A (adjusted to 
pH 7.4 with KOH). The remaining ventricle tissue were chopped into small pieces with 
scissors and washed with buffer several times to reduce the contaminating blood and kept 
in ca. 15ml IB prior to homogenisation. To obtain coupled mitochondria, this stage should 
be performed quickly, taking ca . 30s following the excision of the heart (Mela & Seitz, 
1979). 
The chopped tissue was homogenised at c a SOOrpm with 3-4 up and down strokes. 
During homogenisation the vessel was kept in an ice-bath. The homogenate was 
transferred into two 15ml centrifuge tubes and spun at 480g for 5 minutes. The 
supernatant were collected carefully, then filtered through two layers of cheesecloth into 
two clean centrifuge tubes, and immediately centrifuged at 7700g (10min). The resulting 
solid light-brown pellets were rinsed carefully with IB. Using a small volume of buffer (2-
3ml), the fluffy layer above the pellets were gently shaken loose and discarded. Care must 
be taken during gentle agitation, as vigorous shaking may disrupt the pellet and result in a 
loss of mitochondria. The pellet was resuspended carefully via aspiration using a 1ml 
Gilson pipette with a cut tip. Alternatively, the pellet may be resuspended very gently 
using a smooth surface or ground-glass rod, rotating around the edges of the dry pellet 
with no pressure, slowly moving towards the centre of the pellet. Buffer (15ml) was added 
to one tube of resuspended mitochondria and pooled with the remaining tube prior to 
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centrifugation at 7700gf (5min). The washing step comprised of rinsing the mitochondrial 
pellet surface, resuspending the mitochondria, and the centrifugation step was repeated. 
The mitochondrial fraction was suspended in incubation buffer (at 0.5ml.g"^ of tissue) 
containing 0.3M sucrose, 20mM triethanolamine, ImM diethylenetriaminepentaacetic acid 
(DTPA), and 0.5g.r^ fatty-acid free B S A (pH 7.4 on ice) to produce a suspension 
containing ca. 20mg.mr^ of mitochondrial protein (Mela & Seitz, 1979). The suspension 
was left on ice to 'rest' for an hour before commencing any experiments. All experiments 
were then performed at 25®C. 
6.3.2 Isolation of Rat Liver Mitochondria (RLM) 
Rat liver mitochondria (RLM) were isolated using a hybrid method adapted from Rickwood 
et ai (1987), Staniek & Nohl (2000), and Trounce et ai (1996). Briefly, RLM were isolated 
from male Sprague-Dawley rats (280-320 grams), after being starved for ca. 24h to 
deplete the tissue glycogen and free fatty acids (FFA) . Livers were removed from two 
anaesthesized animals and p laced into ice-cold mitochondrial isolation buffer (MIB). Ice-
cold MIB was used throughout unless othenA/ise stated. MIB c o m p r i s e d of 275mM 
mannitol (analytical grade), ImM E G T A . 5mM H E P E S and 0.1% B S A (pH 7.4 using 4M 
KOH). The livers were rinsed and the lobes were cut off and weighed. The lobes were cut 
into smaller pieces with scissors and homogenised with three 5s bursts. The homogenate 
(15% w/v) was then centrifuged at 1500g (5min) and the supernatant were centrifuged 
under the same conditions (pellets were discarded). The supernatant was then 
centrifuged at 8000g (15min). The pellets were washed to remove the fluffly white layer 
(by gentle aspiration; 6.3.1) and resuspended in a smaller volume of MIB (ca. 60% of 
initial volume). The resuspended pellet was centrifuged (8000g for 15min) before gently 
resuspending in ice-cold respiration buffer (RB) at O.lml.g"^ (wet weight of tissue). Ice-cold 
R B (pH 7.4) comprised 5mM H E P E S , 5mM KH2PO4. 275mM mannitol, ImM 
diethylenetriaminepentaacetic acid (DTPA) and 0.1% B S A (fatty acid free). The RLM were 
left on ice for ca . one hour to 'rest' prior to starting any experiments. 
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6.3.3 Mitochondrial ROS Production by CO and/or Hyperoxia 
Rat liver mitochondria (RLM) were incubated (for 5min) in a normoxic environment (21% 
O2; control group), with 0.05% CO (CO group), hyperoxia (95% O2; HPO group), CO 
(5min) followed by HPO (5 min; CO+HPO group). RLM were equilibrated by gentle 
bubbling (ca. 1 bubble.s'^) with the appropriate gas into the mitochondrial suspension held 
in a sealed glass cuvette whilst being stirred. Following each treatment the RLM 
suspensions were incubated at 25**C whilst stirred for lOmin. The mitochondrial 
suspensions were then centrifuged at 8.000g (15mln) and the supernatant was carefully 
removed and stored at -20°C (for later determination of hydrogen peroxide; 6.3.5). The 
pellets of RLM were resuspended and stored at -20°C (for determining the protein 
content; 6.3.6). A positive control for the mitochondrial production of H2O2 were performed 
by incubating RLM with 2^g.mr^ antimycin A (final concentration). The antimycin A from 
Streptomyces sp. (Sigma; Lot 117H4102) was prepared as a stock solution at 2mg.mr^ in 
ethanol (EtOH; analytical grade) and used at a final concentration of 0 .1% EtOH in the 
RLM suspensions. Suitable experiments with RLM in 0 .1% EtOH sen/ed as a blank for the 
antimycin A (positive control) group. 
6.3.4 Respiratory Control Ratio (RCR) 
Mitochondrial respiration was measured using a Clarice type oxygen electrode using the 
method described by Moody (1983; PhD Thesis). The platinum electrode was maintained 
at -0.6 volts (with respect to the silversilver chloride reference). 2ml of respiration buffer 
(pH 7.4 at 25^C; 6.3.2) were pipetted into the electrode chamber and 200^1 of RLM (in 
respiration buffer) were added to the stimng contents before placing the stopper. The 
background rate of oxygen uptake was measured for 3-4min. State 4 substrate (25iil 0.4M 
succinate) were added using a 50|J Hamilton syringe and the rate (of oxygen uptake) was 
measured over 3-4min. Next, the state 3 substrate (ADP; 10^1 40mM stock) was added 
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and the rate of oxygen uptake recorded. The RCR is determined from the ratio of state 3 
to state 4 respiration. The state 3 and 4 respiratory rates were performed at least three 
times for each mitochondrial batch. 
6.3.5 Detection of H2O2 
The assay for H2O2 was performed as described by Staniek & Nohl (2000) using 
homovanillic acid (HVA). The fluorescence measurements were performed using a LS50-
B fluorimeter (Perkin Elmer) with 5nm slit widths for both excitation and emission. HVA 
was prepared fresh prior to use. The assays were perfonned at 25°C in a 3ml fluorimeter 
quartz cuvette and stirred with a paddle after adding the sample (100^1). The calibration 
was performed using samples of known concentrations of H2O2 (prepared in respiration 
buffer; 6.3.2) to quantify the level of H2O2. All samples were kept on ice prior to analysis 
and assayed in triplicate. 
6.3.6 Mitochondrial Protein Content 
The protein content of the isolated mitochondria were determined using the Biuret method 
with BSA as standards. 
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6.4 Results 
6.4.1 CO and Hyperoxic Exposure of Mitochondria 
Using chemical reagents to specifically detect superoxide radicals formed within intact 
mitochondria is restricted by the permeability of the outer mitochondrial membrane 
(OMM). Therefore, the rapid dismutatlon of superoxide along with the mitochondrial matrix 
bound superoxide dismutase (SOD), both yield H2O2 that easily diffuses out of the 
organelle into the extra-mltochondrial space. The method of Staniek & Nohl (2000) was 
used to quantify the level of H2O2 using fluorescence spectroscopy (after removing 
mitochondria to minimise interference by light scattering). In the presence of H2O2. a 
horse-radish peroxidase (HRP)-catalysed the decrease in fluorescence (using scopoletin 
as substrate), or increase in fluorescence (using homovanillic acid) was recorded. 
Hyperoxia did not appear to produce mitochondrial superoxide and neither did the 
hyperoxia treatment following CO exposure (Table 6.1). The production of superoxide 
was confirmed in all the Isolated mitochondrial batches with the positive control using 
antimycin A (Table 6.1). Carbon monoxide and/or hyperoxia appears to decrease the 
production of superoxide (and/or hydrogen peroxide), although, ths reduction was not 
significantly different to the normoxic treatment (control). No significant changes in the 
state 3 and state 4 respiration for the RLM were found following the CO and/or hyperoxia 
treatment (Table 6.2), however, CO and hyperoxia appeared to lower the rate of state 3 
respiration. The positive control (with antimycin A) inhibited both mitochondrial states to 
show a zero RCR. 
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Experimental condition Rate of production of H2O2 RCR 
(n = *4 or 5) (nmoles.mg'^ protein.mln'^) 
Positive control 1171.50 ±88.65 0 
(using antimycin A prepared in EtOH) 
EtOH blank 38.81 ± 20.98 4.16 ±1.79 
Normoxic treatment; control 18.40 ± 10.18 2.48 ± 0.42 
(21% O2, 5 minutes) 
Carbon monoxide treatment 1.28 ± 19.71 4.90 ± 1.47 
(0.05% CO. 5 minutes) 
Hyperoxia treatment (95% O2. 5 minutes) -16.60 ± 15.68 5.05 ± 1.87 
•CO (0.05%, 5 minutes) followed by -5.48 ± 8.24 2.05 ± 0.62 
hyperoxia (95% O2, 5 minutes) 
Table 6.1 Rate of mitochondrial production of hydrogen peroxide (H2O2), the dismutation 
product of superoxide, following CO exposure during normoxia and/or hyperoxia treatment 
(to simulate hyperbaric oxygen treatment). Mitochondria were Isolated from fasted 
(overnight) adult male Sprague-Dawley rat livers and 'rested' on ice for ca. one hour prior 
to any experiments. The rat liver mitochondria (RLM) had its respiratory control ratio 
(RCR) detemiined prior to any experimental treatment (as described in the Materials & 
Methods). The mitochondria were treated in a glass cuvette with a stirrer under the 
conditions before removing the RLM and freezing the supernatent for the later analysis of 
H2O2 (using the method of Staniek & Nohl, 2000). The positive control was tested using 
antimycin prepared In ethanol (EtOH) and a suitable blank to rule out any effect of EtOH. 
The RLM had their RCR determined after the experiments were conducted and showed 
no significant change in RCR prior to performing the experiments (see Table 6.2). The 
data shown Is the mean ± SEM for n hearts in each group. 
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Experimental condition State 3 State 4 RCR 
(n = 3 or *2) (nmol (nmol (State 3/State 4) 
02.min'^ per 02.min'^ per 
mg protein) mg protein) 
'Rested* mitochondria 0.052 ± 0.003 0.014 ±0.006 5.42 ± 2.07 
Positive control 0 0.001 ±0.001 0 
(using antimycin A prepared in 
EtOH) 
EtOH control 0.048 ± 0.002 0.015 ±0.005 4.16 ±1.79 
Normoxic treatment 0.065 ± 0.029 0.026 + 0.012 2.48 ± 0.42 
(21%02. 5min) 
Carbon monoxide treatment 0.052 ±0.009 0.014 ±0.006 4.90 ± 1.47 
(0.05% CO. 5 min) 
Hyperoxia treatment 0.050 ± 0.009 0.012 ±0.004 5.05 ±1.87 
(95% O2. 5 min) 
*CO (0.05%, 5 minutes) followed by 0.036 ±0.009 0.018 ±0.000 2.05 ± 0.62 
hyperoxia (95% O2, 5min) 
Mitochondria *at end' (after 0.045 ±0.013 0.013 ±0.006 5.00 ±1.61 
completing the above treatments) 
Table 6.2 The respiratory control ratio (RCR) of rat liver mitochondria (RLM) following 
exposure to CO and/or hyperoxia. The RLM were isolated from animals that had been 
fasted overnight as described in 6.3.2. The isolated mitochondria were 'rested' on ice for 
ca. one hour before commencing any measurements to detenmine the RCR. The data 
shown is the mean ± SEM for n hearts in each group. The RCR was determined for each 
treated batch of mitochondria and expressed as the mean ± SEM for each treatment 
group. 
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6.5 Discussion 
The lack of hypoxia during CO exposure here rules out any reperfusion-lnjury in producing 
the oxidative stress (shown in Chapter 5). Therefore, this naturally led us to examine the 
source(s) and type(s) of ROS that may be produced after CO exposure, and/or other 
mechanism(s) responsible for the CO-induced depletion of glutathione. Mitochondria are 
shown to produce ROS and contribute In reperfusion-induced tissue damage (Fannin et 
a/., 1999). Isolated mitochondria were used to examine whether the production of ROS 
(after CO exposure) were responsible for the oxidative stress (In Chapter 5). Using intact 
mitochondria from rat heart tissue would have complemented the Isolated rat heart model; 
however, this was not possible and rat liver mitochondria (RLM) were used. The (liver) 
mitochondria were isolated from rats that were fasted for 24h to utilise glycogen and free 
fatty acids and so minimise uncoupling (Casolo et a/., 2000). tn contrast, the isolated 
hearts were perfused with glucose during the entire period (in Chapters 4 and 5). The 
role(s) of glucose in CO poisoning have not been Investigated, although It may involve 
glucose oxidase in producing ROS after CO exposure (below). 
Isolated RLM were used to determine the mitochondrial production of superoxide by 
measuring the levels of its dismutatlon product, hydrogen peroxide. RLM showed no 
production of H2O2 suggesting that mitochondria were not the source of CO-induced ROS 
production (either superoxide or H202 species). The absence of ROS production could be 
due to the lack of hypoxia (Davies, 1989) under the conditions used, therefore, the role of 
mitochondria in ROS production following CO exposure cannot be ruled out in vivo. The 
lack of a CO-free period following CO-treatment in the isolated mitochodria (as performed 
for the isolated hearts) is not attributed for inducing ROS production, as no evidence of 
ROS production were found following the hyperoxic treatment after CO exposure (Table 
6.1). However, mitochondria are damaged following CO poisoning (Tritapepe et a/., 1998) 
and this could arise following direct ROS production and/or following secondary cellular 
damage. The mitochondrial volume density, heart rate (HR) and rate of oxygen 
consumption has a close correlation (Barth et a/., 1992). Therefore, any change in 
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mitochondrial volume (from oxidative damage) may Impair mitochondrial functioning and 
alter the oxidative capacity to produce more ROS (Smith et a/., 1996). 
In contrast to our findings, RLM is shown to produce superoxide anion (Du et a/., 1998). 
However, their animals were not fasted before isolating the mitochondria and could 
Indicate a possible role of glucose oxidase in CO-induced oxidative stress. The greater 
antioxidant capacity of RLM relative to RHM (Evelson et a/., 2001; Venditti ef a/., 2001) 
and/or using sucrose in the mitochondrial isolation buffer may account for the lack of H2O2 
production. Sucrose can form highly stable soluble complexes with metal Ions, especially 
iron (Konstantinova et a/., 2000), and this may have removed functional metal Ions from 
some mitochondrial components Involved In CO-induced ROS production. The 'intactness' 
(coupled state) of Isolated mitochondria may have a role In ROS production after CO 
exposure. The isolated RLM were coupled, however, a higher quality preparation (with 
greater coupled mitochondria) could have provided a more accurate conclusion regarding 
mitochondria as a potential source of ROS production (in CO poisoning). The inclusion of 
bovine serum albumin (BSA) in experiments using RLM may have prevented some 
appearance of ROS, as albumin has antioxidant properties particularly in binding 
peroxynitrite (Watts & Maiorano. 1999). 
Tissue differences could play a role In ROS production, as rat brain mitochondria are 
shown to produce hydroxyl radicals after CO poisoning in vivo (Plantadosi et a/.. 1995; 
Zhang & PiantadosI, 1992). RHM also have a higher oxygen affinity in the ADP-stimulated 
state (or state 3) compared to RLM, and is proportional to their higher content of 
cytochrome c oxidase (Gnaiger et a/., 1998). Furthermore, CO may Inhibit Complex I as it 
Is shown in Rhodospirillum rubrum to inhibit the transcriptional activation of CO 
hydrogenase by binding to protein subunits homologous to those found in eukaryotic 
Complex I (Fox et a/., 1996). Complex I could be impaired following CO exposure (by 
oxidative stress) as it is sensitive to attack by ROS (Borutaite et a/., 1996). The impaired 
activity of Complex I may alter other metabolic pathways within the mitochondrion 
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(Weinberg et a/., 2000) and lead to inefficient bioenergetics that compromise myocardial 
function. 
The hyperoxic treatment were performed to simulate the elevated blood level of dissolved 
oxygen to that found during hyperbaric oxygen therapy (HBOT). The isolated mitochondria 
treated with hyperoxic conditions showed no increase in the production of H202 (Table 
6.1). However, hyperbaric oxygen treatment (HBOT) Is shown to increase the production 
of H2O2 in RLM (Boveris & Chance. 1973). This could suggest that some pressure effect 
may be responsible for mitochondrial oxidative stress and warrants further attention. 
Cytochrome c oxidase requires cardlolipin (a polyunsaturated phospholipid localised in 
mitochondrial membranes) for maximal activity and function (Jiang et a/., 2000). The 
absence of cardiolipin leads to defects in protein import and other mitochondrial functions. 
Cardiolipin Is tightly bound to cytochrome c oxidase and its removal during enzyme 
purification leads to a loss in the activity of cytochrome c oxidase (Lenaz et a/., 1999; 
Soussi et ai, 1990). The oxidative stress found in hearts after CO exposure may initiate 
lipid peroxidation (LPO) that could disrupt the stability of cytochrome c oxidase through 
oxidation of cardiolipin. The high content of polyunsaturated phospholipids in 
mitochondrial membranes makes the mitochondrion susceptible to LPO. and LPO is 
shown to occur following CO exposure (Miro et a/., 1999; Kudo a/., 2001). Whether any 
LPO occurred here (following the CO exposure) remains to be determined, however, any 
impaired activity of complex IV disturbs proton translocation (Karpefors et a/., 1998) and 
could affect mitochondria at a respiratory level within the myocardium (Kadenbach et a/.. 
2000). The disruption in complex IV may produce an altered state(s) of other respiratory 
complexes within the mitochondria (to compensate for the affected complex IV) and this 
may eventually lead to an altered metabolic state and/or execute apoptosis (Vlllani & 
Attardi, 2000). The compensatory changes of the mitochondrial respiratory carriers 
following CO exposure are protective mechanisms (Chance et a/., 1970). Any loss of 
cytochrome c oxidase activity could potentiate the incomplete reduction of oxygen and 
augment the formation of ROS within the myocardium. Following this, the oxidative stress 
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(following the CO exposure) could lead to myocardial failure responsible for CO-
assoctated cardiac morbidity. The activity of cytochrome c oxidase in the mitochondrial 
fraction (from homogenate prepared from perfused hearts) were not determined as its 
activity is significantly lost during storage (Prohaska, 1983). 
CO-induced oxidative stress is thought to involve RNS (derived from NO production) and 
involves many other organs in vivo that show oxidative stress following CO exposure 
(Thom et a/., 1997). The production of cardiac NO is mostly found within the endothelial 
cells of the vasculature (Chapter 4). This nitrative stress (by RNS) could be responsible 
for the depressed coronary flow after CO exposure and/or inhibition of cytochrome c 
oxidase (Cassina & Radi, 1996). Ascorbate enhances the S-nitrosation of glutathione by 
peroxynilrite ten-fold (Schrammel et at., 2003), however, this does not account for the 
preserved content of glutathione. One possible site of oxidative stress suggested by Thom 
et a/. (1997) following CO exposure are the erythrocytes and this could suggest that 
myocardial haemoprotein(s) may have a role in the production of ROS. The absence of 
haemoglobin here suggests that another haemoprotein, myoglobin (Mb) could be a source 
of ROS production in CO poisoning (Chapter 7). The type(s) of reactive species were not 
determined, however, many ROS (or RNS) could be produced following CO exposure 
(Ischiropoulos et ai., 1996; Piantadosi et aL, 1995). The production of the hydroxyl radical 
(Piantadosi a/., 1997) and NO (Thom et at., 1997) following CO poisoning may produce 
other reactive species through Fenton chemistry-based reactions within the cell (Bartfay et 
a/., 1999). 
Rat brains show LPO following CO exposure in vivo that were suggested to arise from 
xantine oxidase-derived ROS (Thom, 1992). Rat hearts have a relatively high activity of 
xanthine oxidoreductase compared to human hearts, however, they also have a higher 
content of SOD compared to human hearts (Janssen et a/., 1993). Xanthine oxidase (XO) 
is also involved in l/R injury (Halliwell & Gutteridge, 1985). However, the evidence rules 
out tissue ischaemia here (Chapter 5) and could suggest that XO is not involved in ROS 
production (under our in vitro conditions). The elevated P02 responsible for exarcerbating 
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the tissue insult following LPO does not require reperfusion (Fisher et a/.. 1991) and may 
arise in vivo after some loss of CO (under normobaric conditions). CO-induced hypoxia in 
vivo may deplete ATP and result in hypoxanthine to accumulate and become oxidised by 
XO to generate superoxide and hydrogen peroxide (Haltlwell & Gutteridge, 1985). 
Another cellular source of CO-induced oxidative stress could be the NADH/NADPH 
oxidase. Changes in P02 are shown to produce superoxide in the vasculature via NADH 
oxidase (MohazzathH. a/.. 1997). Pretreating myocytes with antioxidants or an inhibitor 
of NADH/NADPH oxidase reduced the Increase in ROS production (Tanaka et a/., 2001). 
This could suggest that NADH/NADPH oxidase may be inhibited by the AO-treatment, 
and/or that ROS production in the isolated hearts were initiated in the vasculature tissues 
before disturbing other tissues, e.g. ventricle tissue. TroloxC accelerates the reaction of 
GPX in vivo (Le et a/., 1992) and this could utilise NADPH. and so limit the production of 
ROS by NADH/NADPH oxidase in this manner, and reduce the loss of glutathione (as 
found with the AO-treatment). !n vivo hypoxia Is shown to reduce the rate of supply of 
NADPH (Tribble & Jones. 1990) and measuring the myocardial content of NADPH could 
prove very valuable (not detemnined here). Glucose stimulates the production of NADPH 
(Le et a/., 1992) and this could have a role in the CO-induced oxidative stress by 
accelerating GR in a protective role (Le et ai, 1995). Catalase (CAT) has a high affinity for 
CO (Coburn, 1979; Hattori et a/.. 1990) and this may affect any detoxifying role during 
oxidative stress following CO poisoning. The absence of CAT In heart and liver 
mitochondria (Scholz et a/., 1997) may potentiate cellular/tissue damage from exogenous 
superoxide. The binding of CO to Hb may reduce the ability of Hb to remove H2O2 in vivo 
(Masuoka et a/.. 2003) and this could potentiate CO-induced oxidative stress in vivo. 
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6.6 Conclusions 
Rat liver mitochondria did not show any production of superoxide (under our conditions) 
and this could suggest that mitochondria are not a source of CO-induced oxidative stress. 
However, tissue differences may have to be considered before any conclusions can be 
made regarding the source of oxidative stress shown to occur in rat hearts following CO 
exposure. 
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6.7 Further Work 
6.7.1 Determination of Mitochondrial Calcium & Glutathione 
To exclusively rule out rat heart mitochondria (RHM) in producing ROS reposnsible for 
depleting glutathione, further work could use isolated RHM to perform the experiments 
(earned out here) examining superoxide production by determining the levels of H2O2. The 
mitochondrial fractions were Isolated here following homogenisation of the ventricle tissue 
(from Isolated rat hearts perfused with CO). It Is proposed to determine the calcium 
content (using ICP-MS; 4.2.6) and levels of reduced and oxidised glutathione (GSH and 
GSSG, respectively). The contents of other thiol proteins (non-glutathione proteins) could 
be measured to accurately determine the redox conditions within the cytosol and 
mitochondria (Lesnefsky et a/., 1991). However, the prolonged storage (at -80°C) with 
protein and the lack of 2-VP (5.2.5 and 6.3.4) may produce inaccurate data for the 
mitochondrial content of GSH and GSSG. unless fresh mitochondria from perfused hearts 
treated with CO are used. Conversion of xanthine dehydrogenase to xanthine oxidase 
upon storage of frozen heart tissue could affect the results (Schoutsen et al. 1983). It may 
also be possible to determine the activities of several components of the ETC. however, 
the reader Is requested to review the stability of these prior to any determination. The 
mitochondrial membrane potential could be investigated in Isolated hearts (Fuchs et al., 
1990) to determine whether CO-induced oxidative stress affects the MPT pore and 
disrupts mitochondrial function after CO poisoning. 
6.7.2 Cytochrome c Content in Rat Heart Ventricle Homogenate & Apoptosis 
The homogenate (of ventricles from rat hearts exposed to CO) could be used to determine 
the content of cytochrome c to evaluate the possible loss from mitochondria. Cytochrome 
c Is a prooxidant component that is localised between the inner and outer mitochondrial 
membranes and its loss results in initiating of the caspases responsible for producing cell 
death by apoptosis (programmed cell death; PCD). Also, other markers of PCD could be 
detenmined to evaluate its contribution (If any) to the cardiotoxicty of CO; particulariy, in 
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light of the cardiac morbidity associated with CO poisoning (Chapter 1). The levels of 
haem oxygenase (HO) could also be determined (Ryter et a/., 1998) to predict any other 
myocardial role(s) of oxidative stress induced after CO poisoning. 
6.7.3 Other Methods T o Investigate Oxidative S t r e s s Further 
Other compounds mentioned in the discussion could be perfused (as pertormed using 
antioxidants here) to Identify the mode(s) of oxidative stress within the heart after CO 
exposure. Such compunds could Include catalase, glutathione peroxidase and/or 
desfemoxamlne (Iron chelator) amongst many others. These could be administered to the 
hearts at different stages of the perfusion to rule out or Identify likely ROS contributing to 
the cardtotoxicity of CO. The myocardial content of ATP (Juengling & Kammenmeier, 
1980) and overall antioxidant capacity of tissue homogenates (Kohen et a/.. 2000) could 
also be detennlned to determine the in vitro effect of CO in hearts for possible 
extrapolation to the in vivo setting. The activity of xanthine oxidase could be measured to 
determine its contribution (If any) during CO poisoning (Terada et at., 1990). 
6.7.4 Cytochrome c Ox idase and C O Poisoning 
Purified cytochrome c oxidase could be used to determine the extent of its reduction by 
ascorbate In order to comment whether this was responsible for the further depressed 
heart rate In hearts treated with CO and antioxidants. These experiments would be valid 
regarding its functional similarity to whole mitochondria (Takahashi & Ogura, 2002). 
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Myoglobin & Oxidative Stress 
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7.1 Background 
Oxidative stress is postulated to occur in numerous disorders (Becker & Ambrosio, 1987; 
BrGmme & Holtz. 1996; Entman ef a/.. 1992; Maulik et a/., 1998). Evidence for this comes 
from markers of oxidative damage, e.g. lipid peroxidation (1.5). The lack of association of 
clinical outcome with blood COHb levels (Chapter 1) warrants a need for accurate 
marker(s) of CO poisoning. The role of oxidative stress In CO poisoning was presented 
earlier (in Chapter 5) and may be exploited here to find a suitable marker of cardiac 
damage. The current status in clinical biomarkers of oxidative damage is limited to carbon 
monoxide (Paredi et a/., 2002). heat shock proteins (Peng a/., 2000), DNA-adducts and 
protein carbonyl groups (Dalle-Donne et a/., 2003). Therefore, the emerging role of 
oxidative stress in initiating and/or causing further tissue/organ dysfunction calls for novel 
biomarkers of oxidative stress (with the potential to allow rapid measurements to be 
made). 
Myoglobin (Mb) is widely found in muscle tissue where its primary role is to facilitate the 
diffusion of intracellular oxygen (Cole, 1983, Wyman, 1966). The difference in oxygen-
dissociation curves for haemoglobin (Hb) and Mb are principally the shapes, sigmoidal 
and hyperbolic, respectively, thus showing the functional differences in oxygen 
dissociation between the two proteins. There is also a possible role in CO toxicity as Mb 
can bind CO, with evidence in the literature suggesting that Mb binds oxygen 2-3 times 
more strongly than Hb (Kjeldsen ef a/.. 1974; Piantadosi, 1996). 
At present Mb is used as a marker to diagnose early myocardial infarction in conjunction 
with other markers such as the creatine kinase isoforms and cardiac troponin T 
(Panteghini. 2000; Penttiia et a/., 2002) and may also indicate damage to skeletal muscle. 
The oxidant hydrogen peroxide, H202, is known to covalently modify Mb in three ways: 
modification of the prosthetic haem group; alteration of the protein itself; and oxidative 
cross-linking of the haem to the polypeptide (Mb-H). Mb modified in the third manner, i.e. 
covalent cross-linking of the haem to the polypeptide, can be detected via its peroxidatic 
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activity on polyacrylamide gels (Osawa & Pohl, 1989; Vuletich & Osawa, 1998). This 
suggests that Mb-H could be a useful marker of oxidative damage. 
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7.2 Aim & Objectives 
The potential role of oxidative stress in a CO-induced l/R-like injury (1,7 and Chapter 5) 
and the possible oxidative modification of Mb led us to investigate this protein as a novel 
marker of oxidative stress. The hypothesis is that R O S produced during oxidative stress 
could alter Mb (as described in 7.1) and that this change (if found) could be an index to 
a s s e s s oxidative damage. 
The main aim was to show if exogenous oxidative stress can modify Mb in situ, and to 
evaluate if Mb-H can be detected via its peroxidatic activity on S D S - P A G E . Specific 
objectives were: 
(i) to perfuse isolated rat hearts with hydrogen peroxide to provide exogenous 
oxidative stress; 
(ii) to use S D S - P A G E to isolate Mb from ventricle homogenate; and 
(iii) to use an enhanced chemiluminescence ( E C L ) assay to detect peroxidatic activity 
in the resolved Mb. 
A second aim was to examine the role of various antioxidants in preventing the oxidation 
of Mb from oxidative stress. 
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7.3 Materials & Methods 
7.3.1 Isolated Heart Preparation 
Rat hearts were isolated by rapid excision following anaesthesia and were then perfused with 
buffer containing HEPES and oxygenated with medical oxygen (100% oxygen) as described in 
Chapter 2. Bicarbonate buffer was unnecessary here since CO2 was absent. The hearts were 
oxidatively stressed by including 430nM hydrogen peroxide in the perfusion buffer. Control hearts 
were perfused in an identical manner (for 90min) in the absence of oxidant. Those hearts which 
failed to resume a regular sinus rhythm within ten minutes were discarded from the study (Palace 
etai, 1999). 
7.3.2 Biochemical A s s a y s 
7.3.2.1 Lactate dehydrogenase (LDH) 
Viability of the perfused organ was a s s e s s e d by measuring the LDH activity from spot 
samples of perfusate taken at various time points. The assay method was performed as 
described by Bergmeyer & Bernt (1974) with minor modifications. 
7.3.2.2 Gfiess assay for nitrite 
Nitrite in the perfusate was detected a s described by Yamamoto at al. (1998). 
7.3.2.3 Ferrozine assay for iron 
Free iron was detected in the perfusate samples as described by Stookey (1970) with 
modifications to work on a 96-well microtitre plate reader. 
7.3.3 Ventricle Homogenate 
Rat heart ventricles were prepared as described by Rouet-Benzineb et al. (1999). 
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7.3.4 Peroxidatic Activity of Myoglobin (Mb) 
Isolated myoglobin (Mb) was resolved from ventricle homogenate constituents using S D S -
P A G E (as described by SchSgger et a/., 1988). The protein was not renatured as we were 
examining the peroxidatic activity derived from the haem group covalently bound to 
myoglobin (Mb-H). The Isolated protein was electroblotted overnight onto nitrocellulose 
membranes and peroxidatic activity was detected as described by Vuletich & Osawa 
(1998) using an enhanced chemilumlnesence ( E C L ) reagent (Super Signal from Pierce). 
7.3.5 H P L C Analys is For Mb-H 
The perfusate taken at 15min from perfused hearts (7.3.1) were analysed for the haem-
protein cross-linked myoglobin species (Mb-H) using reverse-phase high-performance 
liquid chromatography (RP-HPLC) . This analysis was performed by Dr. Brandon Reeder 
(University Of Essex , UK) using their own in house method (Reeder et a/., 2002). Briefly, 
the perfusate samples were concentrated using a lOkDa MW cut-off filter and this 
concentrate was injected for H P L C analysis (below). The low MW wash was also 
analysed under the same conditions. The H P L C analysis were perfomried using an Agilent 
HP1100 H P L C using diode array detection. The column used was a Zorbax StableBond 
300A C 3 packing material (250 x 4.6mm) fitted with a guard column (12 x 4.6mm). Solvent 
A was 0.1% trifluoroacetic acid (TFA) and solvent B (B) was 0.1% T F A in acetonitrile. A 
gradient system was used starting at 35% solvent B (for lOmIn) that Increased to 37% B 
over 5min; to 40% over Imin and then to 4 3 % B over a further lOmin. The flow rate was 
Iml.min*^ and the temperature was 2 5 X . 
7.3.6 Antioxidant Protection of Mb in vitro 
Various non-enzymatlc antioxidants were tested to a s s e s s their role in protecting the 
degradation/oxidation of Mb during oxidative conditions (i.e. in the presence of H2O2). 
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Briefly the antioxidants were incubated with Mb for 10min; then oxidative stress was 
induced by the addition of H2O2. Changes in Mb were a s s e s s e d by following the spectral 
changes over time. All incubations were earned out in 50mM sodium phosphate buffer (pH 
7.4) at 25*'C and performed in triplicate. 
7.3.7 Data Ana lys is 
Each point in the perfusion study measurements was made in triplicate before averaging 
for each animal. The data shown is the mean ± S E M for three animals. Statistical analysis 
was perfonned on data where stated. 
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7.4 Results 
7.4.1 Perfusions 
Control hearts were perfused with perfusion buffer (PB) containing no hydrogen peroxide 
(H2O2); these showed no change In colour during the 90min experimental period, and 
continued to beat regulariy for the entire perfusion. Treated hearts were perfused with P B 
containing 430nM H2O2 after an initial washout/stabilisation period (ca. 15min). The 
amount of oxidant required to modify isolated myoglobin to Mb-H is a three-fold excess 
(Vuletich & Osawa, 1998). An excess of oxidant, i.e. 100-fold, is shown to degrade the 
haem group and therefore yield no peroxidatic activity. The level of Mb in skeletal muscle 
is 0.2mM (Galaris et a/., 1989a) and is expected to be higher In heart tissue (ca. 0.3-
0.4mM; Arai et a/., 1999). We therefore chose 430^M H2O2 to compensate for the organ's 
antioxidant capacity. This level of oxidant is similar to that shown previously to cause 
considerable structural and functional damage (Harrison et a/., 1994; Onodera a/., 
1992). The 90min duration was chosen as any covalent cross-linking that occurred would 
remain permanent as it were considered an irreversible process. 
Ail treated hearts had stopped beating by 15min of perfusion. However, a distinct change 
in colour relative to the control hearts was observed after 5min of perfusion. Control hearts 
remained red-brown in colour during the entire perfusion, whereas, treated hearts 
gradually changed to an off-green colour after 5min of H2O2 perfusion. At 60min of H2O2 
perfusion, the upper part of all the treated hearts (comprising the atria) were relatively pale 
in colour compared to the rest of the organ, and devoid of the green colouration observed 
eartier. This loss of colour had spread to the entire organ by 90min of H2O2 perfusion 
resulting in yellow-brown hearts. All treated hearts showed increasing back pressure at 
ca. 15min as observed by an increased volume of PB in the bubble trap used. The 
observed loss of contractile function in H20rtreated hearts occurred before any loss in 
tissue viability (below). 
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7.4.2 T i s s u e Viability 
The viability of the heart tissue was a s s e s s e d by monitoring the release of lactate 
dehydrogenase (LDH) into the perfusate. Figure 7.1 shows the LDH release from control 
and treated hearts per gram of heart tissue. Control hearts showed none or little LDH 
activity in the perfusate samples over the entire 90min measurement period. Treated 
hearts showed a similar trend up to 15 minutes followed by a significant increase in LDH 
release reaching a maximum at ca. 30min. LDH activity in perfusate from treated hearts 
decreased after 30min, however, it remained elevated above that of the control hearts. 
There is clear evidence of severe oxidative damage to the tissue as observed previously 
(Dulchavsky et a/., 1996). 
The perfusates from control and treated hearts at 30min were run on a gel and showed 
the presence of only Mb in treated heart perfusate. This finding supports the role of Mb as 
a mariner of cardiac damage, due to its negligible levels in the blood, it is used as a 
cardiac-specific marker in assessing the development/regression of myocardial infarctions 
(Ebisuno etal., 1986). 
40 60 
time (min) 
Figure 7.1 Activity of LDH in rat heart perfusates from control (open circles) and hydrogen 
peroxide (filled circles) perfused hearts. Data shown is the mean ± S E M {n = 3). 
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7.4.3 Nitric Oxide & Iron R e l e a s e Into Perfusate 
The production of reactive oxygen species (ROS) induces type 2 nitric oxide synthase 
(iNOS), thus resulting in nitric oxide (NO) production, which serves as a signalling 
molecule in a number of tissues especially of vascular and endothelial origin (Joe et al., 
1998; Sherman et al., 1997). These findings from other studies suggest that the 
peroxynitrite radical may be responsible for the delayed underiying tissue dysfunction 
observed (Singh et al., 1996). W e investigated NO for a possible role In early-immediate 
damage from constitutive sources of NO such as endothelial NO synthase. Nitrite Is used 
as an indirect measure of NO production as NO is short-lived and nitrite Is a breakdown 
product of NO (Yamamoto et al., 1998). No differences in the nitrite levels were observed 
in perfusates from control and HjOa-treated hearts (results not shown). However, in both 
groups, nitrite levels increased steadily throughout the perfusion. 
Perfusate Iron levels were determined because of evidence of iron release from Mb as 
indicated by the colour changes observed during perfusion with hydrogen peroxide 
(7.4.1). Figure 7.2 shows the iron levels in the perfusates from the two groups over the 
90min period. Similar iron release was observed up to 15min for both groups of hearts. 
The control hearts showed a fall in Iron release after 15min, however, the treated hearts 
showed a significant rise which reached a maximum at ca . 30min that declined over the 
remaining period. The iron released after 15min In treated hearts remained elevated 
during the entire time course relative to the controls. 
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Figure 7.2 Iron content in perfusate samples from control (open circles) and HjOz-treated 
hearts (filled circles). Data shown Is the mean ± S E M {n = 3). 
7.4.4 Oxidative Modification of Myoglobin 
The supernatant fraction containing myoglobin (Mb) from ventricle homogenates were 
resolved using S D S - P A G E (Figure 7.3) and transferred onto nitrocellulose (NC) 
membranes. S D S - P A G E had successfully resolved the myoglobin a s identified with the 
myoglobin standard. The NC membranes were then exposed to the E C L reagent. Any 
peroxidatic protein bands would produce luminescence which w a s detected after 
exposure to X-ray film (Figure 7.4). The E C L assay were repeated three times and 
produced similar results each time. H P L C analysis of the perfusate samples (by Dr. 
Brandon Reeder) taken at 15mln showed no appearance of Mb-H (results not shown). 
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Mb (17 kOa) 
Cyt c(12 5kDa)-
Mb 
Figure 7.3 {above) SDS-PAGE shows myoglobin (Mb) in control (C) and H202-treated (T) 
heart ventricle homogenate 
Figure 7.4 (above) Detection of peroxidatic activity on nitrocellulose membranes using the 
enhanced chemiluminescence (ECL) assay. Dark bands (following 2min exposure to X-
ray film) correspond to luminescent signals f rom peroxidatic material: myoglobin (Mb), 
cytochrome c (Cyt. c) and unknown low molecular-weight (X). Lanes correspond to 
polyacrylamide gel l ^g untreated Mb (1 and 8); 5^g protein from control and H2O2-
treated heart ventricle homogenate (lanes 2 and 3. respectively), concentrated perfusate 
from treated hearts at 30 min (4); 0.25. 0.5 and I .Oiag of treated Mb (lanes 5. 6 and 7, 
respectively) 
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7.4.5 Antioxidants, Myoglobin and Oxidative S t r e s s 
The likely role of oxidative stress in C O toxicity suggests that the protective effect of 
exogenous and endogenous antioxidants may clearly be significant in protecting 
intracellular Mb. The work of Vuletich & Osawa (1998) showed the in vitro modification of 
Mb by hydrogen peroxide. Therefore, the maintenance of functional Mb in the cell may be 
altered under conditions of oxidative stress, where its oxygen storage/transfer function 
could be compromised by oxidative damage. There has been much work in heart tissue 
on the protective effect of various antioxidants against l/R injury (Ladilov et a/., 1998; 
Nakamura et a/., 1998). It was therefore decided, concurrently with the perfusion study, to 
examine the protective effect of antioxidants against the degradation/modification of Mb in 
vitro by hydrogen peroxide. 
The non-enzymatic antioxidants tested were the hydroxyl radical scavenger 
dimethylthiourea (DMTU), /V-acetyl-L-cysteine (NAC) and ascorbic acid (vitamin C ) . In the 
absence of oxidant, none of the antioxidants tested resulted in the loss of Mb (at I I^M) 
signal over 90min (not shown). The effect of oxidant on Mb was examined by adding a 
three-fold molar excess of hydrogen peroxide (H2O2). A three-fold molar excess of H2O2 
(relative to Mb) were used as this level of oxidant is shown to cause modification of Mb to 
produce Mb-H without the degradation of any haem (Vuletich & Osawa , 1998). The level 
of oxidant used was found to result in significant loss of the haem signal and a shift in the 
absorption maximum of the y (Soret) absorption band (Figure 7.5). An approximate 55-
fold molar excess of H2O2 to Mb resulted in complete loss of the haem signal (Figure 7.5 
inset). 
Each antioxidant was incubated with Mb for 10 minutes before the addition of H2O2 
(resulting in a three-fold excess relative to the final Mb concentration). The absorption 
spectra of the Mb was then examined. DMTU did not preserve the haem signal after the 
addition of oxidant when used at ca. 5- and 50-fold e x c e s s to Mb (Figure 7.6). Similar 
results were obtained when NAC were tested using the same concentrations of DMTU 
(results not shown). Ascorbate (at a molar equivalent to Mb) showed some protective role 
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by the delay in loss of signal compared to the other two antioxidants tested (not shown). 
The higher level of ascorbate tested (ca. 10-foId relative to Mb) showed more protection 
relative to the equivalent dose used to Mb under the same conditions (Figure 7.7). 
The antioxidants were also tested in combination for any synergistic activity in protecting 
Mb. No protection of Mb was observed when DMTU and NAC were used together each in 
55-fold molar excess to Mb (treated a s before with a three-fold excess of oxidant; results 
not shown). Ascorbate with DMTU and/or NAC showed similar results to that observed 
with ascorbate alone (results not shown). 
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Figure 7.5 Change in absorption spectrum of Mb ( 1 V M ) treated with ca . three-fold 
excess of hydrogen peroxide (35nM H2O2). The inset shows the effect of a higher level of 
oxidant (600nM). Concentrations are final levels in 50mM sodium phosphate buffer (pH 
7.4) at 250c. 
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Figure 7.6 The effect of 570nM dimethylthiourea (DMTU), a hydroxyl radical scavenger, 
on the bleaching of Mb by H2O2 (same conditions a s given In Figure 7.5). 
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Figure 7.7 The protective role of ascorbate (lOO^M) against bleaching of Mb by H2O2. 
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7.5 Discussion 
Oxidative stress Is Implicated in cardiac dysfunction associated with various pathologies 
and ischaemia-reperfusion (l/R) injury (Abete et a/., 1999; Br6mme & Holtz. 1996; Hess & 
Manson, 1984; Janssen et a/., 1993; Maulik et a/.. 1998). Reactive oxygen species (ROS) 
including free radicals are shown to be generated under these conditions. Oxidative stress 
is shown to occur after hyperbaric oxygen therapy (HBOT; mentioned in 2.1). HBOT Is 
routinely administered to victims of fire-smoke inhalation to aid the clearance of carbon 
monoxide from the body and also to promote wound healing (1.3.1). At present, 
biomarkers of oxidative stress are limited and are not tissue-specific. The present study 
was perfomied to investigate whether covalently modiHed myoglobin (Mb-H) could be 
induced in the perfused rat heart model under oxidative conditions. Hence, the aim was to 
determine whether Mb-H could be used as a novel biomarker of oxidative stress in the 
myocardium. 
Myoglobin (Mb) is a haemoprotein that is abundant in the heart; this protein contributes to 
the dark reddish-brown colour of this organ (Carlez et a/., 1995). Prolonged exposure to 
C O is shown to increase the myocardial concentration of Mb (Pankow & Ponsold, 1979) in 
the right ventricle (Turek et a/., 1973). Mb Is shown to form a predominant protein radical 
species in heart tissue under oxidizing conditions (Detweiler et a/.. 2002). The role of Mb 
appears to be an oxygen storing/supplying intermediate, passing oxygen from the blood to 
the mitochondria, so that cardiac tissue can function using the A T P formed from oxidative 
(aerobic) respiration (Cole, 1983; Wang et a/., 1997; Chapter 5). The haem in native Mb 
is non-covalently bound (Vuletich & Osawa, 1998). Oxidative damage to Mb can occur in 
three ways: modification of the haem group, modification of the polypeptide, and the 
covalent linking of the haem group to the polypeptide (Mt)-H) (Ortiz de Montellano, 1990; 
Osawa & Pohl, 1989; Vuletich & Osawa, 1998). The third modification is the basis of the 
current investigation. We thought that Mb-H may be formed during oxidative stress, 
therefore, allowing this species to be used as a diagnostic indicator to a s s e s s the degree 
of oxidative stress within the myocardium. 
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Oxidative stress were induced in the isolated heart preparations by perfusing with 
hydrogen peroxide (H2O2) (Abete et a/., 1999). The in vitro modification of purified Mb to 
Mb-H occurred using H2O2, however, the purified Mb used was predominantly in the met 
form when tested by us (results not shown). The two electron oxidation of ferric Mb 
(metmyoglobin) results in an oxy-ferryl intermediate, [Fe'^=0]^^ and a protein free radical, 
the tyrosyl residue (Tyrioa) of the Mb polypeptide (Catalano et a/., 1989; Ortiz de 
Montellano, 1990; Ramirez et a/.. 2003). Mb exists predominantly in the oxy-ferrous form 
in situ. The electrons are derived from the haem iron in the oxidation by H2O2. this 
produces the oxy-ferryl intermediate with no concomitant formation of the protein radical, 
hence no Mb-H is formed. The fonnation of ferryl myoglobin is strongly associated with 
inducing apoptosis in endothelial cells (D'Agnillo & Alayash, 2002) and may have 
contributed to the depressed perfusate flow (Chapter 4) following CO-induced oxidative 
stress (Chapter 5). This fenyl species is capable of inducing lipid peroxidation in rabbit 
cardiac myocytes (Turner et a/.. 1991). Oxidation of substrates by the ferryl oxygen 
requires the substrate and haem group are in close proximity of the haem pocket in Mb 
(Boffi et a/., 1997; Hamberg, 1997). The altered protein chemistry may enhance the 
proteolysis of these modified proteins in vivo (Osawa & Pohl. 1989) and minimise the 
potential oxidization of cellular components, also making them less suitable as potential 
biomari<ers here. Any in vivo modification of the haem group in Mb may result in an 
altered flux of intracellular oxygen diffusion and metabolism (Glabe et a/., 1998) and may 
contribute to tissue dysfunction following C O poisoning. 
The lack of Mb-H in treated heart homogenate (relative to control hearts) is complicated 
by the redox cycling of myoglobin. Mb undergoes peroxidatic redox cycling in situ, driven 
by electrons from ascorbate and reduced glutathione (GSH) (Galaris et a/., 1989a). In the 
latter case, there is a possibility that the Tyrios radical could be fonmed, as the peroxidatic 
cycle involves metMb. This lack of H202-induced Mb-H formation shown here in situ 
suggests that the occupancy of this forni must be low or it decays rapidly (under the 
experimental conditions). 
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The early colour change observed relative to peak LDH release (5min versus 15min, 
respectively) in treated hearts, suggests that haem-lron had been oxidised to the ferryl 
oxidation state (Fe'^). This greenish coloured species has been observed and identified by 
other workers and can be confidently attributed to the observed colour change described 
here (Arduini et a/., 1990; Galaris et a/., 1989a). The observed quali tat ive loss of ferryl iron 
could be attributed to a reductive mechanism resulting in ferrous (Fe") or ferric (Fe'") iron. 
Hovi/ever, if the loss of Fe'^ was accounted for by its reduct ion, the green-brown colour 
formed in the tissue would have reverted back to the pretreatment colour. The 'bleaching' 
or loss of green-brown colour observed after 60min of HaOrper fus ion suggests loss of the 
ferryl species from the tissue. Therefore, we assayed for iron in the perfusate, to conclude 
whether the iron had been reduced or lost through t issue damage. Increasing levels of 
iron were found by ca. 15min of H20rper fus ion relative to the controls (F igure 7.2). 
The period of initial iron release in the perfusate coincided with the release of LDH in all 
treated hearts. The use of LDH to assess t issue viability suggests the likely 
disappearance of the ferryl-species is due to the loss of cellular integrity, therefore, 
resulting in the loss of cellular/tissue constituents {i.e. myoglobin in F igu re 7.4). The role 
of metal transition ions in generating ROS is establ ished with reference to iron in radical 
generating systems (Gutteridge. 1986; Sull ivan, 1989). The addit ion of peroxynitrite, an 
oxidant, to caeruloplasmin releases copper (Halliwell & Gutter idge, 1999). Similarly, the 
production of an oxidising species (H2O2) may be responsible for the release of iron from 
cellular Iron binding sites such as femtin and haemoproteins. Conversely, the released 
iron may have primarily disrupted cell integrity by Fenton-mediated lipid peroxidation of 
the cell membrane(s). which would also result in a loss of t issue viability. The lag-time 
observed before the loss in viability and iron release is consistent with the depletion of 
intracellular antioxidants such as GSH or ascorbate (Vaage et a/., 1997). The release of 
iron into the perfusate of H202-treated hearts (relative to controls) could also account for 
the tissue bleaching observed (7.4.1). 
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The possible sources of cellular iron, such as haemoglobin, can be ruled out as most of 
the blood was washed before starting the experiment. The Ferrozine assay was also 
tested to examine if the reagent could displace haem iron from Mb. The Ferrozine reagent 
did not remove haem iron (results not shown), therefore, the Mb found in treated heart 
perfusate could not account for the released iron. However, if haem w a s degraded in Mb 
following oxidant treatment, then the possibility of haem as the source of iron cannot be 
ruled out (Turner et a/., 1991). The released iron could also derive from the degradation of 
the Mb-H (protein-haem) adduct (Osawa & Wil l iams, 1996). W e assessed the degradation 
of haem under physiological condit ions by examining the absorbance spectra of the haem 
moiety. Our findings of haem degradation do not agree with those reported by Vuletich & 
Osawa (1998) who showed no degradation of haem under similar condit ions. These 
workers reported that haem degradation occurred in Mb when H2O2 levels were used In 
100-fold excess to Mb, however, this was determined using different condit ions compared 
to our method. Our results showed a significant loss of the haem signal to occur when a 
three-fold excess of H2O2 was added to the Mb solution (F igure 7.5). This finding agrees 
with the reaction of a molar excess of oxidant producing iron release through haem 
degradation (Nagababu et a/., 1998). It is very likely that the iron in the perfusate of 
treated hearts was derived from haem iron of Mb in the presence of hydrogen peroxide 
(Harel et a/., 1988). Another likely source is intracellular ferritin (Gutteridge. 1986; Reddy 
et a/.. 1989). The source of iron remains to be determined here, however, it is likely that 
the iron released by oxidant(s) could participate in producing further oxidative stress 
(Gutteridge, 1986). These findings along with the CO-induced oxidative stress (Chapter 
5) may implicate haemoproteins in causing further damage to heart t issue(s) after CO-
induced oxidative stress has ceased (Hidalgo et a/.. 1990). The lowered intracellular pH 
(acidosis) found during C O poisoning in vivo could exacerbate t issue damage from the 
released iron through its increased reactivity favoured by its improved solubility (Schafer & 
Buettner. 2000). In fact, an acidic pH favours the formation of ferryl-Mb under oxidizing 
conditions (Reeder & Wilson, 2001). and this may suggest that myoglobin-induced 
oxidative stress could have contributed to the CO-induced oxidat ive stress (shown in 
Chapte r 5). The presence of iron from haemoproteins (i.e. Mb) may account for the 
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oxidative stress found in the isolated hearts exposed to C O and could explain the absence 
of oxidative stress in isolated mitochondria exposed to C O and hyperoxia (Robb et a/.. 
1999; Chapter 6). Iron increases the activity of xanthine oxidase and this may play a role 
in CO-induced oxidative stress (Sull ivan, 1989). 
It is shown that the release of myoglobin from ruptured cardiac myocytes is an early 
indicator of myocardial infarction (Bourne et aL, 1997; Ebisuno et a/., 1986). The observed 
loss of heart myoglobin following oxidative stress could occur after C O poisoning in vivo 
and may be responsible for producing rhabdomyolysis resulting in renal failure (Cooper et 
a/., 2002). Myoglobin is directly implicated in regulating myocardial metabol ism (Doeller & 
Wittenberg, 1991; Glabe et a/., 1998) and this may be inhibited by C O binding as a l igand. 
The human cases of myonecrosis described following C O poisoning (Finley et a!., 1977; 
Herman et at., 1988; Shapiro et a/., 1989) could suggest that haemoproteins may 
themselves be cytotoxic under condit ions of oxidative stress (Chen & Tappel , 1995; Eaton 
ef a/., 2002; Mason ef a/., 2002; Witt ing ef a/.. 2001). 
The abundance of myoglobin in heart t issue may be protective dur ing acute hypoxia, 
however. CO-hypoxia inhibits its facilitative function (Glabe et a/.. 1998) and may even be 
a prooxidant under these condit ions. Myoglobin may also have a protective cellular role by 
binding oxidant radicals produced in mitochondria (Hidalgo et a/., 1990). The reduced 
cardiac level of Mb in people with heart disease (McGrath. 2000) could exacerbate 
cardiac damage following CO poisoning in this group of people; fur thermore, CO could be 
responsible for the depressed myoglobin levels in hearts prior to producing heart disease. 
The role of myoglobin in toxicology remains to be further investigated in light of its redox 
recycling, and pro- and anti-oxidant properties (Galaris ef a/., 1989b). 
The role of nitric oxide (NO) in endothelial functioning and its role as a 'stress' messenger 
under oxidative stress is establ ished (Joe et a/.. 1998; Sherman et a/.. 1997). Any N O 
released into the perfusate was detenmined (using the Griess assay) by measuring its 
immediate breakdown product: nitrite (NO2*). We found no dif ference in perfusate nitrite 
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between either group of perfused hearts. Other studies in the literature have shown 
elevated NO levels and inducible nitric oxide synthase ( iNOS) message and protein after 
24 hours in culture models or after chronic exposure in animals (Igarashi et a/., 1998; 
Jones et a/., 1999; Kumura et a/.. 1996). Our results rule out the role o f NO in immediate 
oxidative damage. 
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7.6 Conclusions 
The in vitro modification of myoglobin by oxidative stress was investigated as a possible 
biomarker of oxidative stress. Our findings showed that rat hearts perfused with hydrogen 
peroxide (H2O2) caused the release of LDH and free iron and produced a loss of t issue 
function. The H202-induced release of iron may undergo redox recycling in the cell by 
tissue antioxidants such as ascorbate. and could initiate oxidative stress in this manner. 
The release of iron may cause oxidative damage in other t issues by mediating the 
production of ROS via Fenton chemistry. The [H2O2] used was sufficient to lead to gross 
organ failure, however, it was envisaged this would modify Mb (under these conditions) to 
the peroxidase Mb-H species. Our results showed no peroxidatic activity in perfusate or 
ventricle homogenate under these conditions, therefore, suggest ing that Mb-H may not be 
used as a cardiac-specific marker of oxidative stress from biopsy or blood samples. 
Whether CO-induced oxidative stress oxidizes myoglobin in vivo remains to be 
determined. 
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7.7 Further Work 
A diagnostic role of Mb-H can be ruled out f rom this study (above) , however, the 
observation of peroxidatic activity f rom low molecular weight protein(s) has raised the 
possibility of microperoxidases being potential markers. It was found that the homogenate 
from H2O2 perfused hearts showed peroxidatic bands in the low molecular weight (MW) 
region after 90 minutes o f H2O2 perfusion. Treated M b showed a loss of this low M W 
peroxidatic material, therefore, this low-weight unidentif ied compound(s) could be 
microperoxidases. This is of interest as this type of peroxidase has not been found in vivo 
(personal communicat ion with Professor Michael Wi lson, University Of Essex). 
The microperoxidases are short peptides f ragments derived f rom haemoprotein 
polypeptide. These peptides have a haem group covalently attached for their peroxidatic 
activity (F igure 7.8). We will address the use of these microperoxidases as potential novel 
markers of oxidative stress by examining their possible degradation/modif ication under 
oxidative conditions (Nagababu ef a/., 1998). 
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Figure 7.8 Structure of MP11 (microperoxidase-11), a ferr ihaem undecapeptide derived 
from cytochrome c. The figure is taken from Spector et a/. (2000). 
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Briefly, the proposed work involves characterizing the unknown low MW peroxidatic 
material. The samples for analysis were derived from rat heart ventricles prior to being 
perfused with hydrogen peroxide for 15 minutes. This is envisaged b y using low M W 
markers on the polyacrylamide gel, in conjunction with a more cross-l inked gel to limit the 
loss of these likely peptides, and to maintain the mariners for molecular weight 
identification. The above was performed by our group using a 10% acrylamide and failed 
to retain the low M W markers, hence, using a more cross- l inked gel is proposed to retain 
the mari<ers to aid characterization. The peroxidatic activity would be detected (as 
performed here) to evaluate its potential use as a novel mariner of cardiac oxidative stress. 
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Chapter Eight: 
General Discussion & Conclusions 
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8.1 General Discussion 
This chapter will discuss the presented findings by extrapolat ing to an in vivo scenario 
with specific emphasis on the likely mechanism(s) responsible for producing CO-
associated cardiac morbidities. 
8.1.1 T h e Card io tox ic i t y O f C a r b o n M o n o x i d e 
S. 1.1.1 In vivo myocardial hypoxia 
The cardiotoxicity of carbon monoxide (CO) is establ ished at the clinical level, however, 
the mechanism(s) of its toxicity are unclear and the direct effects within the body are also 
not fully known. Binding of CO to haemoglobin in vivo and the subsequent production of 
tissue hypoxia is well documented (Killick, 1940) and considered to be responsible for 
some of the symptoms of CO poisoning (Chapter 1). Our hypothesis postulated that CO 
exposure in vivo produces cardiac morbidities via an ischaemia/reperfusion (l/R)-l ike 
injury (1.7). Using isolated rat hearts as a suitable model (Chapter 3) al lowed the 
hypothesis to be addressed and presented some changes similar to those found occumng 
in l/R injury. The novel findings (presented in Chapters 4 and 5) were evident under 
normoxic condit ions and rule out hypoxia (with the levels of C O used here) in producing 
the described changes. 
Lactic acidosis of the blood is associated with C O poisoning in vivo (Chapter 5) . This 
increase in lactate production would appear to be protective under systemic hypoxia 
(following severe acute inhalation of CO) by increasing the release of oxygen from 
myoglobin (Giardina et a/., 1996). This could provide oxygen for the t issues, however, it 
could increase the availability of haem sites for CO to bind to (in myoglobin) and 
potentiate the CO-induced hypoxia in vivo (Jaffe, 1997). This deoxygenat ion of myoglobin 
may limit the availability of oxygen to the mitochondria (Wittenberg & Wit tenberg. 1985). 
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In vivo hypoxia stimulates the production of NO (Chapter 1) and this may also arise 
during CO poisoning (Ischiropoulos et a/., 1996; and 8.1.1.2). NO can bind readily to 
haemoproteins such as cytochrome c oxidase (Complex IV; 6.1.1.4) and impair its 
function in cell respiration (Sarti et a/., 2003). This could account for the decrease in the 
activity of Complex IV shown by CO (Somogyi et at., 1981). Al though C O can only bind to 
the reduced haem centre of cytochrome c oxidase. NO can also nitrate Tyr residues in 
various proteins and interfere with many biochemical pathways within the myocardium 
(Mallozzi et a/., 2001). The inhibition of mitochondrial respiration by NO could contribute to 
the apoptosis (8.1.1.2) that is found after CO poisoning (Piantadosi a/.. 1997). 
8.1.1.2 Oxidative stress 
It is reasonable to conclude that CO may elicit its cardiotoxicity by producing oxidative 
stress based on the findings (in Chapter 5). Furthermore, the postulated hypothesis which 
may be more realistic in an in vivo setting could undergo l/R injury and exacerbate any 
CO-induced oxidative stress. However, the source of reactive oxygen species (ROS) 
production remains unclear as ROS are implicated in organ injury following l/R injury 
(Sussman & Bulkley. 1990) and C O poisoning (Zhang & Piantadosi. 1992). Isolated 
mitochondria showed no production of ROS here (Chapter 6). therefore, other sources of 
cellular oxidation are briefly discussed. Oxidative stress was inferred f rom the depletion of 
intracellular reduced glutathione in heart ventricle t issue exposed to C O (Chapter 5). 
Oxidative stress may have arisen by an increase in the product ion of ROS induced by C O 
and/or a depletion of antioxidants by CO (Chapter 5). The source(s) of the oxidative 
stress do not lie solely in the ventricle t issue (that is comprised mostly of cardiac 
myocytes), as endothelial t issue is shown to be a source o f ROS product ion, particularly 
the superoxide radical (Serrano Jr. et at., 1996). Oxidat ive stress by the production of 
ROS are also partly responsible for the oxidant-mediated cytotoxicity through altered 
calcium channels (Az-ma et a/.. 1999). The importance of glutathione in cells (described in 
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Chapter 5) and its thiol chemistry involved in regulating cellular redox state (Schafer & 
Buettner. 2001) and conferring cytoprotection may be associated wi th apoptosis. A 
molecule temied SAG (sensitive to apoptosis gene) has 12 cysteine residues and is 
thought to play a vital antioxidant role in the heart (Kim et a/., 2003). Any depletion of this 
protein (as shown for glutathione) could lead to myocardial apoptosis that may contribute 
to eventual myocardial failure. The depletion of GSH is shown to reduce the activities of 
myocardial glutathione peroxidase (GPX), and glutathione-S-transferase (Leeuwenburgh 
et a/.. 1996) and increase the activity of superoxide d ismutase (SOD). The activity of GPX 
is decreased in severe cases of atherosclerosis in the coronary artery (Ramos et a/.. 
1997) and could suggest that the CO-induced oxidative stress may lead to atherosclerosis 
(8.1.1.5). Apoptosis is tr iggered by oxidative stress (Chandra et a/.. 2000) and found in the 
reperfused ischaemic myocardium (Maulik et a/., 1998). Following this, oxidative stress 
shown here and the likely validity of the postulated hypothesis in vivo suggests that 
apoptosis could play a major role in detemnining myocardial outcome following CO 
poisoning. Apoptosis is found to contribute in neuronal cell death in the brains of Sprague-
Dawley mate rats exposed to 0.25% CO for 30min (Piantadosi et a/., 1997). Lipid 
peroxidation (LPO) cannot be ruled out following the CO-induced oxidative stress. Tissues 
with limited antioxidant reserves show a generation of C O associated with LPO (Vreman 
et a/., 1998) and this could exacerbate the initial oxidative insult (by CO) leading to a 
vicious circle of cytotoxic events. This lethal cascade of events could propagate down to 
the mitochondrial level and alter the bioenergetics of the myocard ium leading to heart 
failure {8.1.1.5). Recent f indings report an anti-apoptotic property of CO at low levels 
(Zhang et a/.. 2003) through its endogenous production by haem oxygenase (Chapter 1). 
The CO-induced oxidative stress may elicit such an anti-apoptotic effect by regulating the 
oxidant effects of hydrogen peroxide, as hydrogen peroxide is found to regulate apoptosis 
by inhibiting pro-apoptotic caspases (Borutaite & Brown, 2001) . 
Xanthine oxidase (XO) produces superoxide radicals fol lowing the hypoxia-induced 
conversion of xanthine dehydrogenase (XDH) to the oxidase (Russel l et al., 1989). The 
role of XO is established in l/R injury (Sussman & Bulkley, 1990). however, it is not 
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considered responsible for producing ROS as no hypoxic condit ions were found under the 
experimental condit ions used (Chapter 5). Furthermore, the presence o f oxidative stress 
in the ventricles could not arise from XO, as X O is only found in endothel ial cells and not 
cardiac myocytes (Gunther a/.. 1999; Kehrer et a/., 1987). Therefore, we conclude that 
X O may not be responsible for the oxidative stress from the lack o f hypoxic condit ions in 
this study. However, hypoxia is shown not to convert X D H to X O in rat hearts (Kehrer et 
a/., 1987), al though, they did report a loss of myoglobin f rom isolated pertused hearts 
during reperfuston (d. 7.7.3). X O is not considered to contr ibute significantly in humans 
during CO poisoning as it is found in low levels in human hearts (Morales et a/., 2002). 
Other evidence shows that peroxynitrite is produced by XDH under aerobic condit ions 
(Godber et a/., 2000) may be responsible for the oxidat ive stress observed here in the 
presence of inorganic nitrite (or nitric oxide) and a reductant. CO-hypoxia in vivo and its 
concomitant production of nitric oxide (Ischiropoulos et at., 1996; Kumura et a/.. 1996) 
could participate in such a reaction with X D H to produce oxidat ive stress that may 
produce brain and heart failure associated with CO poisoning (Chapter 1). 
8.1.1.3 Myoglobin as an oxidant 
The abundance of myoglobin (Mb) in heart t issue is postulated to have a protective role in 
scavenging nitric oxide (NO) in vivo by Ascenzi et al. (2001). This could become impaired 
during C O poisoning and may account for oxidative stress through the production of 
reactive nitrogen species (RNS; described in Chapter 5). However, the production of NO 
following CO exposure is shown in rat brain tissues (Ischiropoulos et al., 1996) and may 
not arise in heart t issue (Chapter 3) and rule out Mb as a possible NO scavenger in heart 
t issue. Although the absence of NO production in heart t issue fol lowing CO exposure 
could indicate effective scavenging of NO by Mb. Glutathione may reduce nitric oxide to 
nitrite, such that it inhibits Mb to affect myocardial function (Glabe e( a/., 1998). 
Furthermore, nitrosation of cysteine residues by peroxynitr i te ( formed from NO and 
superoxide) could account for the depletion of reduced glutathione after C O exposure. 
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The S-nitrosated haemoglobin has a higher affinity for oxygen than nat ive Hb (Patel et a/.. 
1999) and may contribute in CO-induced hypoxia in vivo and oxidat ive stress. The 
inhibition of Mb by oxidation of its haem iron and/or via CO-binding has negative 
chronotropic properties by impairing oxygen delivery to mitochondria (Glabe a/.. 1997; 
White & Wittenberg. 1997) that could decrease the heart rate (shown in Chapter 4). Of 
particular interest is that the [Mb] has a good correlation with the level of cytochrome c 
oxidase (Cole. 1983), another potential target of CO (Chapter 1) that shall be discussed 
later (in 6.1.1.4). 
Typical conditions found during oxidative stress could oxidise the haem iron of Mb to the 
ferric fomn and so prevent the binding of oxygen to the predominant cellular form, i.e. 
ferrous haem (Chapter 7). The ferryi form of Mb is found dur ing ischaemia in isolated rat 
hearts (Arduini et a/.. 1990) and may occur during C O poisoning in vivo. This oxidised 
ferryi fomri of myoglobin may function as an intracellular oxidant (discussed in Chapter 7) 
and such myoglobin-catalyzed oxidative reactions may initiate and/or exacerbate vascular 
t issue injury responsible for producing the depressed coronary f low (in Chapter 4; 
Jourd'heuil et a/., 1998). In vivo CO-induced hypoxia can produce lactic acidosis and 
these conditions favour the formation of the oxidising ferryi species of Mb (Reeder & 
Wilson, 2001). The oxidative form of Mb (ferryl) has not been found in heart t issue in vivo 
and this could be attributed to the enhanced proteolysis of this modif ied protein. Oxidative 
stress can alter intracellular calcium balance (Chapter 4 and 8.1.1.2) that could impair 
haem binding in Mb and/or haemoglobin (Pappa & Cass. 1993) to reduce the oxygen 
carrying function of these proteins. This may infer that aerobic metabol ism may remain 
nonfunctional until the calcium balance is restored fol lowing CO poisoning in vivo. Mb may 
have a significant role in the cardiotoxicity of C O in vivo (fol lowing acidification) by 
augmenting the production of superoxide and hydrogen peroxide that occurs under 
normal conditions of metmyoglobin formation (Gunther ef a/.. 1999). The localisation of 
Mb along the sarcoplasmic reticulum and the mitochondria in myocytes may contribute to 
site-specific t issue damage contributing to stunning and arrhythmogenesis (Chapter 4). 
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The depletion of glutathione (GSH) following C O exposure (Chapter 5) may have arisen 
from the oxidative (ferryl) Mb species conjugat ing with intracellular proteins (0s tda l et a/., 
1999) such as GSH. The relative scavenging reactivities of the T r p ^ peroxyl radical in Mb 
(produced from the reaction of Mb with hydrogen peroxide as oxidant) is ascorbic acid > 
urate > TroloxC > GSH (Irwin a/., 1999). These scavenging properties support the 
protective role of antioxidants in CO poisoning (8.1.1.6) and highlight the role of ascorbic 
acid and TroloxC (in Chapter 5). The f indings from Irwin et al. (1999) also suggested that 
ascorbate may be the primary antioxidant in preventing the depletion in G S H . It is possible 
that ascorbate reduced the oxidised ferryl species of Mb (Galaris et a l . , 1989) prior to it 
producing any oxidative damage within the cells, and/or directly scavenged the peroxyl 
radical before it can covalently modify Mb to its peroxidatic form (Chapter 7). GSH can 
reduce the ferryl form of Mb. however, it cannot reduce metmyoglobin (Galaris et al., 
1989) and interfere in the peroxidatic activity of modif ied Mb (Vulet ich & Osawa, 1998). 
Metmyoglobin can bind NO to yield NO-adducts that could produce nitrosoglutathione in 
the presence of GSH (Reichenbach a/., 2001) and possibly deplete GSH in this 
manner. However, this is unlikely in vivo as there is no Mb in brain t issue where NO 
production is reported to occur following C O exposure (above); neither is it anticipated in 
heart t issue as the production of NO in heart t issue were not found fol lowing CO exposure 
(Chapters 3 and 7). However, a neural equivalent of Mb termed neuroglobin has been 
identified (Ascenzi et a/., 2001). and this may have a role in brain t issue damage fol lowing 
CO poisoning similar to the proposed oxidative damage by Mb in heart t issue. 
Although the above has described the oxidising nature of Mb, it must be stressed that 
other haem centres do undergo similar oxidative changes to yield oxidising species. 
Haemoglobin can also undergo similar oxidat ion to produce ferrylhaemoglobin that is 
thought responsible for oxidative lesions (Herold & Rehmann, 2003). When the 
irreversible covalent modification of haem to the globin (protein) occurrs, its peroxidatic 
activity cannot be dampened by C O binding to its reduced haem centre (Newton et a/.. 
1965). This is physiologically important as it implies that oxidative stress by these 
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haemoproteins cannot be regulated unless the haem centre is degraded or the metal ions 
at the haem centre is selectively sequestered (8.1.2). 
8.1.1.4 Free radical theory of ageing and mitochondria 
Mitochondrial respiratory function is gradually uncoupled and the activities of the 
respiratory enzymes decrease with age (Wei et al., 1998). Mitochondrial DNA (mtDNA) is 
susceptible to oxidative damage by reactive oxygen species (ROS) and free radicals 
(Kadenbach et al., 1995). Impaired respiratory components increase the electron leakage 
and ROS production by an one-electron reduction of molecular oxygen and this 
contributes to the oxidative stress and concomitant oxidative damage to the mitochondria. 
Heart t issue has an age-related decrease in its tolerance to oxidative stress (Abete et al., 
1999). The activity of catalase decreases with age in rat hearts (Boucher et al., 1998). 
This mitochondrial production of free radicals and its associated oxidative stress with 
ageing encompass the 'free radical theory of ageing' (Cadenas & Davies, 2000). Human 
hearts show an age-associated damage in their mtDNA (Hayakawa et al., 1992). The 
fragility of mtDNA (due to the lack of histones for binding) and its oxidising environment is 
thought to contribute to the failing heart through apoptosis (Ozawa. 1998). This loss of 
mitochondrial function is thought to be responsible for many pathologic condit ions 
including those related to heart failure (Ramachandran et al., 2002). 
An increase in ROS production by deenergised mitochondria opens the mitochondrial 
permeability transition (MPT) pore in cardiac myocytes (Zorov et al., 2000). This pore 
opening phenomenon is dependent upon the cellular ROS-scavenging mechanisms, 
particulariy glutathione. This could suggest that an opening of the MPT pore fol lowing CO 
exposure may lead to loss of the mitochondrial t ransmembrane potential (A^m) by 
oxidative stress (Chapter 5) and produce more ROS (Zorov et al., 2000) and/or apoptosis 
{8.1.1.2). However, no ROS production were found in isolated mitochondria following C O 
exposure under the experimental condit ions used (in Chapter 6). a l so ruling out this 
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occurrence. Hydrogen peroxide is reported not to affect mitochondrial respiration in dog 
grastrocnemius-plantaris muscle (Cole, 1983). Al though other factors could have 
contributed to the lack of R O S production by mitochondria exposed to C O in vitro 
(Chapter 6). Heart mitochondria are swollen and show f ragmented cristae following CO 
poisoning in vitro (Somogyi et al., 1981). The results suggest that mitochondria may not 
be directly responsible for producing oxidative damage and could be a target of other 
cellular damage leading to mitochondrial failure during CO poisoning. 
The possible production of NO following CO exposure (8.1.1.2) and/or cytokines (8.1.1.5) 
may inhibit mitochondrial activity (Brown. 2001 ; Oddis & Finkel, 1995). NO can modulate 
other factors involved in the apoptotic cascade and directly inf luence mitochondrial 
function. The compromised function of mitochondria is involved in a number of vascular 
pathologies and could arise following CO-induced oxidative stress. Damage to mtDNA is 
found in ischaemic heart disease, cardiomyopathy, atherosclerosis, and hypertension 
(Ramachandran et al., 2002). Cytochrome c oxidase may also have a protective role 
within mitochondria to scavenge NO (as described for myoglobin in 8.1.1.3; Sarti et al., 
2003). 
The fragility of the mtDNA does not appear to be the sole vict im by attack from oxidising 
species. The membranes of the mitochondrion are also susceptible to lipid peroxidation 
(LPO) with age. Over t ime the cardiolipin content decreases ca. 4 0 % in aged rats 
(Paradies et al., 1999) and this may potentiate the intrinsic lethality of LPO. Exposure to 
CO may exacerbate the decline in cardiolipin content through oxidative stress. The 
decrease in cardiolipin content contributes to the depressed activity of cytochrome c 
oxidase with age, therefore, this suggests that C O could potentiate ageing within the heart 
t issue (above and Chapter 6). Apoptosis contributes to brain cell death in CO poisoning 
(Piantadosi a/.. 1997). The loss of mitochondrial membrane integrity could release 
cytochrome c and stimulate the pro-apoptotic pathway (Borutaite et al., 2001). Cardiolipin 
is also closely associated with cytochrome c and their loss is thought t o initiate apoptosis 
(McMillin & Dowhan, 2002). CO inhalation significantly lowers the content of cytochrome c 
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in heart ventricles (Penney et a/.. 1983) and supports a possible loss of cytochrome c by 
oxidative stress through LPO. Whether apoptosis following the loss of cytochrome c 
occurred under our conditions remains to be determined; however, its loss would 
inevitably produce a shortfall in the activity of cytochrome c oxidase that may contribute to 
the lowered activity of Complex IV found after C O poisoning (Pankow & Ponsold, 1984). 
There are two types of mitochondria found in rat heart tissue: interfibrillar mitochondria 
(IFM) found between myofibrils; and subsarcolemmal mitochondria (SSM) that reside 
under the plasma membrane. Evidence suggests that the IFM are more susceptible to 
oxidative stress than S S M (Fannin et a/.. 1999) and may explain the loss of contractile 
function associated with ageing that could be potentiated following C O poisoning. 
8.1.1.5 Pathogenesis of heart disease 
Oxidative stress is one of the principle insults in promoting cardiac myocyte death (Clerk 
et a!., 2003). Cardiac myocyte death through apoptosis or necrosis may contribute to 
many cardiac pathologies (Latif et a/., 2000). DNA damage is frequently found in cells 
exposed to oxidative stress. Following this, coronary artery d isease (CAD) is 
characterised with DNA damage (Botto et at., 2001) and decreased activities of G P X 
(Ramos et a/., 1997) that are associated with the severity of atherosclerotic disease. DNA 
damage was a s s e s s e d by Botto et a/. (2001) by determining the levels of DNA adducts in 
cardiac tissues. Increased levels of DNA adducts are found in the hearts of both smokers 
and rats exposed to mainstream or environmental cigarette smoke (Izzotti et a/., 2001). 
The presence of C O in cigarette smoke may be responsible for DNA damage (either 
nuclear or mitochondrial; Q.I.1.4) by oxidative stress and lead to heart failure in such a 
manner (above). Human hearts are more sensitive to atherosclerosis relative to rats, 
therefore, an equivalent depletion of glutathione (shown in Chapter 5) and possibly other 
myocardial antioxidants in the human heart could produce severe symptoms or potentiate 
the rate of myocardial damage or failure. 
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Further oxidative stress through the action of neutrophils may arise following the 
myocardial damage after C O poisoning. The recruitment of neutrophils and macrophages 
can compromise the microcirculation and prolong tissue injury (Massey et ai, 1995), R O S 
produced by neutrophils activate collagenases and gelatinases and lead to irreversible 
tissue damage (Weiss, 1989). Neutrophils are activated in response to 
ischaemia/reperfusion (l/R) injury to cardiac myocytes (Hansen & Stawski, 1994; Kukielka 
et a/., 1993). The recruitment of neutrophils to cells requires the expression of intercellular 
adhesion molecule-1 (ICAM-1) on the myocytes and an enhanced expression of CD-18 by 
neutrophils for intercellular adhesion (Entman et a/., 1992). The expression of ICAM-1 is 
expressed in the ischaemic myocardium in a time-dependent manner. Any oxidative 
myocardial injury following C O poisoning in vivo may be further exacerbated by neutrophil 
recruitment and activation. The likely reoxygenation (or reperfuslon phase) following 
severe acute C O poisoning could potentiate the degree of neutrophil recruitment and 
exacerbate myocardial tissue injury after C O exposure has ceased. 
Cytokines are important mediators of cardiovascular disease (Kukielka et a/., 1995). 
Tumour necrosis factor alpha (TNFa) will be discussed here, although, other cytokines 
such as the interleukins (ILs) show a similar pattem of expression and function. The 
expression of these proinflammatory cytokines is responsible for the pathogenesis of 
many cardiovascular diseases (Maekawa et a/., 2002; Meldrum et a/., 1998; Nozaki a/.. 
1998). Briefly, T N F a (and ILs) are upregulated eariy relative to ICAM-1 during ischaemia 
and may mediate the expression of ICAM-1. These cytokines also stimulate the 
expression of low-density lipoprotein receptors (Mehta & Miller, 1999; and below). 
Coincidentally, l/R injury stimulates the expression of other genes with KB-response 
elements including inducible NOS (Chandrasekar et at., 2000). This could potentiate 
myocardial injury after C O poisoning from cytokines/neutrophils contributing to further 
oxidative damage. Mitochondria could be involved in myocardial failure as cytokines can 
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directly inhibit mitochondrial function in cardlomyocytes (Zell et a/.. 1997) and may lead to 
R O S production (8.1.1 A). 
Cytokines mediate the induction of calcium-independent NOS in the heart (Schutz et aL, 
1995) and this modulation of myocardial NO could have a role in CO-associated cardiac 
morbidities. Nitric oxide is thought to contribute in the depression of heart function through 
inhibition of cardiac mitochondrial respiration (Ramachandran et a/.. 2002; Ramesh et a/., 
1999; Xie et aL, 1996). This could explain the negative inotropic response shown by TNF 
(Yokoyama et a/., 1993; and 8.1.1 A). NO is implicated in decreasing intracellular cAMP 
following /7-adrenergic stimulation in cardiac myocytes (Joe et a/., 1998). Heart failure is 
also characterised by down*regulation of the >9i-adrenergic receptor message (Bristow et 
aL, 1993). The cascade of events described above highlight the likely progression of 
cardiac morbidity following C O poisoning. Furthermore, the above events may be 
potentiated further by C O from haem oxygenase (HO-1) induced by cytokines (Guo et aL, 
2001), thereby producing a downward cycle of events for the heart. 
The production of R O S is essential for activation of p38 mitogen-activated protein kinase 
(p38-MAPK) in rat hepatocytes (Herrera et aL, 2001) and could suggest this occurs in 
heart tissue following CO-induced oxidative stress. The failing heart has a higher activity 
of p38-MAPK compared to normal hearts (Cook et aL, 1999). This could suggest that 
protein kinases may have a role in heart failure following C O poisoning. p38-MAPK is 
shown to decrease the expression of low-density lipoprotein (LDL) receptors and 
consequently increase the plasma levels of LDL (Mehta & Miller. 1999). Oxidising 
myoglobin (8.1.1.3) from ruptured myocytes could oxidise this L D L (oxLDL) to a cytotoxic 
species (Hogg e^ aL, 1994; Morel et aL, 1983) that may lead to the initiation and/or 
progression of heart disease (Ramirez aL, 2003; Reeder & Wilson. 2001) associated 
with C O poisoning. Oxidised LDL plays a major role in the formation of atherosclerotic 
plaques (Miller et aL, 1996; Shamrian aL, 2002). The increase in levels of oxLDL 
produces autoantibodies that is a risk factor for the initiation or progression of 
cardiovascular disease (Van Tits et aL, 2001). 
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6.1.1.6 Other contributing factors 
Any factors involved in changing the state(s) involved in precipitating oxidative stress are 
briefly described here. Differences in age could have a role in patient outcome following 
C O poisoning as aged rats are more susceptible to apoptosis within the myocardium 
following l/R compared to young hearts (Liu et a/., 2002). This may be explained from the 
reduced antioxidant capacity of the myocardium that is found to occur with age (Abete et 
a/.. 1999; Boucher a/., 1998) and render the myocardium more prone to apoptotic death 
after oxidative stress. Sex may play a role as females have a higher antioxidant capacity 
in tissues and mitochondria (Borrds et ai, 2003), however, no studies have been found (to 
date) examining the outcome of female versus male victims of C O exposure. Male mice 
have a higher turnover of glutathione (Ma et ai, 1998) that may contribute to iron- and 
myoglobin- catalysed free radical reactions (8.1.1.3). Diet may alter the cellular 
antioxidant capacity that could influence patient outcome after C O poisoning. A diet high 
in haem iron is associated with an increased risk of Ml (Klipstein-Grobusch et a/., 1999) 
presumably from its prooxidant properties that may be potentiated during C O poisoning. 
Diets high in polyunsaturated fatty acids render heart tissue more susceptible to oxidative 
damage (O'Farrell & Jackson, 1997). Cholesterol-rich diet can increase the activities of 
glutathione peroxidase (GPX) and catalase (CAT) in rat liver, whereas significant 
decreases in these enzymatic antioxidants are found in rabbit livers (Mahfouz & 
Kummerow, 2000) indicating possible outcomes of C O poisoning due to differences in 
animal s p e c i e s . 
Ci rcannual c h a n g e s in heart antioxidants have been found (Bell6-Klein et a/.. 2000). Rat 
hearts have maximal activities of G P X and CAT in the summer season. Whether this 
occurs in humans remains to be determined, however, it may associate with the increased 
number of cases in accidental C O poisoning found over winter (attributed to faulty heating 
boilers). Lifestyle factors such a s the consumption of alcohol (Husain & Somani, 1997) 
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and smoking cigarettes (Baskaran et a/., 1999) could exacerbate C O poisoning due to 
their prooxidant effects. The vapour phase of cigarette smoke contains C O (Chapter 1). 
The lower dietary-intake of antioxidants by smokers (Waldren et a/., 2001) could account 
for the higher oxidative stress found in smokers that may be potentiated after C O 
poisoning. 
Other health d isorders could potentiate C O poisoning and contribute significantly in 
myocardial failure. Diabetic patients have increased oxidative stress (Fitzl et at., 2001; 
Stefek ef a/.. 2000) that could contribute to CO-induced oxidative stress. Post-
chemotherapy treatment involving the administration of adriamycin may potentiate the 
cardiotoxicity of C O as this drug is cardiotoxic (Kumar a/., 1999; Luo et a/., 1997). A 
history of antibiotic(s) may influence patient outcome following C O poisoning as some 
findings indicate that some bacteria may cause heart d isease (Bradley. 2002; Nicholson, 
1999). Finally, genomic screening has discovered several polymorphisms that may 
influence patient outcome according to their race. A polymorphism for the gene encoding 
the subunits of glutamate-cysteine ligase limits the biosynthesis of GSM in individuals of 
African descent (Willis ef a/., 2003). This suggests that race could account for some of the 
differences in patient outcome after C O poisoning and may rule out some socio-economic 
factors. 
8.1.2 Therapeut ic Intervention 
Myocardial ischaemic preconditioning is thought to adapt the heart to become resistant 
to any subsequent ischaemic insult (Nakano et a!., 2000). Although CO-preconditioning 
has not been evaluated or developed, this type of vaccine method may be beneficial to 
those at high risk such a s fire-fighters. p38 mitogen-activated protein kinases (p38-MAPK) 
may be involved in this preconditioning mechanism (below), therefore, a fine balance 
would have to be determined to prevent any toxicity {8.1.1.5). Other therapeutic 
intervention for victims of severe C O poisoning could include minimising some (or all) of 
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the likely pathways involved in myocardial morbidity following C O exposure (described in 
8.1.1). 
The likely involvement of intercellular adhesion molecule-1 (ICAM-1) following C O 
poisoning {8.1.1.5) may minimise or prevent CO-induced myocardial failure. Expression of 
ICAM-1 could be inhibited by an inhibitor of the complement pathway (Buerke et a/.. 1998) 
prior to reoxygenation (either normobaric or hyperbaric). Hyperbaric oxygen also inhibits 
the expression of ICAM-1 (induced by hypoxia) in endothelial cells through a mechanism 
involving nitric oxide (Buras et a!., 2000). Hyperbaric oxygen could also increase the 
antioxidant capacity by inducing S O D (Evelson & Gonz^lez-Flecha. 2000), however, its 
prooxidant properties (Chapter 1) may have to be evaluated for use during the treatment 
of C O poisoning. P-selectin (or granule membrane protein-140) is involved in recnjiting 
neutrophils to endothelial cells (Weyrich a/.. 1993). Similarly a s ICAM-1, the inhibition of 
P-selectin expression prior to myocardial reperfusion by HBO also protects the heart 
(Thorn. 1993). 
Carbon monoxide enhances the migration of human neutrophils (Andersson et a/., 2002; 
VanUffelen et a/., 1996) and may directly activate neutrophils and target them to the heart 
due to the sink conditions of the myocardium through its abundance of myoglobin 
{8.1.1.3). Such an indirect mechanism is plausible and remains to be determined. If 
proven, C O scavenging drugs may be a potential development to minimise C O -
associated cardiac morbidities. Other inhibitors of neutrophil recruitment are also potential 
targets for therapeutic intervention (Entman et a/., 1991). This could include ant i -TNF-a 
(Ferrari. 1999; 8.1.1.5) and/or anti-ICAM-1 treatment (Ma et a/., 1992) following C O 
poisoning particulariy prior to any (post-CO) HBO treatment. Furthermore, neutrophil 
recruitment via the activation of cytokines and expression of adhesion molecules 
precedes by activation of p38-MAPK (Gao et a/., 2002). The inhibition of p38-MAPK 
may also be a potential therapy after C O poisoning, although, the extent of its inhibition 
could otherwise be pro-apoptotic as it found to mediate the anti-apoptotic properties of C O 
(Brouard a/., 2000). 
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Myocyte death is responsible for many cardiac pathologies, therefore, limiting the death 
pathways of mitochondria may offer therapeutic strategies in cardiology. In the isolated 
perfused heart model where myocardial reoxygenation injury (after C O exposure) may be 
produced by mechanisms other than neutrophils, the inhibition of p38-MAPK may 
attenuate myocardial injury via apoptosis (Mehta & Miller, 1999; and 8.1.1.4). The 
possible role of mitochondria in myocardial failure (Oddis & Finkel. 1995) after C O 
poisoning also warrants further investigation. Decreasing the degree of mitochondrial 
damage may reduce the amount of myocardial injury (Sakamoto et a/.. 1998). This could 
be achieved by administering antioxidant dnjgs that specifically target the mitochondria. 
Dietary changes including a higher intake of antioxidants in various combinations 
(Haramaki e^ a/., 1998) may alleviate the rate of myocardial failure after C O poisoning. 
The use of antioxidants with oxygen therapy needs cautious development in C O 
poisoning. Hypothermia may reduce the production of ROS/oxidative species after C O 
poisoning (Kudo et a/., 2001). 
8.2 Conclusions 
The work has shown many effects of carbon monoxide (CO) using the in vitro isolated 
perfused rat heart model. The physiological effects of C O (in Chapter 4) suggested that 
C O has direct effects in the heart that may arise not due to hypoxia (Chapter 5). The 
degree of CO-induced oxidative stress in the myocardium may be exacerbated in vivo due 
to the hypoxic conditions that can arise during severe C O poisoning. The discussion (8.1) 
has raised the paradoxical effect of C O (Omaye. 2002; Otterbein, 2002) and suggests that 
further work at the molecular level is required. 
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Appendix A - Determination of Glutathione ( G S H ) & Its Disulphide ( G S S G ) 
The glutathione pool is measured with an enzymatic recycling assay using glutathione 
reductase (GR) modified from the method of Tietze (1969). This a s s a y sequentially 
reduces glutathione by G R using NADPH. The resulting reduced G S H is oxidized by 5,5'-
dithiobis(2-nitrobenzoic acid) (DTNB; Ellman's reagent). The rate of 2-nitro-5-thiobenzoic 
acid formation is monitored at 412nm. The principle of the a s s a y has been summarized in 
Figure A . I . 
To determine the redox state of the tissue the reduced glutathione (GSH) and oxidized 
glutathione ( G S S G ) levels must be quantified. G S H was derivatized with 2-vinylpyridine 
(2-VP) prior to assaying, so that G S H would not be oxidized by DTNB and interfere with 
the determination of G S S G . i.e. contribute to the G S H derived from the G S S G pool via 
G R . If derivatisation is not perfonmed (using 2-VP), the assay will yield the total pool of 
glutathione, i.e. G S H plus G S S G . 
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Figure A.I Schematic of the glutathione assay used to determine the reduced and 
oxidized glutathione, GSH and GSSG. respectively. 5,5'-dithiobis(2-nitrobenzoic acid) 
(DTNB) oxidizes GSH producing the glutathione conjugate and the p-nitrothiobenzoate 
anion is measured at 412nm G S S G is reduced by glutathione reductase (OR) and the 
resulting GSH is determined with DTNB Prior to GSSG determinat ion, the reduced GSH 
is derivatised with 2-vinylpyridine (2-VP) to prevent it being oxidized by DTNB. thereby 
allowing quantification of both GSH and GSSG. 
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Our assay were modified to accurately detemiine the levels of G S H and G S S G . Firstly, 
the tissue homogenates were deproteinised using perchloric acid (HCIO4) to limit the 
degree of oxidation of G S H (Bernt & Bergmeyer, 1974). Other workers have also used 
sulphosalicyclic acid to remove protein (Baker et a/., 1990; Griffrth, 1980; Hoshida et al. 
1996), however, we used perchloric acid as it would be compatible with the determination 
of other analytes, e.g. pyruvate. The derivatisation step was performed to block the G S H 
and prevent it from contributing to the G S H derived from the reduction of G S S G (via G R ) . 
Various reagents can be used for derivatisation (Abete et ai, 1999; Cavins & Friedman, 
1970; Ellman. 1958; Katritzky et al., 1984; Winters et a!.; 1995; Wu et al., 1971). 2-
vinylpyridine (2-VP) were chosen to derivatize G S H , as it does not inhibit G R like N-
ethylmaleimide, therefore we eliminate the clean-up step (Winters et a/.; 1995). Although 
excess use of 2-VP can underestimate the G S S G content a s it would block the oxidation 
of G S H (derived from the G S S G pool) by DTNB. Derivatisation of G S H with 2-VP requires 
neutral pH, therefore, the deproteinised extract was neutralized with K O H (in Tris buffer) 
as performed by Humphrey et al. (1987). The titration data is not included here. Note, that 
using triethanolamine (to neutralize the pH) is shown to interfere with the glutathione 
assay (Griffith. 1980). The p-nitrothiobenzoate anion which results (after the oxidation of 
DTNB) is highly coloured and measured at 412nm (£„= 13 600 at 412nm) (Ellman, 1959). 
Alternative methods for determining glutathione include the use of reverse-phase H P L C 
(Jue & Hale. 1993; Morrison et al., 1985). These assays can also be performed in 
microplates and sensitivity is increased further by using fluorescent plate readers. DTNB 
can be replaced with o-phthalaldehyde when using the fluorimetric assay (personal 
communication with Dr. Matthew Whiteman, Nanyang University, Singapore). 
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Patel et a/. (2000) 
Patel. A. P.; Moody, A. J . ; Handy. R. D. & Sneyd, J . R. (2000) Myoglobin As A Marker Of 
Myocardial Damage. Toxicol. Lett. 116 (Suppl. 1). 78-79. 
We have investigated myoglobin (Mb) as a marker of cardiac damage due to its 
abundance in heart tissue. Oxidative stress was induced by perfusing isolated rat 
hearts with H202. Tissue viability was determined by measuring LDH activity in 
the perfusate and was maximal at 30 minutes in all H202-treated hearts relative to 
the controls. Treated hearts released Mb into the perfusate, whereas no release 
was detected in control hearts. Covalently bound haem to protein (globin) results 
in modified Mb (Mb-H) which shows increased peroxidatic activity. Findings 
showed no difference in peroxidatic activity in myoglobin from treated heart 
ventricles relative to controls. Mb released into the perfusate also showed no 
peroxidase activity. 
Treated hearts showed an Increase In perfusate free Iron levels with respect to 
the controls. The release of iron implies further oxidative stress by the mediation of 
Fenton and Haber-Weiss generation of hydroxyl radicals. The role of various 
antioxidants. NAC, DMTU, and ascorbate were investigated by assessing the 
degradation of Mb. Our results showed no antioxidant activity with NAC or DMTU. 
Ascorbate showed minor antioxidant activity during the incubation, however, the 
haem was fully degraded by the end of the study. 
These findings suggest that blood/plasma Mb can be used as a marker to show 
cardiac damage. Absence of Mb-H peroxidase activity suggests that Mb is not a 
suitable biomarker of oxidative stress. The work also highlights the problems in 
choosing suitable antioxidant regimes to minimise damage caused by trauma such 
as in hyperbaric oxygen treatment or surgery. 
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Patel etaL (2001) 
Patel, A. P.; Moody. A. J . ; Handy. R. D. & Sneyd, J . R. (2001) Carbon monoxide toxicity in 
the heart: evidence for ischaemia/reperfusion like injury. Biochem. Soc. Trans. 30 (1), 
A34-A34. 
We hypothesise that carbon monoxide (CO) induced cardiac dysfunction 
is associated with R O S production in an 
ischaemia-reperfusion (l/R)-like injury. Isolated rat hearts were used 
to investigate the effects of C O on cardiac function.Hearts were 
exposed to C O (30min) under normoxic conditions followed by a 
90min CO-free period. In hearts treated with 0.01 and 0.05% C O 
heart rate (HR) decreased to ca. 85±10% (mean±SE) compared to 
controls (0% CO) . The 0.01% C O group showed signs of contractile 
recovery during the post-CO period, whereas the 0.05% C O 
group showed no recovery. Coronary flow (CF) decreased signlfi-cantly 
(P<0.05) during the post-CO period, to 93±0.7% and 
87±3% of controls with 0.01 and 0.05% C O , respectively. Activities 
of LDH, C K and troponin I were elevated in perfusate from treated 
hearts. To investigate the likely role of R O S hearts were perfused in 
the presence of two antioxidants (TroloxC and ascorbate). These 
eliminated the decrease in C F following exposure to 0.05% C O 
(SOmin) relative to controls. Whereas the decline in HR was 
augmented with antioxidant treatment to 57±14%. These findings 
suggest some oxidative role in regulating contractile function that 
cannot be attributed solely to cytochrome c oxidase inhibition since 
normoxic conditions were used. R O S may be produced during the 
(hypoxic) C O period and are responsible for a decline in coronary 
function following C O exposure. 
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Carbon monoxide exposure in rat heart: glutathione depletion 
is prevented by antioxidants 
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Abstrmct 
Rai hearts were perfused Tor ISmin with buffer equilibrated with 0.01% or O.OSVo CO. The buffer vras equilibrated with 21*/* Oi 
throughout. The ventricular glutathione content decreased by 76% and 84%, 90min posl-cxposure lo 0.01% and D.OS% CO. re-
spectively, compared u-ith 0% CO controls (0.45 ± 0.01 ^mol/g M-et tissue; ±SEM. n = 3). Both reduced and oxidised glutathione 
contributed lo this decline. When ascorbaie and Trolox C vtrre included during exposure to 0.05% CO the gtuiaihionc poo) was 
partly proiocicd; here the gjutalhione decrease was 46%. In most hearts additional creatine kinase aaivity in the perfusate indicated 
minor (issue injury occurring immediately after the stan and/or about lOmin afur the end of exposure to 0.01% CO or 0.05% CO. 
Ventricle lactate levels were unaffected by exposure to 0.01% CO. This evidence supports a role Tor oxidative stress in CO car-
diotoxtcity. 
e 2003 Elsevier Science (USA). AU rights reserved. 
Key^vords: Carbon monoxide; Oiidative iircs*; Ral heart; Gluuiihionc: Aniioudanu 
Since cardiac and nervous tissues are highly oxygen 
dependent they are vulnerable to CO toxicity via CO-
induced tissue hypoxia [IJ. CO can induce tissue hypoxia 
by competitively reducing the oxygen carrying capacity 
of haemoglobin (Hb) and by attenuating the dissocia-
tion of oxygen botind to Hb at low partial pressure. 
However, as discussed in detail elsewhere, this does not 
explain all of the pathophysiology of CO toxicity [1]. 
Oxidative stress has been implicated in the cellular 
mechanisms of CO toxicity in brain tissue reviewed in 
(1}. Thorn (2) found evidence for oxidative stress posi-
CO exposure in the form of enhanced lipid peroxidation, 
while Zhang and Pianiadosi (3) found a decrease in the 
rotiocbondrial reduced glutathione (GSH) to oxidised 
glutathione (GSSG) ratio. These results are consistent 
with the idea that exposure of brain to CO leads to 
tissue hypoxia. Hence, on removal of the CO exposure, 
the situation is analogous lo that seen in reperfusion 
after tschaemia, where the elevated reactive oxygen 
species (ROS) production, at least partly of mitochon-
drial origin, leads to tissue tlamage (4). 
While a role for oxidative stress i n CO toxicity in the 
brain seems certain there is a lack o f equivalent evidence 
for this in the heart. It is already established that glu-
tathione levels decline during reperfiision o f isolated rat 
hearts following ischaemia [5]. Hence, in this study we 
have examined the effect o f CO on the ventricular glu-
tathione in perfused isolated rat hearts. CO caused a 
depiction o f both reduced and oxidised glutathione, 
which could partly be protected against by including 
antioxidants in the perfusion buHer. thereby providing 
clear evidence of an involvement o f oxidative stress in 
CO cardiotoxicity. However, the concentrations of CO 
used appear to have been insufTtctcnt to have caused 
tissue hypoxia during the exposure, raising the question 
of the source of the oxidative stress. 
Materiab and methods 
Corresponding author, fax: 't-44.|7S2-232-970. 
E-mail eddrea: jmiH>0>!ti'Pl>iiH>uih.;iL'.ul (A. Jobs Moody). 
Adul l male Spraguc-Dawlcy r a u (262 ± 3 0 g body weight: 
means ± S D , n = 35) were used. Animab were maintained with free 
0 0 0 6 - 2 9 I X y 0 3 « - sec froni mailer e 2003 Ebcvicr Science ( U S A ) . A l l righu reserved, 
doi: 10.101 &S0006-291 X(03)00l 9 0 4 
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access lo rood i n d vntcr before collection of the bcmri; exfjerimenu 
were cooductcd in tccordinoc n i lb cthkal ippravsL Certified C O g u 
inuiu ics (0-D.OPA C O in 31% oiyscn. S% cafbon dioxide and baS-
Boced with oitrogcn) u c r c auppfied by B O O (Gni ldronl . U K } . T r o k i i 
C (±»-6-hydro»y.2^.7,8-icirancihyfchrom4nc-2-c»rbojybc acid, 
came from R u k a (Pootc. U K ) . A l l OJhei rca£ciiti were obtninod from 
Sigma (Pook. U K ) . 
H c a r u ( l . 4 S ± 0 . I S g : m e a n s ± S D . n = 35) w n c rapidly etcised 
foHoning anicf lhcria ( « i t h inirapcriiontal lodium pentobarbitone) 
and pciftBcd (ai 3 6 L 9 " 0 in a non-rccircubting Langendorrf apparatia 
at 6ml/mtn/g wci w-cight of hcan as described previoody [6]. Perfusion 
buflcr ( l l 8 m M N a O . 4 .7mM K C l 1.2mM K H i P O . . l . 2 m M 
MgSOo I . S m M C a O i . 2 0 m M N a H C O , . and l l m M glucose) was 
constantly gassed with 21% oxygen. S% carbon dioiide (balanced with 
nitrogen) to p H 7.4. 
Hearts u r r e perfuKd for I S m i n loa-ash om contaminating blood. 
C O exposure vas then started by perfusion with buffer thai was u t -
urated wUh 0%, 0.01%, or 0.05% C O (0.100. or iOOppm. rcspectivdy). 
for 30nrin, followtd by a 90niin CO-free period. Note that the buflcr 
vu saturated with 21% oxygen throughout. In range-finding cxpcri-
mcnu (onpubltsbed) C O conccnlralions of 0 J % ltd to hcan failure. 
The hcan ventricles were then btoited and weigbed before snap 
freezing for biocbemicaJ analysb (lee below). In some perfusions hearu 
were collected immediaicly af^cr the 30min of pcrfosion with C O . In 
others (he antto&idant) Trolox C and sodium ascoriaie were included 
in the pcifusiofl buibr (ai 0.2 and 1 m M . respectively) during the initial 
equilibration period and during the exposure to C O . bat not during the 
90min of perfbsion after (he C O exposure. In these • stock lohition of 
aseorbatc was prepared and added to the perfusion boBer immediately 
before the start of the perfusion. Note thai (he presence of ascorbatc 
required greater buflcring capacity in ihc perfusion buflcr. so thb u i u 
tupplcmenied with l O m M Hepes. 
In all experiments, in order to assos (issue injury, the activities of 
crcoiine kinase and b n a i c dehydrogenase in the pofujo lc were de-
lennined using commcfeial kits (Sigma ki is 47 and 228. respenively). 
In all experiments, for (be detcmination of ghiuthione. lactate, 
and protein, the frozen rat hcan vcntridcs (Uored at - S 0 * O were 
homogenised as described prcviouslr. however, tetrahydrobioptenn 
was omitted from the homogcntsation bufler [7]. T h e 10% {vtvi bo-
mogcoatcs (I g o f wet weight tissue per tOml bomogcntsalion bullier) 
were deprotdniscd immediately on ice ( I 3 m i n ) adding 8% (w/v) 
perefakmc add (2 volumes) to the bomogcnate <l volume), with oc-
casional gentle t n v m i o n . foUowod by ccntrifufation (10 min at 200C|g). 
The pcrebloric acid extract (supcmatanl) was snap-frozen for b i e r 
analysb of gluialhione content using the method of GrifBib (6]. T h e 
ghitatbione analytb of each heart extract w a i carried out in tripUcate. 
T h e lactate contcnU of the homogcnaics were determiiicd osmg a 
conunerdal kit (Sigma kit 826). 
Unless otherwise slated Siudent't / test was used for statistical 
comparison of means. 
Results 
Fig. IA shows the cfTects o f CO exposure on the 
glutathione content o f rat hean ventnclcs. There were 
significant decreases in the total {^utathione pool of 76% 
i P < l x I 0 - " ) and 84% (/> < I x 10 ' ' ) for hearts 
treated with 0.01% and 0.05% CO, respectively, com-
pared with controls perfused in the same manner but 
without exposure to CO. Both the reduced (GSH) and 
the oxidised (GSSG) forms contributed lo the decline in 
total glutathione. 
To investigate the possible role o f reactive oxygen 
spedcs (ROS) in the CO-induccd depletion of glutathi-
one, we performed perfusions with 0.05% CO in the 
presence of a combination of two aniioxidanis (Trolox 
C and ascorbate). Fig. I B shows that at the end of the 
perfusions both the control groups (with or without 
antioxidants) had similar Icvcb of GSH. When antiox-
idants were present there was a lower level o f GSSG 
(decrease of 31% ± 15%. 95% confidence interval); a 
n r i n r a 
0 % C O 0.01% C O 
treatment 
0.05% C O 0% 0 % * A O 0.06% 0 0 S % * A O 
C O treatment 
Fig . I . Depletion of the glutathione content of rat hean ventricle tissue induced by carbon monoxide ( C O ) in the presence o f oxygen and the 
protective ellixt of antioxidants. (A) Isolated rat hcarU were perfused with buflcr equilibrated with 0%^ 0.01%, or 0.05% C O ( B > indicated) for 30 min 
followed by a 90min C O - f r f c period; buBer was taluraicd with 31% oxygen throughout Reduced ghitathioae ( G S H ) a n d oxidised ghiiaibiooc 
disulfide ( G S S G ) contenu of the ventridc tissue were determined as described in the Malerials and methods. The data shown ore means ± S E M . 
A = 3 (0% C O ) , A » 10 ( O . O I % C O ) and 1 B } (0 .05%CO). Asterisks indicatesigntfioint diflerenocs al the9S%confidence level ( />< 0 ^ ) relative to 
the 0% C O control. The hatched f>-mbol ((*) indicate* a sigmficanl diflcrencc at the 90% conSdcncc levd ( f < 0.1) relative to the 0.01% C O treated 
beam. (B) Isobted rat bcarU were exposed toO%or 0 . 0 S % C O , with or without aniioxidanu ( A O ) as indicaicd. The ontioiidants ( O J m M T r o l o x C 
and l i > m M ascorbate) were odminittcred before and during the C O exposure, followed by a 90nnn CO-frce period with no antioxidanU present 
Oxygen w x j present at 2t% tbroughouL T h e data shown ore m e a n s ± S E M (a « 3 , 0 % C O ; a o 10.0.01% O O ; n - 3. 0.05% C O ; n « 3. 0% C O > 
A O ; and 1 1 ° 5.0.0S% C O A O ) . The auerisk indicates a tigniflcant dillerence al the 95% eonfidenoe levd {P < 0.05) relative to the 0% C O ooBtrol. 
The hatched symbob ( « ) indicate significani di&rencea at the 95% confidence level (P < 0.05) relative to the 0.05% CO- lrca tcd hearts. 
294 
Publications 
A.r. Ptitrlrt al. I IlliHhttwfa! <"t*i OhiphyxUnI H,:warth Ctvtwiunu,nu>nj .W2 JV2-J')(, 
slightly lowered loial glulaihionc pool (decrease ot' 
6 .7yr. i 6.0%. ySVn confidence inlcrval); and :in increased 
GSH.GSSG ratio (median value ol'7.1 u i i h antto.xidants 
compared lo 4.9 wiihout: P = (I.UJJ. comparison of me-
dians using Munn-Whiincy W icsi). Fig. IB shows thai 
the combination ofmiiio.xidanis used partially protected 
the glutathione pool from the depletion as a result oI CO 
exposure. The decrease was only 46% with the antioxi-
dants present compared to SAVo uithout (relative to the 
appropriate control in each case). 
The CO-induced glutathione depletion that we have 
observed is not explained by non-specific leak of intra-
cellular material from damaged ventricle into the per-
fusate. In all the perfusions described here we also 
monitored the activity of creatine kinase (CK) and lac-
tate dehydrogenase ( L D H ) in the perfusate as indicators 
of tissue injury. Fig. 2 shows ihc cumulative CK. activity 
in the perfusate for control hearts and lor those exposetl 
to 0.01% CO. Note that thc lcvcl of CK in the perfusate 
was also monitored in the I5min equilibration period 
(sec Materials and methods) before the start of the ex-
posure <f = 0). 'Phis starting level was small, but varied 
(cumulative CK activity. / = 0. was .^ .60 ± 1.65 lU/g wet 
tissue, means ± SD. / i = 13). so the lime c o u r ^ of CK 
accumulation in perfusate are e.sprcsscd as the percent-
age increase above the cumulative CK activity at time 
zero. The mean cumulative CK activities at / = I20min 
were l S . 2 ± 2 . 2 I U / g wet ti>sue (a_SKM. n = ?) for 
3 200 
I 
asnuol 
0 30 SO 90 m 
tune (run) 
Kig. 2. Time c o u r s a of creatine l^iiuxr t C K i iictumubiinn in ihr 
pcil'usaic from r j l ticans c \ p c » v J in C D in ihc prcMncc ot o^ygcn. ITic 
iiobtcd m hearts c iposn l m 0 iconirol) or O.OIV- C O for JOmin 
^n = y ;iiuJ 10. rripcctivclyi Ibllowrd by a W m i n CO-trc« period. "I hi; 
t i l jL 'k bar dcnolo (he [K'rioO uf C O exposure. The C K iicl iviu in 
perfusate frDeiioRS »w mrasuml described in .MDierials and 
methods. The d a u i h o u n uiu incan»l2;SEM» ol eumuljii^c C K ac-
liviiics cxpnss4.ll as pca"crnut'» rel:iu*c to llic C K uclnilv UL^umi*-
b l r d in the pcrfuuie in Ihc 15 min equilihmiion period tvforc the C O 
exposure (wc MateriaU and methods). Note that the t i m » indicuted 
rrprricni (he mid-point of ihc period over which ihe p»;rlu.*;iic fnniion 
M-ns eollccEed. The uur/ show* ttu: time cntirwi foi three individii:il 
hearti exposed to 0.01% C O . 
control hearts and 31.4 ± 6..'^  lU/g wet tissue ( ± S E M , 
n = 10) for hearts exposed to CO. These values are not 
signiticantly dilTerenl (P = 0.29) and there is no corre-
lation between cumulative CK activity in the perfusate 
and ventricular glutathione content. 
For individual control hearts there was a uniform 
exponential decrease in CK activity in the perfusate with 
lime; hence, the mean cumulative CK data shown in Fig. 
2 for the control hearts can be filled well with a single 
exponential rise to a maximum. However, this is not the 
case for the mean cumulative CK data for ihe hearts 
c.tposed to 0.01% CO. Moreover, the mean data obscure 
a variety of responses that individual hearts showed lo 
the CO perfusion. This is illustrated in the inset in Fig- 2. 
Individual hearts showed (a) no CO-induced tissue in-
jury (3 out of 10). (b) CO-induccd injury, i.e.. an in-
crease in the rate o f accumulation of CK. at the 
beginning of the exposure to CO (2 out of 10). (c) injury 
shortly after the end of the exposure to CO (3 out of 10). 
or (d) injury both at the beginning and shortly after the 
end o f the exposure to CO (2 out o f 10). f n all cases the 
cumulative L D H activity in the perfusate showed the 
same pattern of behaviour as that shown by cumulative 
CK activity (data not shown). 
Since there was evidence for some tissue injury at the 
beginning and shortly after the end o f perfusions with 
CO. it was of interest to find out when the CO-induccd 
depletion of glutathione occurred in relation to this. 
Furihcr information was gained by measuring the glu-
tathione levels in ventricles f rom hearts where the per-
fusion was stopT>ed immediately after the equilibration 
period, before exposure (i.e., at / =s 0) or immediately 
after the CO exposure (i.e.. ai i= 30min). The results 
from these arc summarised in Table I . The CO-induccd 
depiction seems to have occurred post-exposure. In the 
controls there w-.is a significant decrease (26%; 
P = 0.0O4) in the total glutathione content of the ven-
tricles over 120 min of perfusion: most of this seems lo 
have occurred within the first 30 min. This was mirrored 
by a 3.9-fold increase (P = 0.0004) in GSSG content. 
Although there was also depletion o f total glutathione 
during ihe 30 min exposure to 0.01% CO, this was no 
greater than that seen in the control. 
Tabic 1 also shows a comparison of the lactate con-
tent of ventricle tissue from hearts exposed to 0% and 
0.01% CO: there is no significant difference in the lactnie 
content cither immediately post-exposure or 90 min 
post-exposure, implying at the lack o f CO-induced tissue 
hypoxia. 
Discussion 
In this study the perfused isolated rat heart model 
was used to evaluate whether oxidative stress during or 
after CO exposure may contribute to the cardiotoxicity 
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39,3 ± 1,6 {n •= 3) 17.7 ± 2 . 0 (n = 10) 
Aore. r&oiulcJ rai hcuris wcrccxp*»cd lo 0% or 0.01% C O for 3Umin follottcil b> a OfPmin CO-frec period, with 21% oxygen prcscoi ihroughoui. 
la Mtme petfiftkm ui^ppiM c n m o l u i e h alirt the u i d u l cqoilitKation pcnnd M m nposura to C O <r = 0 ) and m otben il n-as sopped 
ensmliaut) - after i f c C O cxpusunr (/ - JOmin. imnialratd; pusK^ptnurct . T h c i l a U J K T W U en n c a m ^ S E M . The hatched tjinbots u n ^ 
nsicr i^k^C). double a s i c r i i L s t " ) , anil i r i p t nwcrttk* f ' t indicate Mgnificyni difference* al ihc 80%. 90%. 9 5 V and 9?X. confidence levels bciwixn 
values and ihc appropriate value ni f = 0. 
d ' C O . To do this ihc ventricle glulailiione pool, a major 
componcni in cnrdiac uniioxidant defence [ 5 1 . was 
monitored. Our key finding is that CO induces a dose-
dcpendeni dcplciion o f both oxidised (GSSG) and 
reduced (GSH) gluiathione (Hig. l A ) . most of which 
appears to occur post-exposure {Toble I) . 'I"hc decline in 
glutathione levels suggests thai oxidative stress occurred 
as a result of the CO c.\posurc. Oxidative stress arises 
from excess production of oxidants (such as reactive 
oxygen species: ROS). or a compromise in anlioxidani 
defences, or both [4]. 
To determine i f ROS w-crc responsible for the de-
pleted glutathione levels following CO exposure, heart 
perfusions were conducted in the priscncc o f two waltr-
solubte antioxidants. The use of the vitamin K analog 
Trolox C and uscorbuie is well-<:stablisheil |4). These 
antioxidants preserved uluiathionc levels in hearts ex-
posed 10 0.05% CO (Fig. IB). Although the gluiathione 
pool was not entirely protected this finding strongly 
suggests that additional ROS were producinJ as a result 
of CO exposure. The evidence (Table 1) suggests that 
most, i f not all . of the decline in glutathione levels oc-
curred after the CO exposure. Hence, the level o f pro-
tection of the glutathione pool nITarded by the 
antioxidants could perhaps have been improved i f they 
had been present in the perfusion buffer ihroughoui. 
rather than before and during the CO exposure. 
)£xposurc to 0.01% CO did not result in a stoiistically 
.•^ignificani increase in mean cumulative creatine kinase 
(Pig. 2) or lactate dehydrogenase (not shown) activities 
in the perfusate at any poini in the perfusions, although 
with most individual hearts some tissue injury was seen 
immediately after the start and/or shortly after the end 
of Ihc perfusion with 0.01"/.. CO. Hence, the loss of 
lilutaihionc iippears to arise from iis function either as a 
single antioxidant or as part o f tlie network of inira-
cellubr aniioxidanis [5] r j iher than us the result o f non-
specific leakage via widespread tissue damage. It is 
likely, therefore, that the glutathione depletion occurs 
by oxidation of GSH followed by loss of GSSG into the 
perfusate [ 9 1 . 
The depletion of glutathione afier the CO exposure is 
reminiscent of the loss of intracellular antioxidants 
during reperfusion after iscliaemia [5J. where a key event 
is thought to be excess ROS production by mitochondria 
during the rcperfusion (lO]. The binding of carbon 
monoxide to myoglobin (Mb), which is obiindant in the 
myocardium, can limit the supply o f O j for use by the 
electron transfer chain (ETC) and hence cause hypoxia 
[\\. However, at the concentrations o f C O and 0> used 
here levels of carboxymyoglobin (MbCO) should be 
negligibtc. Using N M K signals Glabc ei at. (1 If found an 
intracellular partition cocfTicieni between CO and O; of 
36. On this basis MbCO:MbOj ratios (equal to 
PCO/PO; y .^ 6) of 0.017 and 0.086 can be calculated at 
the concentrations of CO used here (0.01% and 0.05%. 
respectively). Glabe ct al. found only evidence, in the 
form of an increase in lactate production, of inhibition of 
ihc mitochondrial ETC when M b C O : M b O i ratios were 
in e.\cess of about 1.5. Consistent with this, we found no 
evidence for elevated lactate levels in ventricle tissue 
immediately after perfusion with 0.01% CO f f ab l e I ) . 
Zhang and Pianiudosi [3] have observed oxidative 
sire.is associated with mitochondria after exposure of rat 
binin lo CO. However, ihey used a much higher con-
centration o f CO (1%) than that used here, sunkienl. on 
the basis of their previous work, lo cause inhibition of 
cytochrome-r oxidase. Hence, their experimental con-
ditions are somewhat analogous to those found during 
ischaemia/reperfusion, so the decrease in the mito-
chondrial GSSG:GS^I ratio that they observed af^er C O 
exposure is perhaps not surprising. However, this raises 
the question of why in our work there is evidence for a 
substantial decline in total glutathione as a result of CO 
exposure, when there is apparently no CO-induccd hy-
poxia during the exposure. 
An interesting observation made by Zhang and 
Piantadosi [3] is that there were two episodes of CO-
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induced o.ttdative stress as indicated b y decreases in the 
mitochondrial G.SHiGSSG r j i i o , one scvn juM after the 
CO exposure and another, more severe episode. 120min 
alter the end oi ' ihc CO exposure. .Soinewhai similar 
behaviour was seen in our experimcnls; when prcsenl. 
(issue injury was seen jusi alter ilie slari o f (he CO ex-
posure andJor lagging after the e n d of the CO exposure 
(Fig. 2. insei). The lag o fa t least lOmin after ihe end of 
CO exposure, before the appearance of tissue injury, is 
consistent with the s l o w in vivo dis.sociatjoii of CO from 
the myocardium; a rale constant of 1.16 x 10 ' s ' has 
been reported tor this dissociation | l l ] . This suggests 
that the CO:0; ratio is an imporiani factor here. i.e.. 
lh.ii the CO-induccd ROS prodiiciion that leads to de-
pletion of the glutathione pool (and sometimes lo tissue 
injury) may occur unly at low C 0 : 0 : ralio^, seen inui-
sienily just alter (he start of the perfu-sion. us the CO in 
the perfusion buffer cquilibra(es w i t h the heart ( I -
I,5inin). and agjiin after (he end of the (K'rru<iion as the 
CO dissociates. 
The cellular componcntl.s) wiih which the CO is in-
tcniciing lo induce (he K(^S production is unknown. 
One possibility is ihal cytochrome-f oxidase is involved. 
Significant inhibition o f cytochromc-r oxidase by CO in 
our exixrrimenls can be ruled oui becau-^ the C 0 ; 0 : 
ratios arc too low [1]. However, cytochromc-r oxidase 
can also catalyse ihe oxidation of CO b y oxygen to C O j . 
i.e.. i i has CO oxygenase activity | )2.I3 | , and this ac-
tivity may invoKc the release of hydrogen peroxide from 
(he enzyme (o complete the catalytic cycle [1.^.141. 
Another candidate for the site of CO-indiiced ROS 
production is .\anihine oxidase. Thom (151 has already 
established that (he conversion ol'xanihtnc dehydroge-
nase (o xanthine oxidase, and (he consequent produc-
tion of ROS via xanthine oxidase activity, can account 
for (he l i p i d peroxida(ion seen after exposure of ml 
brain lo CO [2). This is consistent with the idea that CO 
lo .Mcity "is a type of post-i.schaemrc repcrfusion phe-
nomenon" [15]. since a role lor xanthine dehydrogenase 
lo o.xidase conversion has been implicaied in rcperfusion 
(reoxygcnaiion) injury after ischacmia (4). However, in 
our cxpcnmcnls there i s no CO-iildiiced hypo.\ia. su 
there appears lo be n o chain of events (ha( cuuld lead lo 
the dehydrogenase to o .Kidasc conversion. Nevertheless, 
given the faci thai xanthine dehydrogenase is part of the 
same family of molybdenum-cofactor-coniaining en-
zymes (ha( includes bacterial CO dehydrogenases [ I6 | . 
there still remains the possibility that the CO-mduced 
ROS produciion comes from a direct mtcraction be-
tween CO. O;. and .xanthine dehydrogenase 
In conclusion, while it is clear that oxidative stress 
has a role in CO cardiotoxicity i i is questionable whe-
ther this always arises as a result of reoxygenaiion fol-
lowing CO-induccd tissue hypoxL-i. The indications here, 
and elsewhere with ni l brain (3|. that oxidative injury/ 
stress occurs during exposure to CO as well as post-
exposure suggest a more direct mechanism of CO-in-
duced ROS proilnciion that remains to be elucidated. 
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